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As more and more microbes develop resistance to conventional antibiotics and the decline
in the approval of new antibiotics in recent years, there is an increasing need for research
on identification and design of new therapeutic alternatives. As a result, antimicrobial
peptides (AMPs) are becoming one of the most promising alternative options to target
pathogens without developing resistance. It is known that AMPs inactivate
microorganisms by forming transmembrane pores in cell membrane through adsorption
and aggregation. Understanding the detailed mechanism of inactivation by AMPs is
necessary for developing new agent for antimicrobial treatment. This study mainly
investigates antimicrobial peptides from four aspects: (i) the action of AMP melittin on
lipid bilayer through molecular dynamics (MD) simulation, (ii) identification of AMPs
from soy protein 7S globulin, (iii) interaction between curcumin and lipid bilayer through
both MD simulation and varied experiments, and (vi) comparison of fluorescence dye
leakage from liposome by melittin and its mutants.
The first part of the study investigated the interaction of multiple melittin peptides with the
lipid bilayer. Melittin is a naturally occurring antimicrobial peptide that has the ability to
kill bacterial cells through cell membrane penetration leading to pore formation. In this
investigation, all atom molecular dynamics (MD) simulation has been carried out to
describe the interaction of 2,4 or 6 peptides placed on the surface of 3:1 ratio of 1,2-

xxv
Dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-di-(9Z-octadecenoyl)-sn-glycero3-phospho-(1'-rac-glycerol) (DOPG) lipid bilayer (a mimic of bacterial cell membrane)
corresponding to protein-lipid (P/L) ratio of 2/96, 4/162 or 6/166 respectively. MD
simulation was also carried out for (i) 1-8 transmembrane peptides (corresponding P/L ratio
of 1/128 to 8/128) in a 3:1 ratio of DOPC/DOPG mixed membrane for symmetric as well
as asymmetric placement of peptides and (ii) 4-8 transmembrane peptides (corresponding
to P/L ratio of 4/128 to 8/128) for pure DOPC lipid bilayer (a mimic of mammalian cell
membrane) for asymmetric placement of peptides. This study also quantified the potential
of mean force through molecular dynamics (MD) simulation for the addition of melittin
into DOPC/DOPG mixed bilayer, a mimic of bacterial membrane, for different extents of
insertion into either a bilayer or a pore consisting of three to six transmembrane peptides.
Critical P/L ratio of 6/166 was observed for penetration of melittin from the surface with
this critical value being 6/128 for water channel formation in case of transmembrane
peptides. The energy barrier for insertion of a melittin molecule into the bilayer was highest
in the absence of transmembrane peptides and decreased for number of transmembrane
peptides from three to six, eventually approaching zero. The decrease in free energy for
complete insertion of peptide was found to be higher for larger pore size. Significant water
channel formation could be observed only for larger membrane pores. The structure of the
pore was found to be toroidal and paraboloid. The prediction of proposed mathematical
model agreed fairly well with the computed PMF profiles.
The second part of the study proposed a methodology that is based on mechanistic
evaluation of peptide-lipid bilayer interaction to identify AMPs from soy β-conglycinin
(7S) subunits. Initial screening of peptide segments from soy β-conglycinin (7S) subunits

xxvi
was based on their hydrophobicity, hydrophobic moment and net charge. Delicate balance
between hydrophilic and hydrophobic interactions is necessary for pore formation. High
hydrophobicity decreases the peptide solubility in aqueous phase whereas high
hydrophilicity limits binding of the peptide to the bilayer. Out of several candidates chosen
from the initial screening, one peptide (coded as 7a16) satisfied the criteria for
antimicrobial activity, viz. (i) lipid-peptide binding in surface state and (ii) pore formation
in transmembrane state of the aggregate. This method of identification of antimicrobial
activity via molecular dynamics simulation was shown to be robust in that it is insensitive
to

initial

structure.

The

antimicrobial

activity

of

this

peptide

against L.

monocytogenes and E. coli was further confirmed by spot-on-lawn test.
The third part of this research studied the interaction between curcumin (CUR) and lipid
bilayer. CUR is a widely used natural food ingredient with known ability of targeting
microorganism cell membrane, but the detailed mechanism remains unclear. In this study,
the interaction of CUR with different types of model lipid bilayer (1-palmitoyl-2-oleoylsn-glycero-3-phosphoethanolamine

(POPE),

1-palmitoyl-2-oleoyl-sn-glycero-3-

phosphoglycerol (POPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), and 1,2-dipalmitoyl-sn-glycero-3phosphoethanolamine (DPPE)), mixture of model lipid bilayer (POPE/POPG with ratio of
3:1), and realistic biological membranes (E. coli and yeast) were investigated by all atom
explicit solvent molecular dynamics (MD) simulation over microseconds. CUR readily
inserts into different types of model lipid bilayer system in liquid state within the first two
hundred nanoseconds of the simulation, staying in the lipid tails region, near the interface
of lipid head and lipid tail. Parallel orientation to the membrane surface is found to be more

xxvii
probable than perpendicular orientation for CUR as indicated by the tilt angle distribution.
This orientation preference is less significant as the fraction of POPE is increased in the
system, likely due to the better water solvation of perpendicular orientation in POPE
bilayer. In E. coli and yeast bilayers, tilt angle distributions were similar to that for
POPE/POPG mixed bilayer. Water hydration number around CUR in these more realistic
bilayers is higher than the corresponding value for POPE/POPG bilayer. In this part,
antimicrobial activities of CUR against L. monocytogenes and E. coli were validated using
bioassay, viability assay, transmission electron microscopy (TEM), and fluorescence dye
leakage experiments. CUR exhibited antimicrobial activity when dissolved in
dimethylformamide (DMF). The minimum inhibitory concentration (MIC) of CUR against
L. monocytogenes was 78 µg/mL, and the MIC of CUR against E. coli was 156 µg/mL,
these values fall in range of reported MIC of CUR. The TEM images indicated CUR may
target these two bacteria with different mechanisms: CUR attacked the gram-positive
bacteria by disrupting both cell wall and cell membrane, and deactivated the gram-negative
bacteria by solubilizing the cell membrane. PMF profiles illustrated an energy barrier for
CUR permeated through the bilayer center, which is consistent with CUR density
distribution. Existence of multiple CUR molecules inside lipid bilayer could promote
permeation of CUR through bilayer center.
The last part of the study compared the fluorescence dye leakage of 1,2-Dimyristoyl-snglycero-3-phosphocholine (DMPC) / cholesterol liposome induced by melittin and its
mutants. The results indicated: (i) dye leakage is dependent on the concentration of peptide,
whereas a critical peptide concentration is needed for pore formation, (ii) a lag time is
needed for pore formation above the critical peptide concentration, which implies that pore

xxviii
formation occurred by nucleation, and (iii) the changes of fluorescence intensity are
consistent with the antimicrobial activities of these peptides. This technique not only
captures the nucleation of pore formation, but also describes the event of growth of pore
size. In addition, the balance between net charge and hydrophobicity is essential for design
of appropriate pore forming peptides.
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1. INTRODUCTION

1.1

Research Motivation

The evolution of pathogenic bacteria has allowed many microbes to develop resistance
mechanisms against conventional antibiotics 1, and this leads to a growing search for new
therapeutic alternatives. As a result, antimicrobial peptides (AMPs) are becoming one of
the most promising alternative options to circumvent the proliferation of antibiotic resistant
pathogens. AMPs are produced from a variety of organisms and have a broad and
nonspecific antimicrobial activity, the antimicrobial mechanism of AMPs is by disordering
and permeabilizing the cell membrane, which is believed that the AMPs are less likely to
promote bacterial resistance compared to the use of antibiotics 2.
Natural occurring AMPs are expensive, limited, and some of them are suffering the toxicity
issues. Producing AMPs from common natural sources, such as soy protein, is therefore
attractive. Soy protein is a good resource of protein, which is abundant, cheap and very
easy to get, even 10% replacement of antibiotics will produce a great value in marketing.
Majority of the existing AMPs prediction methods are based on existed AMPs database
and therefore lack of limited correction. A methodology needs to be developed for
identification of AMPs from natural protein sources.
Although a lot of research focus on the mechanism of AMPs action on cell membrane, the
atomic details still remain unclear. Understanding the interaction between AMPs and cell
membrane will provide insights on designing synthesis AMPs to replace antibiotics. There
is considerable value in logically designing synthetic peptides (SP) with less toxicity to
specific microorganisms thereby avoiding or reducing costs associated with empirical
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selection. In order to better design SP for specific microorganism, it is necessary to
understand the mechanism of permeabilization of cell membrane.
Polyphenolic molecules are another group of antimicrobials. It has been shown that these
types of molecules may also target microorganism by altering properties of cell

3-5

.

Curcumin (CUR), as a classic polyphenolic molecule, has been reported to exhibit broadspectrum antimicrobial activity and multi-anti properties. Cumulative studies have shown
that CUR possess the ability of disrupting bacterial cell membrane, whereas the detailed
interaction information is still adequate. The study of interaction between CUR and cell
membrane will provide insights on the atomic interaction and shed light on designing more
novel antimicrobial drugs that target cell membrane.

1.2

Objectives

The following objectives will be pursued in this research:
1. Molecular dynamics study of pore formation by melittin in 1, 2-Dioleoyl-snglycero-3-phosphocholine (DOPC) and 1, 2-di-(9Z-octadecenoyl)-sn-glycero-3phospho-(1'-rac-glycerol) (DOPG) mixed lipid bilayer to characterize both binding
and transmembrane state of the peptides on cell membrane.
2. Potential of mean force for insertion of antimicrobial peptide melittin into a pore in
mixed DOPC/DOPG lipid bilayer by molecular dynamics simulation to calculate
the free energy and characterize the structure of pore.
3. Identification of antimicrobial peptides from soy protein 7S globulin to demonstrate
a methodology and validation for identifying AMPs from soy protein.
4. Molecular insights of interaction between curcumin and different types of lipid
bilayers to investigate the effect of lipids on the behavior of curcumin.
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5. Pore formation of bacterial and liposome membrane by curcumin through a
combined experimental methods and molecular dynamics simulation.
6. Dye leakage of liposome induced by melittin and its mutants to compare the pore
formation efficiency of these peptides.

1.3

Organization of Dissertation

The description of research motivation and objectives for this research are presented in
Chapter 1. A literature review is presented in Chapter 2. The main chapters of this
dissertation (Chapter 3-8) are in manuscript format.
Chapter 3 presents a general MD simulation of antimicrobial peptide, melittin, interacting
with DOPC/DOPG mixed lipid bilayer. Both surface state and transmembrane state of the
peptide, effect of number of peptides, orientation of peptides in the pore, and distribution
of peptide will be discussed in this chapter.
Chapter 4 presents an umbrella sampling MD simulation to calculate free energy of
insertion of a melittin peptide into bilayer in the absence and presence of a pore. The free
energy change along reaction coordinate, comparison with different pore size, structure of
the pore, and comparison with a mathematic model calculation are presented.
Chapter 5 presents a methodology of identification of AMPs from soy protein 7S globulin.
The screening of peptides from protein sequences, MD simulation for binding and
transmembrane results, and validation of antimicrobial activity of identified candidates are
described in this chapter.
Chapter 6 presents the MD simulation of a single CUR molecule action on different lipid
bilayers, including six model lipid bilayers and two realistic membranes (E. coli and yeast).
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The insertion time, distribution, orientation, and hydration properties of CUR, as well as
the membrane properties comparison, are discussed in this chapter.
Chapter 7 presents the experimental results and MD simulation results for characterization
of pore formation and antimicrobial activity of CUR on lipid bilayer. In this chapter,
antimicrobial activity of CUR against L. monocytogens and E. coli, membrane disruption
property induced by CUR will be presented. In addition, two different membrane
disrupting mechanisms are proposed.
Chapter 8 presents the fluorescence dye leakage from liposome induced by melittin and its
mutant variants (G1I and I17K). The pore forming abilities, rate of pore formation, and
rate of dye leakage are compared in this chapter.
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2. LITERATURE REVIEW

2.1

Antimicrobial Peptides

Antimicrobial peptide (AMP) is a kind of peptide that can kill microorganisms by forming
pores in their cell membrane and leading cell leakage to death. AMP is also defined as host
defense peptide because of their essential role in constituting the innate immunity system
2, 6-8

. The very first AMP, named gramicidins, was isolated from Bacillus brevis since 1939

and was found to exhibit activity against a wide range of Gram positive bacteria

9, 10

.

Gramicidins were successfully used in treating the infected wounds on guinea-pig skin later
11

, indicating their therapeutic potential for clinical use, and were the first commercially

manufactured AMPs as antibiotics 12. In the following decades, AMPs became a research
focus when cecropin from moths 13, 14 and maganin form frogs 15 were characterized. Till
now, over 5000 AMPs have been discovered and raised numerous research interests
ranging from design 8, 16, 17, isolation 18-20, synthesis 21-23 to application 19, 24-26.
AMP has been shown with broad-spectrum antimicrobial activities against various
microorganisms, such as bacteria, fungi and viruses 6. They usually contain less than 50
amino acids and can be classified into different groups based on their properties.
Based on their amino acid composition, AMPs can be classified into five subgroups 27-31.
One subgroup of AMPs is short cationic peptides (less than 40 amino acid residues) without
cysteine residues. These kind of peptides are usually disordered in aqueous solution but
change into helical structure when exist in sodium dodecyl sulphate (SDS) micelles,
phospholipid vesicles and liposomes

30, 32

. Another subgroup of AMPs is anionic

antimicrobial peptides. These peptides are mostly used for host defense throughout the
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prokaryotic kingdom, and are produced by either of two biosynthetic routes: they may be
gene-encoded or manufactured by ribosome-independent pathways 33. The third subgroup
of AMPs is Cysteine rich AMPs. The first cysteine-rich peptides were human neutrophil
peptides HNP-1, -2 and -3 isolated from human granules 34. These α-defensins contain 30
amino acids and rich in cysteine residues. These cysteine residues could form disulfide
bridges, with most positions between C1–C4, C2–C5 and C3–C6 31. The fourth subgroup
of AMPs contains high numbers of regular amino acids. For example, Histatin, an AMP
isolated from human saliva, is rich in histidine residues and is active against C. albicans 35.
Cathelicidins are proline rich AMPs with irregular structures 36, while indolicidins 37 and
tritripticin

38

are rich in tryptophan. Another subgroup of AMPs is peptides with rare

modified amino acids. The bacteria themselves usually produce such peptides. Nisin, for
example, is one such peptide produced by Lactococcus lactis and is composed of rare
amino acids like lanthionine, 3-methyllanthionine, dehydroalanine and dehydrobutyrine 39.
Based on their secondary structure, AMPs can be classified into four families 40: alpha (α),
beta (β), alphabeta (αβ), and non-alphabeta (non-αβ). AMPs in α family mainly have helical
structures (e.g. cecropins and magainins), the β family consists of AMPs with beta-strands
(e.g. human α-defensins). The αβ family consists of AMPs with both α-helical and βstrands (e.g. β-defensins), while the non-αβ family (also referred to as extended structures
by others) contains neither α-helical nor β-strands (e.g. indolicidin).
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2.2

Mechanisms of Pore Formation by Antimicrobial Peptides

Generally, AMPs disorder the cell membrane of microorganism and form pores in the cell
membrane

2, 29, 41

, and three mechanism models described the pore formation of AMP in

the cell membrane: barrel stave model, carpet model and toroidal model.
In barrel stave model, the peptides adsorb onto the surface of the membrane first. After
binding to the lipid bilayer, the conformation of peptides changed, inserting their
hydrophobic residues into the membrane. At the same time, the phospholipid heads were
forced aside by the peptides which resulted in membrane thinning. When the surface
peptides reach a threshold concentration, multiple peptides would aggregate and insert
deeply into the lipid bilayer and form transmembrane pores. A barrel stave pore is
surrounded by peptides only and all the hydrophilic residues expose to the interior of the
pore 42. Alamethicin has been considered as a good example to describe such mechanism
43,

44

. Numerous experimental studies have been conducted to investigate its

physicochemical properties 45-48. The sequence of alamethicin (Ac-Aib-Pro-Aib-Ala-AibAla-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Glu-Gln-Phol)

contains

a

preponderance of a helical generic amino acid, namely α-aminoisobutyric acid (Aib). Also,
there is a proline close to the center of the molecule at position 14 and a phenylalaninol
residue (Phl) at C-terminal. Multiple Aibs make the alamethicin adopts α helical structure
easily whereas the presence of proline provides a central kink in the helix

49

. Both

experimental and simulation studies suggested that alamethicin adopt random coil structure
in the solution but change to α helical structure when adsorbed and inserted into the
membrane
dependent

49, 50
50, 51

. It was also found that channel formation by alamethicin is voltage

. The channels could switch the conductance levels rapidly (on a ~10ms
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time scale) in a wide range. These investigations provide us a better understanding of the
barrel stave pore mechanism.
In carpet model, a high density of peptides accumulates onto the surface of the target
membrane. The peptides then disrupt the membrane by orientating parallel to the surface
of the lipid bilayer and form an extensive layer like a carpet. When the surface peptides
concentration is high enough, membrane fluidity changes and the permeation of the
membrane occurs. Unlike barrel stave model, peptides in carpet model did not insert into
the membrane and they do not involve channel formation. Therefore, it is not necessary for
them to penetrate into the hydrophobic cell membrane core, it is also not required for them
to adopt a specific structure when binding onto the membrane surface 52, 53. Since the initial
driving force to the negatively charged cell membrane is electrostatic attraction, AMPs
using this mechanism were therefore positively charged. Dermaseptin natural analogues 54,
55

, cecropins 13, 14, the human AMP LL-37 56, caerin 1.1 57 are all good examples that can

describe this model. Both experiments and simulation studies have been employed to
investigate this mechanism. For instance, cecropin P1, derived from moth hemolymph,
appears to target microorganisms in this manner. FTIR spectroscopy reflected that initially
this peptide adopts a parallel orientation to the membrane and does not penetrate into the
hydrophobic environment. This orientation disrupts the packing of phospholipids and the
concentrated peptides result in final disorder of the cell membrane

58

. Likewise,

fluorescence spectroscopy results demonstrated that, to any significant degree, the
tryptophan-rich AMP indolicidin does not insert into the lipid bilayer 59. MD simulations
of Dermaseptin-B revealed that the lipid bilayer stabilizes the α-helical conformation of
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the peptide relative to simulations in vacuum, this result was also proved consist with FTIR
data 60.
Toroidal model is the one of the most well characterized peptide-membrane interactions 53.
The main difference between a toroidal pore and a barre-stave pore is phospholipid heads
taking part in the pore formation together with the peptides for the former one. In this
model, peptides, such as maganin and melittin, in the extracellular environment take an αhelical structure as they interact with the charged bacterial membrane. Helices are initially
oriented parallel to the membrane surface as confirmed by multiple experimental ways,
such as NMR, fluorescence quenching, and oriented circular dichroism 61. After adsorption
on the surface of the lipid bilayer, the hydrophobic residues of the bound peptides displace
the polar head groups and flip into the core region of the hydrophobic lipid bilayer, creating
a breach in the hydrophobic region and inducing positive curvature strain in the membrane
61

. When the peptide-to-lipid ratio reaches a threshold (e.g., estimated to be 1:30 for

magainin), peptides orient from parallel to perpendicular to the membrane. At this point,
peptides may begin to self-associate, such that their polar residues are no longer exposed
to the membrane hydrocarbon chains. This transient and multimeric composite forms the
dynamic peptide-lipid supramolecular or toroidal pore complex.

2.3
2.3.1

Effect of Charge, Hydrophobicity, Helicity on Antimicrobial activity of AMPs
Charge

Typically, natural AMPs are positively charged. It has long been recognized that, peptides
with positive charge could be attracted onto the negatively charged membrane of bacteria
due to electrostatic attraction. A lot of charge modification attempts have been made to
improve the antimicrobial activity or weaken the hemolytic activity. Krishnakumari V. et
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al found that increase of charge by replacing negatively charged residues with lysine could
improve the antibacterial activity

62

. Matsuzaki S.K. et al reported that replacement of

glutamic acid with glutamine could increase the positive charge of magainin and enhance
the antimicrobial activity 63. On the other hand, gradual reduction of the positive peptide
charge could result in a loss of antimicrobial activity, while the hemolytic activity was less
influenced or even increased as shown for magainin 63 and pardaxin 64. However, effect of
increasing the net charge is limited. Dathe M. et al presented that reinforcement of
electrostatic interactions had an activity-reducing effect on negatively charged lipid bilayer
65

. Other studies of designed AMPs showed that highly cationic peptides would even lost

the antibacterial activity and enhance the hemolytic activity 66, 67. Distribution of charged
residues also plays an important role on antimicrobial activity. Yin L.M. et al showed that
redistribution of positive charges by placing three lysine residues at both termini while
maintaining identical sequences would minimize self-aggregation and antimicrobial
activity of the peptide 68. Jiang Z.Q. et al also demonstrated that the number of positively
charged residues on the polar face is important for antimicrobial activity and hemolytic
activity 67.
Understanding how the charge of peptide effect the membrane affinity is important to
elucidate the mechanism of membrane permeabilization by peptide. The role of
electrostatic interaction in the binding membrane step has long been established. It was
found that an increase of magainin peptide concentration could enhance the negatively
charged membrane affinity; subsequently a specific interaction of positively charged
peptide with negatively charged membrane could be excluded 69, 70. Increasing affinity in
connection with enhancement of negative charge density of lipid bilayer was also reported

11
for cecropin P1 13, cecropin B2 71, magainin 72, 73 and melittin 74. In addition, some peptides,
for example magainin 2 amide, there exist a threshold for both their antibacterial and
hemolytic activity. Beyond this threshold, either increase or decrease the charge would
result in a decrease of antibacterial and hemolytic activity 65.
2.3.2

Hydrophobicity

The hydrophobicity of AMPs could reflect the capacity of peptide to move from aqueous
solution into a hydrophobic environment

75

, it’s calculated by average of the

hydrophobicity of each amino acid. Different hydrophobicity scale could be applied, such
as Eisenberg et al 76, Kyte and Doolittle 77, Rose et al 78, Janin et al 79 and Englemen et al
80

. Different scales usually based on different situations for amino acid, but their overall

classification for amino acid were similar. As a strong modulator of membrane activity,
peptide hydrophobicity has to fulfill two criteria to be an AMP: (i) the peptide should be
able to soluble in the aqueous solution even in high concentration so that the peptides will
transport to membrane efficiently, which requires peptide should have low hydrophobicity;
(ii) the peptides should be able to interact with the hydrophobic region of the lipid bilayer
so that the membrane disordered will happen, which require peptide should have higher
enough hydrophobicity. Since higher hydrophobicity will induce self-aggregation of
peptides and peptides with low hydrophobicity will have an insufficient lipid affinity, a
balance of hydrophobicity is therefore required for antimicrobial activity.
Several studies addressed the role of hydrophobicity on antimicrobial activity. Mee R.P. et
al investigated the hydrophobicity effect on a set of analogues of the antimicrobial peptide
CAMEL0, and concluded that hydrophobicity was, beside amphipathicity, the most
important feature for determining their antibacterial activity 81. Chen Y.X. et al tested the
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effects of peptide hydrophobicity on the mechanism of action of antimicrobial peptides
using the 26-residue amphipathic α-helical antimicrobial peptide V13KL, they found that
higher hydrophobicity was correlated with stronger hemolytic activity. But an optimum
hydrophobicity window existed for high antimicrobial activity, either increase or decrease
the hydrophobicity beyond this window would dramatically cause a decrease of
antimicrobial activity

82

. Yin L.M. et al also claimed that peptides designed with high

hydrophobicity (rich in leucine) would display strong self-association, antibacterial activity
and hemolytic activity 68. However, when Pathak N. et al studied the peptide derived from
magainin 2, they found that hydrophobicity was not as important as hydrophobic moment
for the antibacterial activity

83

. Other research even indicated there was no strong

correlation between hydrophobicity and antibacterial activity 84-86.
It needs to be noted that, modifying hydrophobicity of the peptide would sometimes result
in change of the other parameters, such as charge, hydrophobic moment or amphipathicity.
Various studies of AMPs-membrane interaction suggested that antimicrobial activity and
hemolytic activity were determined by a balance of peptide hydrophobicity and charge
distribution

65, 68, 87

. Although researchers tried to design model AMPs KLAL analogues

with varied hydrophobicity but keep other parameters unchanged, they still obtained a
strong correlation between hydrophobicity and antimicrobial/hemolytic activity, and the
relative influence on hemolytic activity was much higher than the antimicrobial activity 75,
87-89

.

2.3.3

Helicity and Hydrophobic moment

Helicity is defined as the fraction of helical structure in the whole peptide sequence.
Member-interacting AMPs with an amphipathic, α-helical conformation are considered to
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be one of the most important class of AMPs that can disorder and penetrate the lipid bilayer
32

. High helicity is one of the important features for this kind of AMPs. When helical

structure formed, peptide will have both polar and nonpolar faces, which allows them to
interact with the amphiphilic structure of the biological cell membrane.
It is well known that certain amino acids favor to form helical structure while others do not
90

. Thus, a variety of studies directed improving the antimicrobial effect by increase the

peptide helicity with substituting or deleting appropriate amino acids. For example, either
deleting glycine or replacing it with leucine in the N-terminal would increase the helicity
of melittin, and subsequently enhance the antimicrobial acitivity and hymolytic activity of
the peptide 91, 92. However, reducing the helix propensity by replacing lysine 7 with glycine
was shown little influence on either antimicrobial or hemolytic activity 93. Substitution of
glycine residues with alanine, which is a helix promoting amino acid, could highly enhance
the antibacterial and hemolytic activity of magainin

94

. The cell penetration ability of

buforin II and its analogs would significantly decrease when substituted leucine with
proline hinge, and their helical contents are also linearly correlated with the antibacterial
activity 95.
Later, more detailed research about the role of helicity on antimicrobial and hemolytic
activity transferred to the replacement of L-amino acids by their corresponding
enantiomers. It was found that helical structure of the peptide could be disturbed by
substituting L-amino acid with D-amino acid, and subsequently reduce the hemolytic
activity of the peptide

96

. Replacement of two neighboring residues with D-enantiomers

(double D-amino acids replacement set) in magainin would result in a decrease helicity and
reduce its penetration activity against both neutral and negatively charged lipid bilayer 97.
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On the other hand, Pathak N. et al used multiple linear regression to quantify the
dependence of hydrophobicity, hydrophobic moment and helicity on the antimicrobial
activity of peptides. They employed magainin 2 as model peptide and designed other
peptides with various parameters (hydrophobicity, hydrophobic moment and helicity)
based on it, their results showed that either hydrophobicity or helicity were not so important
as the amphiphilicity

83

. Hydrophobic moment is a quantitative measure of peptide

amphiphilicity, it is defined as the vector sum of the hydrophobicity of all the amino acids
in the peptide sequence 76. This term was originally developed to study protein folding 98,
but it was found to be applicable when describing the structure of membrane-interacted
peptide. A hydrophobic moment plot could be used to predict the membrane activity of
peptide helices, and it reflects the dependence of the hydrophobic moment per residue on
the mean hydrophobicity 99. It was found that peptide with transmembrane ability clustered
in a certain area, but this may be not enough to predict this correlation between hydrophobic
moment and activity. This is because: (i) calculation of hydrophobic moment is based on
an ideal helical structure of the peptide, and obviously, most peptide would not adopt an
100% helical structure even when they interact with the membrane; (ii) some AMPs, their
hydrophobic residues and hydrophilic residues were not regularly distributed in the
sequence, like melittin, its N-terminal part is more hydrophobic than C-termial, this would
result in a bias to predict their membrane penetration ability with hydrophobic moment
only.
To some extent, hydrophobic moment could still be a factor related to antimicrobial activity.
Dathe M. et al investigated the correlation between hydrophobic moment and membrane
activity using magainin 2 and its analogues, they found that the hemolytic and gram
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positive antibacterial activity of the peptide is increased with hydrophobic moment

87

.

Matsuzaki et al. did not observe a relationship between the hydrophobic moment and the
membrane permealization ability of several peptides (magainin, alamethicin, tachyplesin
and gramicidin S)

100

. This was understood because these peptides also have large

difference in other parameters, like hydrophobicity, overall charge, secondary structure of
peptides, etc. As more parameters involved in the consideration, the correlation between
these parameters and membrane lytic activity becomes more complicated.
2.3.4

Online predict tool for identification of AMPs

Due to limited production from natural resource, screening and designing novel AMPs
become a research focus in recent years. Involvement of computational approaches highly
accelerates the process of AMPs discovery and design101. Online predict tools therefore
provide a more convenient way for predicting new AMPs.
Different predict tools usually based on different bioinformatics properties. Comparison of
online tools is shown in table 1.
AMPs predict research has developed more than ten years. Most prediction methods are
based on large amount of validated AMPs, the number of peptides in these databases
ranging from 177~6750. Some databases are from the same resource, for instance,
ANTIBP and DBAASP built their databases from APD database. Some predict methods
aim to identify specific AMPs, such as ANTIBASE for bacteriocin, PhytAMP for plant
AMPs and DBBASP for linear cationic AMPs. The most frequently used predict
algorithms are Support Vector Machines (SVM), Sequence Alignment (SA) and feature
selection method. Nowadays, data training and testing method, such as MCC and jackknife
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testing, were employed to evaluate the accuracy of the predicted algorithms, most of them
were pretty high with over 70~90% accuracy.
APD 66, 102 may be one of the most popular predict online tool. AMP prediction of APD is
based on similarity and some known principles of AMPs. When users input a new peptide
sequence, the program will analyze the residues in this peptide. Based on the properties of
known AMPs, amphipathic helix is necessary for AMPS interacting with cell membrane.
Therefore, the program will predict an amphipathic helix if the hydrophobic residues
appear every two or three residues in the peptide sequence. Sequence alignment program
will compare the input sequence with existing AMPs in the database, and display the most
similar peptide sequences with similarity percentage.
CAMP

103

is another one of the most popular predict online tool. CAMP prediction

algorithm is based on statistical method and contains four basic steps: (1) Creation of
datasets. Both positive (antimicrobial) and negative (non-antimicrobial) datasets were
created, where the positive datasets include the experimentally validated AMPs and the
negative datasets include the UniProt database 104-106 without “antimicrobial” annotation.
(2) Calculation of sequence features. 257 sequence features, such as hydrophobicity,
polarity, charge, secondary structure, were computed for classification. (3) Prediction
methods. (3.1) Random forest (RF). RF uses an ensemble of trees for classification and
regression problems 107. (3.2) Support vector machines (SVMs). The original data can be
transformed into a higher dimensional feature space by means of SVM kernel functions 108.
Among the three kernel functions (linear, polynomial and radial basis), polynomial model
has a good performance and therefore be employed in this study. (3.3) Discriminant
analysis (DA). DA can predict each of the dependent variables from the group membership
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through linear combination of independent variables

109

, it uses stepwise selection

algorithm with backward elimination for variable selection. (4) Feature selection. To
eliminate the background noise and identify the most informative features, recursive
feature elimination (RFE) method based on RF Gini score was employed for classification.
The models accuracy was further validated using 10-fold cross, and Matthews Correlation
Coefficient (MCC) was used to balance of the performance of the algorithm. In RF
evaluation, 64 features showed the best performance and therefore were further used to
build the SVM and DA models for classification. The overall accuracy of CAMP predict
method was claimed to be higher than 85%.
LPredict

110

implemented two methods in the predict tool: the sequence alignment based

on the BLASTP

111

and the feature selection method with amino acid composition and

pseudo amino acid composition features

112

. For the BLASTP method, the input peptide

will be compared with training data set, and the high-score segment pairs (HSPs) will be
calculated by BLASTP with default parameters. For the feature selection method, amino
acid composition and pseudo-amino acid composition were employed to code the AMP
sequences. Statistical methods, namely Maximum Relevance, Minimum Redundancy
(mRMR) method 113 and Incremental Feature Selection (IFS) method, were further used to
optimize the AMPs features, Nearest Neighbor Algorithm (NNA) 114 is finally employed
to classify and build the complete model. Jackknife test was applied to test the accuracy of
the predict model. Based on the prediction model, amino acid composition plays very
important role for prediction. The accuracy of prediction method could efficiently increase
with integration of multiple methods.

18
CS-AMPPred

115

predicts

AMPs

based

on

an

updated

SVM

model

and

structure/physicochemical properties of AMPs. After constructing the data sets (positive
and negative data sets), nine properties were chosen for statistical analysis, including
average charge, average hydrophobicity, hydrophobic moment, amphipathicity, a-helix
propensity, flexibility and indexes of α-helix, β-sheet and loop formation. A principal
component analysis (PCA) was applied to get main feature descriptions of AMPs (average
hydrophobicity, average charge, flexibity and indexes of a-helix and loop formation). As
the authors mentioned in the paper, use of net charge shows a clear bias while hydrophobic
moment was proposed to solve this bias 116. But hydrophobic moment was not good enough
to be a main feature for prediction; therefore, use of this method must be used with the
cysteine patterns of cysteine-stabilized AMPs.
One of the future directions of research is to enhance the prediction accuracy. AMPs from
different area usually contain different features, and the accuracy of prediction algorithms
for AMPs heavily depends on the correctness and extent of information available in the
training datasets used for the study 103, therefore the prediction of particular AMPs, which
are from specific area, could be a future research trend. Combination of multiple selection
methods is another way to increase the prediction accuracy. Since it is not enough to predict
whether it’s AMP or not, another future research direction is to predict the specific
antimicrobial features, such as antibacterial, antifungi, antivirus, anticancer and so on.
Current web-based prediction needs to be improved and its performance be accelerated.
These prediction methods exhibit some drawbacks: The chemical–physical features of a
peptide that are more important for antimicrobial activity are still not clear. Although
APD2 and CAMP databases contain very general information about peptides of all types
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having antibacterial, antifungal or antiviral activities and originating from either eukaryotic
or prokaryotic cells, some specific AMPs, such as bacteriocins, are not described with a
useful amount of detail in either of these databases. Both APD and CAMP algorithms do
not classify AMPs based on their target-specificity. AntiBP training sets are limited to N
and/or C termini residues of antibacterial peptides (positive dataset) and non-secretory
proteins (negative dataset). The users are constrained to predict the antibacterial activity
for peptides that have to be at least 15 residues long. ANTIBASE and PhytAMP for AMPs
predictions is restricted to predict antimicrobial activity for peptides from required sources.
CS-AMPPred algorithm is limited to predict cysteine-stabilized AMPs. AMPA method is
unable to predict antimicrobial regions with a content of some specific amino acid, such as
proline or phenylalanine.

2.4

Molecular Dynamic Simulation

Molecular dynamics (MD) is the science that study the motions of particle system through
simulation method 117. It is a computer simulation in which atoms of a molecule are allowed
to move according to Newtonian mechanics under the constraint of interatomic forces. It
has long been applied to various biological molecule systems to investigate the atomic
details of the trajectory movement and the interaction between molecules as a function of
time. MD simulation can address some specific questions about the properties of a model
system, while it is not easy for experiment or actual system study. Many biological
functional details are of interest, for instance, how do AMPs form pores in lipid bilayer?
Although circular dichrosim experiment could obtain different state of peptides in the
membrane, it is still not clear about the detail of structural change of specific amino acids
118

. Therefore, computer simulation acts as a bridge that connects microscopic length and
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time scales with the macroscopic world of laboratory: we come up with an idea at
interactions between molecules based on experimental results, and employ MD simulation
to figure out the hidden detail behind the bulk measurement. MD simulation, on the other
hand, could provide the localized structural change of peptide when interacting with lipid
membrane at atomic level. Another significant aspect of MD simulation is, the potentials
applying on the molecules are completely under users’ control, which means, some specific
contributions to the system can be examined by adding or removing them. This is mostly
demonstrated by using ‘computer alchemy’, which is transmuting the potential from that
representing one system to another during a simulation, in the calculation of free energy
difference 119.
2.4.1

History, basic theory of MD simulation

In the late 1950’s, Alder and Wanwright were the first one who performed MD simulation
to study the interactions of hard sphere systems 120. Great concerns about the behavior of
simple liquids were raised up from their studies, and later in 1964, Rahman firstly
performed simulation with a realistic potential for liquid argon

121

. Following in 1974,

Rahman and Stillinger carried out the first simulation in liquid water

122

. The first

simulation on protein was reported in 1977 which is performed by McCammon JA et al,
they simulated the bovine pancreatic trypsin inhibitor (BPTI) in vacuum for 9.2ps in the
system

123

. By comparison, current simulation has greatly expanded, the systems often

include 104-107 atoms (instead of 500 atoms) and simulation time are usually 100-500 ns
for all-atom simulations, or even over microseconds for coarse-grain simulations. In
addition to the longer performance of the computation, multiple and parallel runs allow the
simulations more accurate with statistical errors.
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Since the first paper from the Karplus lab, over millions of MD simulations have been
carried out in the laboratories of Berendsen (one of the pioneers in molecular dynamice,
the one who has developed GROMACS) 124-126, Brooks (who has developed CHARMM)
127-129

, Kollman (who has developed AMBER and contributed in application of free energy

simulation) 130-133, Schulten (who has developed VMD and NAMD) 134-136, Gunsteren (who
has developed GROMOS force field)

137-139

, Jorgensen (who has developed OPLS force

field and contributed in free energy simulations) 140-142, Daggett 143-145, Pande 146-148, Baker
149-151

, McCammon 152-154, Levitt 155-157, and others. Several reviews 158-161 have discussed

earlier work in this field. The discussion here focuses on techniques to solve the classical
equations of motion.
MD simulation not only get the motion of the molecule, but also can provide the potential
energy as a function of the atomic coordinates. MD simulation consists of the numerical,
step-by-step, solution of the classical equations of motion, which can be written as:
� (� ) = −∇�(�)
Where � is the force acting on the atoms, � is the potential energy and � represents the set
of atomic coordinates. A typical molecule usually contains different type of atoms, and
multiple atomic interactions need to be considered, the energy functions used for proteins
are generally composed of bonding terms including bond lengths (�), bond angles (Θ) and
torsional angles (Φ), and non-bonded terms representing van der Waals interactions and
electrostatic contributions. The widely used expression 162 can be written as:
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Where E is the energy, a function of the Cartesian coordinate set. The first term in the
equation represents the instantaneous displacements from the ideal bond length �T by a
Hooke’s law (harmonic) potential. The bond force constant �S determines the flexibility
of the bond and can be evaluated from infrared stretching frequencies or quantum
mechanical calculation 117. This term is the first approximation to the energy of a bond as
a function of its length. The second term, which represents the bond angle energy, is also
calculated by a harmonic potential. The torsion angle potential function is given as the third
term in the equation. This potential is assumed to be periodic and calculated by a sum of
cosine functions. The last term is the expression represents the contribution of non-bonded
interactions and contains three parts: a repulsive term preventing atoms from
interpenetrating at very short distances, an attractive term accounting for the London
dispersion forces between atoms, and an electrostatic term that is attractive or repulsive
depending on whether the charges �h and �U are of opposite or the same sign. The first two
non-bonded terms combined to give the van der Waals radii of the atoms, where the third
non-bonded term is the electrostatic contribution. Parameters A and B depend on the atoms
involved and can be determined by various methods, D is a Coulomb potential with the
effective dielectric function for the medium and r is the distance between the two
atoms/charges.
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There are several approaches to perform simulation after given the potential energy
functions. The molecular dynamics algorithm in most common use today may even have
been known to Newton

163

. To begin a MD simulation, an initial atomic coordinates and

velocities are required. The coordinates can be obtained from either experimental data (Xray crystallographic or NMR structure) or model-building. After setting up the initial
coordinates, the structure needs to be refined by using a minimization algorithm to relieve
local stresses due to overlap of non-bonded atoms, bond length distortions and so on. Next
step is to assign velocities to atoms at random from a maxwellian distribution for a low
temperature, and gradually heat the system to a higher temperature. One thing needs to
emphasis is that heating procedure should be in stages, because this can reduce the chance
of blow up for the system when allow it to equilibrate at each temperature

164

. Long

equilibration is the final step for molecule generating coordinates and velocities of the
atoms as a function of time.
2.4.2

MD simulation of AMPs and lipid bilayer

Research of interaction of AMP with lipid bilayer could be divided into two major parts.
The first one cares more about the configuration properties of AMPs while the other is
more interested in the membrane properties that altered by AMP.
It is well known that most AMPs adopt either helical or sheet structures when they bind to
membranes, while some AMPs appear to random structures both in aqueous and lipid
environments, such as B2088 (one of the dimeric peptides) 165 and 7s16 (one of soy protein)
166

. Therefore, conformation change of AMP from aqueous solution to bilayer surface

through MD simulation is a major studied aspect. In fact, a lot of AMPs such as cecropin167,
melittin168, alamethicin169, piscidin170 and other novel AMPs

171, 172

were shown with the
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ability of forming helical structure parallel to the bilayer surface for binding. The
conformation structures obtained from MD simulations could be verified by solid-state
Nuclear Magnetic Resonance (NMR) 170, 173 and Circular Dichroism (CD) 174 studies. The
helical structure formation on bilayer surface could be attributed to the sequence and
distribution of amino acids: helical structure could result in an amphiphilic structure with
hydrophilic residues facing one side and hydrophobic residues facing the opposite side.
Binding of the peptide onto the surface of lipid bilayer could induce the hydrophobic
residues embedded into the bilayer firstly, which has been validated by multiple studies 170,
175, 176

. In addition, some non-natural AMPs could also bind onto the lipid bilayer, with a

separation configuration of hydrophobic and hydrophilic residues at the bilayer surface 177.
After binding onto the bilayer surface, AMPs will then aggregate or penetrate the lipid
bilayer. Since the details during this procedure remains largely unclear, it motivated a lot
of research to investigate multiple AMPs peptides interaction within lipid bilayer, or
behavior of AMPs in transmembrane state. The situation became more complicated when
multiple peptides were involved into the bilayer system. Therefore, it was not surprising
that simulations have been performed in different ways. Baul U el al

178

investigated the

interaction of multiple antimicrobial polymers with model lipid bilayer through MD
simulation. They put a stable aggregate with four polymers above one of the bilayer leaflets,
their results showed that the individual polymers in the aggregate are released into the lipid
bilayer, by adopting facially amphiphilic conformations other than helical structure. Sun F
el al studied the AMPs assembling on membrane interface by using MD simulation

179

.

What they did is, performing MD simulation by placing multiple (15-40) peptides either
above or on the surface of lipid bilayer. For the peptides initially above the bilayer, the
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peptides will aggregate and bind to the lipid bilayer; for the AMPs initially binding on the
surface of lipid bilayer, the peptides will diffuse together by forming aggregate, and disrupt
the cell membrane at the same time. They also employed AFM and Confocal fluorescence
leakage experiments to validate their proposed mechanism. Both their experimental and
MD results suggested that membrane disturbance was cooperation of the membraneinserted and the periplasmic peptides. As more peptides are involved, it cannot ignore that
the systems are becoming larger, which make the simulation more expensive. As a result,
coarse-grained (CG) MD simulations has been employed when the research focus is on a
larger picture of peptide-membrane interaction. For example, Nawae W et al 180 used CG
MD simulation to gain further insight into the membrane disruption ability of AMP Kalata
B1. They found membrane disruption occurs at higher peptides concentration, and the
membrane disrupted by forming positive curvature. Santo, KP et al studied the pore
formation on DPPC/POPG lipid bilayer by melittin using CG simulation, their results
indicated the peptides assembly on the surface first, followed by peptide insertion and pore
formation 181.
The important role of lipid on the mechanism of membrane targeting AMPs have been
reviewed by Epand RM et al 182. They highlighted several important lipid components that
was favored for AMPs binding, such as Cardiolipin (CL) and Phosphatidylethanolamine
(PE). Berglund NA el al investigated the interaction of the antimicrobial peptide,
Polymyxin B1 (PMB1, sequence: DABC – Thr – Leu – DPhe – DAB – DABC – DAB –
Thr – DAB - CO(CH2)4CH(CH3)CH2CH3 where DABC represents the cyclic linkage,
DPhe represents D-Phenylalanine, and DAB represents α, γ-Diamino Butyric acid) with
complex models of both the inner and outer membrane of E. coli to address the effect of
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different compositions on the interaction mechanisms of AMP and membrane183. They
found that PMB1 is likely to interact with membranes via distinct mechanisms: the PMB1
peptides will form aggregates on the top of upper leaflet of the outer membrane, which
contains lipopolysaccharides (LPS); the PMB1 will insert into the inner membrane by
dragging water molecules into the lipid tails region. Their research showed the important
role of lipid compositions in the interaction mechanism of AMP and lipid bilayer.
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3. MOLECULAR DYNAMICS STUDY OF PORE FORMATION BY
MELITTIN IN 1,2-DIOLEOYL-SN-GLYCERO-3PHOSPHOCHOLINE (DOPC) AND 1,2-DI-(9ZOCTADECENOYL)-SN-GLYCERO-3-PHOSPHO-(1’-RACGLYCEROL) (DOPG) MIXED LIPID BILAYER

3.1 Introduction
Antimicrobial peptides (AMP) have the ability to penetrate cell membrane and kill the cell
by cell membrane rupture. They are a unique and diverse group of molecules, which are
divided into subgroups on the basis of their amino acid composition and structure 184-187.
They are mostly amphiphilic with a net positive charge

188

. Pore formation by AMP in

phospholipid bilayers begins by electrostatic attraction followed by attachment and
penetration of the cell membrane and has been subject of several investigations

189-193

.

Experimental techniques such as fluorescence 194, oriented circular dichroism 191 and NMR
195

spectroscopy, x-ray crystallography

191

have been employed to monitor the pore

formation, secondary conformation of AMP, orientation of AMP as well as the lipid and
thinning of the membrane.

Several studies of pore formation by AMP on model

membranes has elucidated different mechanisms of pore formation such as hydrophobic
(barrel-stave) pore, hydrophilic (toroidal) pore or micelle formation (carpet mechanism)
and has helped identify key factors that control pore formation. Peptides have been shown
to bind in two physically distinct states. At low peptide/lipid ratios, they adsorb and embed
into the lipid head group region in a functionally inactive state (referred to as the surface
or S state) that stretches the membrane 196. The extent of membrane thinning is specific to
the peptide and directly proportional to the peptide concentration. At high peptide/lipid
ratios, peptide molecules are orientated perpendicularly and insert into the bilayer, forming
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transmembrane pores (referred to as the I state). The I state peptide/lipid ratio varies with
both the peptide and target lipid composition 191.
Melittin is a much investigated antimicrobial peptide from the venom of European
honeybee

(Apismellifera).

It

contains
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amino

acid

residues

(GIGAVLKVLTTGLPALISWIKRKRQQ), which are predominantly hydrophobic in the
amino-terminal region whereas the carboxy-terminal region is hydrophilic bearing 4 out of
the total number of 6 positively charged residues 197-199. In aqueous environment, melittin
exhibits random coil conformation and is monomeric at low concentrations. At sufficiently
high concentrations, it tends to agglomerate forming tetramers at high pH and ionic
strengths 199, 200 . In phospholipid environment, melittin has been shown to adopt α helical
conformation 201-203.
Molecular dynamics (MD) simulation, a technique in which the evolution of positions of
all atoms belonging to AMP when interacting with phospholipid bilayer accounting for
interatomic interactions such as van der Waals, electrostatic etc has been employed to
evaluate the potential energy of interaction
orientation

206

204

, peptide conformation

205

, peptide

and deformation of lipids207. AMBER force field has been employed to

describe the interatomic interactions in systems containing lipids 208, 209. Even though the
quantitative results of MD simulation may vary from one force field to the other, the
qualitative features of these results will be the same. Melittin is shown to adsorb onto the
phospholipid membrane surface 203 although its subsequent penetration into the bilayer is
found to occur when the N terminal is protonated 202. Penetration of melittin into the bilayer
from the surface occurs only above a critical P/L ratio 210 and involves an energy barrier
which is found to be lower for larger P/L ratio

211

. Transmembrane tetramer of melittin
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inserted into the bilayer is found to result in bending of phospholipids consistent with
toroidal pore structure

212

. For pure 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine

(POPC) membrane, arrangement of four transmembrane melittin formed a stable toroidal
pore with a water channel 203, 213. Increase in net charge of N terminal in mutant melittin
resulted in more disordered pore 214. However, removal of charge of basic residues seem
to prevent pore formation 210.
In this manuscript, we investigate the interaction of melittin with mixed membrane (a
mimic of bacterial cell membrane) consisting of 1, 2-Dioleoyl-sn-glycero-3phosphocholine (DOPC) and 1, 2-di-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-racglycerol) (DOPG) by MD simulation. Specifically, we investigate the effect of number of
melittin molecules (placed either on the membrane surface or transmembrane) and
orientation on the formation and growth of pores. Results indicate the formation of stable
pores for symmetric as well as asymmetric orientation of transmembrane melittin only
above a critical P/L ratio.

3.2

Simulation Methods

We performed multiple all-atom simulations with antimicrobial peptides melittin for both
surface and transmembrane states. Details of all the simulation systems are given in Table
3.1.
For the surface arrangement, simulations were performed for the case of 2, 4 and 6 peptides
placed on the membrane surface as shown in Figure 3.1. For two peptides, they were placed
parallel to each other with two cases. In the first case, the two N terminals belonging to the
two peptides were near each other. In the second case, C and N terminals belonging to the
two peptides were near each other. For 4 and 6 peptides, N terminals of all the peptides
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faced each other. The initial distances between peptides in all the cases can be seen in
Figure 3.1. It is to be noted that the number of lipids increased as more peptides were placed
in the system (see Table 3.1).
We also simulated a system containing single or multiple transmembrane peptides (1, 2, 4,
5, 6, 7 and 8) and 128 mixed lipids (3:1 DOPC/DOPG) as well as pure DOPC lipids.
Initially, these peptides were asymmetrically placed in the mixed or pure membrane center
with hydrophilic residues facing together. In addition, we compared structural differences
between asymmetric and symmetric arrangement with 6 peptides in 128 3:1 DOPC/DOPG
mixed lipids.
All the simulations were performed following the same procedure below. All MD
simulations were carried out using AMBER 215 software. The AMBER ff99SBildn 216 force
field was employed for the peptides, whereas Lipid11 force field 217 was employed for all
the lipid force field. TIP3P model
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was used for water molecules. The snapshots were

visualized using VMD 219 software.
The initial peptide structure was obtained from protein data bank (PDB ID 2MLT chain A).
The initial lipid bilayer with peptide structure for the simulation was built using the
CHARMM-GUI
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website (http://www.charmm-gui.org). The bilayer in the simulation

was represented by either pure DOPC or 3:1 ratio of mixed DOPC (neutral) / DOPG
(negatively charged) bilayer. Pure DOPC bilayer mimicked mammalian cell membrane
whereas DOPC/DOPG mixed bilayers are negatively charged membrane, mimicking
bacterial cell membrane. Counter ions were added to neutralize the system and the final
ionic (KCl) concentration of the system was 0.15M to reproduce physiological conditions.
The periodic box was filled with water molecules based on the TIP3P potential.
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Careful minimization to remove bad contacts and steric hindrances was performed before
slowly heating the system to 303 K: first, the configurational energy of the system was
minimized by performing 2000 steps of a steepest descent algorithm followed by 3000
steps of a conjugate gradient algorithm

221

. The protein-membrane system, then, was

relaxed prior to running heating MD using constant pressure (NPT) to reach the target
temperature (303K). During the heating, the position of lipid atoms was kept fixed with
harmonic constraints. A 5 ns MD simulation at 303 K with a NPT ensemble was performed
to equilibrate the system followed by 50/100 ns production runs of constant surface tension
“γ” (NPγT) simulation. Langevin dynamics was employed with a collision frequency γ =
1 ps−1. Semiisotropic pressure scaling was used to maintain the pressure at 1 atm with a
constant surface tension value set to 15 dynes/cm, since this value was found to describe
different membrane properties such as porosity, surface area and electron density for pure
DOPC membrane well 217, 222. Nonbonded interactions were calculated with a cutoff at 10
Å; full electrostatics was employed using the particle-mesh Ewald method. Covalent bonds
involving hydrogen atoms were held rigid with the SHAKE algorithm, allowing a 2 fs time
step.

3.3
3.3.1

Results and Discussion
Peptide reorientation on the surface of the lipid bilayer

Snapshot of 3:1 DOPC/DOPG mixed membrane and DOPC pure membrane in the absence
of melittin and the density profiles of water and lipid head are shown in Figure 3.2 and 3.3.
The left panel (a) shows the lipid tails which are not shown in the right panel (b).
Two melittin (P/L = 2/96) were placed on the top leaflet of 3:1 DOPC/DOPG mixed
membrane parallel to each other with the distance between the two backbones of ~ 7.68 Å
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and with two orientations. In the first, the two N terminals were placed adjacent to each
other. The initial structure of melittin was obtained from PDB. Since the hydrophobic
residues of melittin were allowed to fully interact with the lipid tails, the molecules were
slightly bent with the N terminals pointing inwards (see Figure 3.4a). In the second case,
the C and N terminals of two melittin were placed adjacent to each other. Melittin consists
of two α-helical regions separated by a characteristic kink at Pro14. Moreover, the five
charged residues are not uniformly distributed along the peptide, but four of them (KRKR)
are concentrated in C-terminus. This resulted in C-terminus being more hydrophilic than
N-terminus. Because of charge repulsion, the two α helical backbones are not parallel when
viewed from the side (Figure 3.4c). The snapshots of initial and 100 ns structures for the
two cases are shown in Figure 3.4. In the first case (NN), the two peptides did not penetrate
the membrane but N terminal bent to the top leaflet (Figure 3.4b). In the second case (CN),
however, because of combined effects of electrostatic repulsion between C and N terminals
and electrostatic attraction between positively charged C and N terminals and negatively
charged leaflets, the protruding C and N terminals shifted towards the top and bottom
leaflets respectively (Figure 3.4d). The other C and N terminals remained anchored to the
top leaflet because of predominant effect of electrostatic attraction with negatively charged
leaflet. Movement of N terminal towards the bottom leaflet led to bending of phospholipid
heads as a result of electrostatic attraction. Normalized density profiles averaged over the
last 30 ns are shown as a function of z coordinate (vertical position within the bilayer) for
the two cases in Figure 3.5. Density profile of melittin for asymmetric (CN) orientation
clearly shows (Figure 3.5b) penetration into the bilayer. For the NN case, lipid heads are
both located around z=±15Å, which reflects the fact that the polar lipid heads are oriented
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nearly parallel to the membrane-water interface. For NC case, however, lipid density
profile does indicate protrusion into the bilayer from bottom leaflet consistent with Figure
3.4b. Even though no pore formation occurs in both cases, an insignificant diffusion of
water into the bilayer can be seen for asymmetric case (Figure 3.5b). For NC orientation,
the density profile of peptides also indicates penetration of peptide from the top leaf into
the interior of the bilayer consistent with Figure 3.4b. The area per lipid remained more or
less constant in both the cases (Figure 3.6).
The snapshots of initial and 100 ns conformations of four and six peptide molecules placed
on the top leaflet of 3:1 DOPC/DOPG mixed bilayer with their N terminals facing each
other are shown in Figure 3.7a, 3.7b and 3.7c, 3.7d respectively. As pointed out above, the
initial orientation of peptides results in protrusion of part of the helical structure with N
terminal into the bilayer because of bend in proline residue and hydrophobic interactions
with the hydrocarbon tails. After 100 ns, four peptides bend back into the top leaflet with
all four peptides residing on the surface of the membrane. Thinning of the membrane can
be observed though no penetration of water molecules occurred. In case of six melittin
molecules, however, after 100 ns, three of the six peptides penetrate into the lower leaflet
whereas the other three continue to remain at the upper leaflet. More bending of the
membrane is found to occur compared to the case of four peptides. One can also see more
phospholipid heads bending towards the peptide both in the top as well as the bottom
leaflets. The density profiles for four and six peptides are shown in Figures 3.8a and 3.8b
respectively. These profiles clearly indicate penetration of peptides as well as more bending
of the membranes for the case of six melittin molecules. In addition, a slight penetration of
water molecules near the top and bottom leaflets can also be seen for six peptides.
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The thickness of the lipid bilayer was inferred from the distance between the peaks in the
lipid density profile. Similarly, the thickness of the region within which the phospholipid
heads were confined in the top and bottom leaflets were also inferred from the widths (>1%
of normalized density) of the lipid density distribution for the top and bottom leaflets
respectively. These values are given in Table 3.2 for different P/L ratio. The distance
between the two peaks decreased from 33.85 Å in the absence of peptides (base line) to
31.05 to 32.60 Å thus clearly indicating thinning of the membrane due to interaction with
peptides. Chen et al.
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reported thinning of DOPC membrane due to interaction with

melittin using x ray diffraction. Broadening of the phospholipid region in the bottom leaflet
was observed (Table 3.2) with the thickness of the region increasing with P/L ratio.
Interestingly, such a broadening was not observed for the top leaflet. This is believed to be
due to electrostatic attraction of the bottom phospholipid heads with N terminal of
penetrating melittin. This is further evidenced by the fact that broadening is most
pronounced for 6 peptides in which three reached the bottom leaflet. Similar broadening
effect was reported for MD simulation for interaction of amphiphilic Corticotropinreleasing factor (CRF) with DOPC bilayer
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. These results also indicate a critical P/L

ratio for penetration of melittin into mixed bilayer, consistent with fluorescent leakage
experiments for pore formation in liposomes
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. Critical P/L ratio for penetration of

melittin into DOPC bilayer in active state was observed by x-ray diffraction

223

. Critical

P/L ratio was also reported from MD simulation of interaction of melittin with DPPC
bilayer 210.
In the following sections, the results of structure of pores consisting of vertical
transmembrane peptides of different sizes are presented. It is to be noted that a transition
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of a horizontal peptide on lipid surface to a vertical transmembrane orientation involves an
energy barrier

211

. The evaluation of this energy barrier is relevant to the description of

different sets of events involved in pore formation. We are currently performing free
energy calculations to evaluate this energy barrier.
3.3.2

Different P/L ration of peptides at transmembrane state of mixed lipid bilayer

Figure 3.2 shows the snapshot of 3:1 DOPC/DOPG mixed membrane without any peptide.
The snapshots of 50 ns conformation of different number of transmembrane peptides with
N terminals inserted into the lower leaflet are shown in Figures 3.9 and 3.10 . In these
figures, lipid tails are not shown for clarity. In addition, the right panels of these figures do
not show the peptide in order to better visualize the formation of water channel, if any.
Normalized water density and lipid density profiles for these cases are shown as a plot of
density vs z coordinate (Figure 3.11). As expected, in case of no peptide, no water
penetration occurred. However, for 1,2 and 4 transmembrane peptides, some penetration
of water molecules occurred though no water channel was formed. The extent of water
penetration was more significant ( upto ±5 Å) only for 4 transmembrane peptides. On the
other hand, density profiles clearly show the formation of water channel for 6 and 8
transmembrane peptides (Figures 3.11) which can also be seen from the snapshots (Figure
3.9). Unlike the simulation results for melittin placed on top leafet, the lipid profiles for
transmembrane peptides were found to be symmetric. No significant broadening of top and
bottom phospholipid regions were observed for 1, 2 and 4 peptides (see Table 3.3).
However, for 6 transmembrane peptides, density profile indicated penetration of lipid head
into the bilayer consistent with toroidal pore structure (refer to Figures 3.9e and 3.9f). In
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addition, no significant thinning of membrane was also observed as can be seen from
inferred membrane thickness for different P/L ratio that is given (see Table 3.3).
Top view of the 3:1 DOPC/DOPG mixed membrane with 6 transmembrane melittin with
their N terminals attached to the bottom leaflet at 0 and 50 ns are shown in Figure 3.12.
Water molecules are not shown for clarity. It is to be noted that at 0 ns, no water molecules
were present inside the cavity formed by hydrophilic parts of the transmembrane peptides.
At 50 ns, however, as pointed out above, water molecules do penetrate to form water
channel. As can be seen from Figure 3.12, the pore size increased with time. Similar results
were obtained for 5, 7 and 8 transmembrane peptides. 0 and 50 ns snapshots and
dimensions of the pore for all the cases are given in Figures 3.13 and Table 3.4 respectively.
Similar results were obtained for MD simulation of four transmembrane melittin in POPC
bilayer 203. It is interesting to note that phospholipid heads were found to line the pores in
addition to the hydrophilic part of the peptide at 50 ns thus demonstrating toroidal pore
structure. Earlier MD simulation results 212, 213 for the structure of transmembrane melittin
induced pores in pure DMPC as well as pure POPC bilayer to be toroidal in that the pores
were lined both with peptides and lipid heads. These results also indicate a critical P/L ratio
for pore formation consistent with earlier reported results 210, 223, 226 as discussed above.
3.3.3

Different number of transmembrane melittin in pure DOPC lipid bilayer

Similar calculations were performed for pure DOPC membrane with 4-8 transmembrane
melittin molecules with their N terminals attached to the lower leaflet. DOPC pure
membrane was chosen to mimic mammalian cell membrane. The results were very similar
to those described above for mixed membrane (mimic of bacterial cell membrane).
Consequently, these results indicate that melittin is toxic in that it exhibits the same
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tendency for pore formation in mixed and pure membranes (indication of its possible
antimicrobial activity and toxicity respectively). Toxicity of melittin has been confirmed
experimentally 227. Similar results of pore formation for pure DOPC membrane has been
reported from MD simulation 210, 212, 228. The snapshot at 50 ns for 6 transmembrane melittin
molecules along with the density profiles are shown in Figure 3.14. Similar plots for 4, 5,
7 and 8 are given in Figure 3.15. Water channel formation was observed only for 6, 7 and
8 transmembrane peptides similar to the results for mixed membrane. This is also clear
from water density profiles (see Figures 3.14c and 3.16). The thickness of bilayer as well
as the thickness of phospholipid head regions in the upper and lower leaflets are given in
Table 3.4. Top view of the pores at 0 and 50 ns for these cases are given in Figure 3.17.
Similar to the behavior for mixed membranes, in case of pure DOPC membrane, pore size
was found to increase only for 6, 7 and 8 transmembrane peptides.
3.3.4

Symmetric versus asymmetric arrangements of six transmembrane melittin in
mixed lipid bilayer

Snapshots at different times for 6 transmembrane peptides in 3:1 DOPC/DOPG mixed
membrane are shown in Figure 3.18 for asymmetric (all N terminals attached to lower
leaflet) and symmetric (equal number of peptides with C and N terminals attached to upper
and lower leaflets respectively) arrangements. Normalized density profiles averaged over
the last 30 ns are also shown for the two cases in Figure 3.19. Water channel is observed
in both cases. Pore is found to be more asymmetric with the size being larger at the top
leaflet for asymmetric case as a result of stronger electrostatic repulsion among charged C
terminals (Figure 3.19a). In addition, peptide density distribution was also asymmetric with
larger peptide density near the top leaflet because of stronger electrostatic attraction of C
terminals with phospholipid heads. The increase in pore size with time was more
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pronounced for asymmetric case whereas for symmetric case pore size was more stable.
Irudayam and Berkowitz213 report stable toroidal pores for symmetric arrangement of
transmembrane melittin in POPC bilayers. Lin and Baumgartner

203

also observed

expansion of asymmetric transmembrane melittin pores in POPC membranes from MD
simulation. Finally, the density of phospholipids in the central region of the bilayer was
higher for asymmetric case as a result of more bending of phospholipid heads (see Figure
3.19 insets).

3.4

Conclusions

All atom MD simulation was performed to investigate the interaction of melittin with 3:1
DOPC/DOPG mixed membrane as well as pure DOPC membrane. These simulations were
carried out for different number of melittin (1-8) placed either on the top leaflet of the
membrane or fully inserted into the membrane. Broadening of phospholipid head regions
in the bottom leaflet as well as thinning of membrane were found to occur for melittin
placed on the top leaflet only for mixed membrane. Critical P/L ratio was observed for
penetration of melittin from the surface as well as for water channel formation for
transmembrane peptides. The pore structure was demonstrated to be toroidal. Asymmetric
transmembrane pores were larger for the top leaflet and grew in size with time whereas
symmetric pores were stable. The behavior for mixed and pure membranes was found to
be similar for transmembrane peptides thus implying high toxicity of melittin consistent
with earlier observations.
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3.5

Figures and Tables
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Figure 3.1 Initial arrangement of different number of melittin peptides when placed on the
surface of lipid membrane; a, c, e and g are the top view of peptides, and b, d, f and h are
the side view of the peptides. Color code: blue: charged residues, green: polar residues and
white: nonpolar residues. Backbones are shown only with secondary structure style. The
ruler scale is 10Å.
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Figure 3.2 Simulation snapshots at 50ns and Normalized density profile of 3:1
DOPC/DOPG mixed membrane in the absence of melittin. (a) is the whole system of lipid
membrane, (b) is the same as (a) in which lipid tails are not shown for clarity. Phospholipid
heads were only shown with phosphate atom for clarity. Color code: yellow: DOPC lipid
heads, pink: DOPG lipid heads, gray: lipid tails, blue: water. (c) is the normalized density
profile of water and lipid headgroup for mixed membrane.
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Figure 3.3 Snapshots at 50ns and Normalized density profile of pure DOPC lipid bilayer
in the absence of melittin. Color codes are the same as those described in Figures 3.1 and
3.2.
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Figure 3.4 Side view of initial and final of two melittin on the surface of the lipid bilayer.
(a) and (b) are the initial and 100ns respectively for NN case, (c) and (d) are the initial and
100ns respectively for NC case. Color codes are the same as those described in Figures 3.1
and 3.2.
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Figure 3.7 Side view of initial and final for four and six melittin on the surface of the lipid
bilayer. (a) and (b) are the initial and 100ns respectively for four peptides case, (c) and (d)
are the initial and 100ns respectively for six peptides case. Color codes are the same as
those described in Figures 3.1 and 3.2.
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Figure 3.8 Normalized density profile of (a) 4 melittin and (b) 6 melittin on the surface of
3:1 DOPC/DOPG mixed membrane averaged over the last 30ns.
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Figure 3.9 Snapshots of 2, 4, 6 and 8 transmembrane peptides in the lipid bilayer at 50ns.
(a) and (b) are the two peptides-membrane system, (c) and (d) are four peptides-membrane
system, (e) and (f) are six peptides-membrane system, (g) and (h) are eight peptidesmembrane system. Lipid tails are not shown in (a), (c), (e) and (g) whereas lipid tails and
peptides are not shown in (b), (d), (f) and (h) for clarity. Color codes are the same as those
described in Figures 3.1 and 3.2.
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1melittin 50ns:

5melittin 50ns:

7melittin 50ns:
Figure 3.10 Snapshots of 1, 5 and 7 transmembrane peptides in mixed membrane at 50ns.
Color codes are the same as those described in Figures 3.1 and 3.2.
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Figure 3.11 Normalized density profile for different number of transmembrane peptides in
mixed lipid bilayer. Refer to Table 3.1 for corresponding P/L ratios.

50

Figure 3.12 Snapshots top view of 6 transmembrane peptides, (a) initial, (b) 50ns. Water
molecules are not shown for clarity. Color codes are the same as those described in Figures
3.1 and 3.2 and purple is K+ and cyan is Cl-. All the molecules are shown with all atoms
style.
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5 Melittin 0ns:
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7 Melittin 0ns:

50ns:

8 Melittin 0ns:

50ns:

Figure 3.13 Top view snapshots of 5, 7 and 8 transmembrane melittin in mixed lipid bilayer
at initial and 50ns. Color codes are the same as those described in Figures 3.1 and 3.2.
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Figure 3.14 Snapshots of six transmembrane peptides at 50ns and normalized density
profile for water and lipid heads. Lipid tails are not shown in (a) and (b); peptides are also
not shown in (b) for clarity. Color codes are the same as those described in Figures 3.1 and
3.2.
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4 melittin 50ns:

5 melittin 50ns:

7 melittin 50ns:

8 melittin 50ns:
Figure 3.15 Snapshots of 4, 5, 7 and 8 transmembrane peptides in pure membrane at 50ns.
Color codes are the same as those described in Figures 3.1 and 3.2.
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Figure 3.16 Normalized density profile for different number of transmembrane peptides in
pure lipid bilayer. Refer to Table 3.1 for corresponding P/L ratios.
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Figure 3.17 Snapshots of top view of 5, 7 and 8 transmembrane melittin in pure lipid bilayer
at initial and 50ns. Color codes are the same as those described in Figures 3.1 and 3.2.
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Figure 3.18 Snapshots of (a) asymmetric and (b) symmetric transmembrane arrangement
for six melittin at various times during MD simulation. Water molecules and lipid tails are
not shown for clarity. Color codes are the same as those described in Figures 3.1 and 3.2.
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Table 3.1 Details of the all-atom MD simulations that were performed
Lipid type

Position

Arrangements

Time

Remarks

1
2

Peptide/Lipid
(P/L) ratio
0/128
0/128

DOPC/DOPG
DOPC

-

-

50ns
50ns

3

2/96

DOPC/DOPG

surface

NC*

100ns

4
5

2/96
4/162

DOPC/DOPG
DOPC/DOPG

surface
surface

NN
NN

100ns
100ns

6

6/166

DOPC/DOPG

surface

NN

100ns

7
8
9
10
11
12
13
14
15
16
17
18
19

1/128
2/128
4/128
4/128
5/128
5/128
6/128
6/128
6/128
7/128
7/128
8/128
8/128

DOPC/DOPG
DOPC/DOPG
DOPC/DOPG
DOPC
DOPC/DOPG
DOPC
DOPC/DOPG
DOPC/DOPG
DOPC
DOPC/DOPG
DOPC
DOPC/DOPG
DOPC

transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane

N inserted
NN inserted
Asymmetric
Asymmetric
Asymmetric
Asymmetric
Asymmetric
Symmetric
Asymmetric
Asymmetric
Asymmetric
Asymmetric
Asymmetric

50ns
50ns
50ns
50ns
50ns
50ns
60ns
60ns
50ns
50ns
50ns
50ns
50ns

No pore
No pore
1 peptide
insertion
surface
surface
3 peptides
insertion
No pore
No pore
No pore
No pore
water diffusion
water diffusion
pore formation
pore formation
pore formation
pore formation
pore formation
pore formation
pore formation

Run

* N: N-terminal, C: C-terminal, Asymmetric: all N-terminals inserted into the lipid bilayer, Symmetric: equal
number of N and C terminals inserted.

59
Table 3.2 Thickness of Lipid heads regions and lipid bilayer #
Lipid heads region >1%
Thickness at lower
Thickness at upper
leaflet (Å)
leaflet (Å)
18.05±1.0062
17.95±0.9585

Run

P/L
ratio

1

0/128

3

2/96

21.30±0.2739

18.15±0.2850

32.60±0.2850

4

2/96

18.80±0.2092

15.95±0.3260

31.35±0.1369

5

4/162

19.15±0.5184

18.00±0.5000

31.05±0.3260

6

6/166

23.85±0.6982

21.85±0.3791

31.45±0.3708

Lipid bilayer thickness (Å)
33.85±0.2850

# the simulation results for 50-80 ns, 55-85 ns, 60-90 ns, 65-95 ns and 70-100 ns were analyzed to obtain the
error bars.
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Table 3.3 Thickness of lipid head regions and lipid bilayer for transmembrane melittin in
mixed lipid bilayer
Lipid heads region >1%
Thickness of head
Thickness of head region
region at upper leaflet
at lower leaflet (Å)
(Å)
18.05(1.0062)
17.95(0.9585)

Bilayer thickness
(Å)

Run

P/L ratio

1

0/128

7

1/128

17.25(0.6614)

18.70(1.2041)

33.50(0.4330)

8

2/128

18.75(0.6374)

18.20(1.1511)

34.90(0.4183)

9

4/128

20.00(1.3110)

19.15(0.4183)

34.85(0.5477)

11

5/128

19.15(0.285)

18.60(0.5755)

34.10(0.7416)

13

6/128

30.69(4.2884)

22.13(1.1087)

34.35(0.5755)

16

7/128

20.10(1.1937)

21.30(0.9585)

35.55(0.2092)

18

8/128

20.45(0.2739)

18.90(0.5184)

34.00(0.3536)

33.85(0.2850)
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Table 3.4 Thickness of lipid head regions lipid bilayer for transmembrane melittin in pure
DOPC lipid bilayer
Lipid heads region >1%
Thickness of head
Thickness of head region
region at lower leaflet
at upper leaflet (Å)
(Å)
18.35(0.2236)
19.00(0.6847)

Bilayer thickness
(Å)

Run

P/L ratio

2

0/128

10

4/128

19.40(0.9117)

18.90(0.3791)

34.35(0.7624)

12

5/128

18.35(1.1806)

20.55(0.5123)

33.59(0.2219)

15

6/128

22.80(0.4108)

19.20(0.7583)

33.90(0.8023)

17

7/128

18.70(1.5752)

19.30(1.1096)

33.80(0.4472)

19

8/128

19.50(0.4330)

19.90(0.4873)

34.55(0.2738)

35.10(0.3354)
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Table 3.5 Pore size vs time for 5 to 8 transmembrane peptides in 3:1 DOPC/DOPG mixed
membrane as well as pure DOPC membrane. Refer to Table 3.1 for the details of
parameters that correspond to different run numbers.
Run
11
12
13
15
16
17
18
19

0ns (nm)
minimum
0.6
0.6
1.2
1.2
1.2
1.2
1.6
1.6

50ns (nm)
maximum
1.1
1.1
1.5
1.5
1.4
1.4
2.5
2.5

minimum
0.3
2.0
1.3
1.5
1.5
1.9
1.8

maximum
0.7
3.1
2.0
1.7
1.9
3.9
3.7
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4. POTENTIAL OF MEAN FORCE FOR INSERTION OF
ANTIMICROBIAL PEPTIDE MELITTIN INTO A PORE IN
MIXED DOPC/DOPG LIPID BILAYER BY MOLECULAR
DYNAMICS SIMULATION

4.1

Introduction

Cell death resulting from pore formation in cell membranes by peptides has important
consequences in biology. An important function of pore forming peptides is in the defense
of plants and animals against invading microbes. These antimicrobial peptides (AMPs)
could be very useful for combating microbes. Pore formation is also believed to be one of
the mechanisms leading to neurological disorders such as Alzheimers disease, Parkinsons
disease, spongiform encephalopathy, amytropic lateral sclerosis, Huntington disease etc.
In these cases, fibrils formed by aggregation of amyloid beta peptides form pores in
neuronal cell membranes causing death. The exact mechanism of pore formation and cell
death is not well understood. Elucidation of this mechanism as a result of the work
proposed here will help greatly in the development of guidelines for design of antimicrobial
peptides to replace antibiotics. AMPs inactivate microorganisms by forming pores in cell
membrane through adsorption and aggregation 6. They are usually cationic and are about
20 to 40 amino acids in length. They can target multiple microorganisms and may not allow
the bacteria to develop resistance thereby making them an attractive alternative to
antibiotics. When the peptide concentration is low, peptides stay on the surface of the
membrane and are bound parallel to the lipid bilayer (referred to as S state) 44. With the
increase of peptide concentration, peptides turn to be perpendicular to the bilayer, insert
into the membrane and form transmembrane pores 229. The nucleation and growth of these
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pores occur through surface diffusion of adsorbed peptides followed by their penetration
into the cell membrane. The pore structure is characterized by the hydrophobic part of the
peptide aligning itself with the lipids and the hydrophilic part of the molecule forming the
interior of the pore 44, 203, 230. For AMP with sufficiently high positive charge, the inserted
transmembrane aggregate induces the lipid molecules to bend so as to partially neutralize
the positive charge of hydrophilic interior of the pore. The lipid molecules tilt from the
lamellar normal and connect the two leaflets of the membrane, forming a continuous bend
from the top to the bottom in the form of a toroidal hole. This type of pore is referred to as
toroidal pore and is formed by magainins, protegrins and melittin 44, 231, 232. Some amyloidrelated proteins/peptides form aggregates which may interact with phospholipid
membranes (cell membranes) where they form pores disrupting cellula homeostatis 233-236.
A summary of different amyloidosis and peptides that are involved in aggregation and pore
formation in a variety of neurological disorders such as Alzheimer disease (AD), Parkinson
disease (PD), spongiform encephalopathies, amytropic lateral sclerosis, Huntington
disease etc. is given

237

. This mechanism of toxicity is similar to that displayed by

antimicrobial peptides. Several investigations have examined pore formation by melittin,
a naturally occurring AMP isolated from the venom of European honeybee (Apismellifera)
44, 229, 238-242

. It contains 26 amino acid residues (GIGAVLKVLTTGLPALISWIKRKRQQ),

which are predominantly hydrophobic in the amino-terminal region whereas the carboxyterminal region is hydrophilic bearing 4 out of the total number of 6 positively charged
residues 197-199.
Molecular dynamics (MD) simulation which accounts for interatomic interactions such as
van der Waals, electrostatic etc. has shown that melittin binds to the phospholipid bilayer
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surface203 although its subsequent insertion into the bilayer is found to occur when the N
terminal is protonated202. MD simulation have also been employed to quantify the potential
energy of interaction of peptides with lipid bilayer 204, secondary peptide conformation205,
peptide orientation206 and deformation of lipids

207

. It has been shown that melittin

monomer adopts a random coil conformation whereas it is α helical in tetrameric form
when exposed to aqueous environment

243-245

. In lipid bilayer environment, melittin has

been shown to maintain a stable helical structure 246. The effect of different environments
on conformation of melittin has been investigated

247-249

. Our previous investigation on

pore formation by melittin in 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) / 1,2di(9Z-octadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol) (DOPG) mixed bilayer using
all atom explicit solvent MD simulation indicated that a critical P/L ratio was needed for
insertion of peptide from the surface into the bilayer as well as for formation of water
channel by transmembrane peptide aggregates

250

. Pore structure in lipid bilayer formed

by melittin aggregates has been shown to be toroidal by MD simulation 181, 250-255. Potential
of mean force for insertion of a peptide into the bilayer, showed a decrease in the free
energy for complete insertion of the peptide with an energy barrier implying thereby that
peptide insertion is favorable. Ladokhin and White 256 estimated that the free energy gain
in a process when melittin transforms from an unfolded structure in water to a folded
conformation on a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membrane
surface is -7.6 kcal/mol. The energy barrier for insertion of a single melittin into POPC
lipid bilayer was ~22 kT (~13 kcal/mol) 257 which was found to decrease for insertion of a
peptide into POPC bilayer consisting of three transmembrane peptides

257

. The energy

barrier for addition of a peptide to an existing pore consisting of aggregate of different
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number of peptides, necessary to describe the rate of pore formation by nucleation, is
lacking. In a previous investigation, we have demonstrated a critical peptide/lipid ratio for
water channel formation for melittin, a model antimicrobial peptide, in bacterial and
mammalian cell membranes. In this manuscript, we employed umbrella sampling method
to quantify the effect of number (0, 3, 4, 5 and 6) of transmembrane peptide aggregates on
the energy barrier for the addition of melittin into a bacterial cell membrane mimic. The
results reported in this manuscript will be useful for the development of a quantitative
model for nucleation of pores by antimicrobial peptides and hence in a rational
methodology for design of synthetic antimicrobial peptides.

4.2
4.2.1

Simulation Methods
Simulation System Setup

The initial structure of the solvated peptide-membrane system was set up using
CHARMM-GUI as described in our previous work

250

. Briefly, the structure of melittin

was taken from protein data bank (PDB ID: 2MLT, chain A) and the lipid bilayer was using
3:1 mixed DOPC/ DOPG lipid molecules mimicking bacteria cell membrane. The periodic
box was filled with water molecules based on the TIP3P

140

potential. The system was

neutralized by adding counter ions, the final ionic (KCl) concentration of the system was
0.15M in order to reproduce the physiological conditions.
Five cases (zero to one, three to four, four to five, five to six and six to seven peptides with
128 lipid molecules) were investigated for free energy calculation. In each case, one
peptide was placed at different positions within the bilayer, from surface state (no insertion
into bilayer) to transmembrane state (complete insertion into bilayer). The reaction
coordinate corresponds to the z component (across the lipid bilayer) of the distance
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between the center of mass of the first three residues near N terminal of the peptide and
center of mass of the lipid bilayer. The reaction coordinate was varied by varying the extent
of insertion of melittin within the bilayer. The increments in the extent of insertion was 1
Å. In the first window, the peptide was placed in the bulk solution parallel to the upper
leaflet of the lipid bilayer. In the next window, the peptide was moved by 1 Å into the
membrane and restrained at that position. The force constant used for restraining the
peptide is 3.5 kcal mol-1 Å-1. Since the thickness of membrane is around 40 Å, the total
number of window is 46 in order to cover all the positions. Other peptides were arranged
as a preformed aggregate in the lipid bilayer to form a pore.
The setup of the simulation was also described in our previous work 250. Briefly, all MD
simulations were carried out using AMBER215 software. The AMBER ff99SBildn216 force
field was employed for the peptides, whereas Lipid11 force field217 was employed for all
the lipid force field. For each restrained location of the N terminal of the peptide, the
system was firstly minimized for 25000 steps in order to remove bad contacts and steric
hindrances. An equilibration of 2ns with a constant surface tension “γ” (NP γ T) ensemble
was performed. The temperature of the system was also heated from 0 K to 303 K during
equilibration. Production simulation was performed for 150ns followed by calculation and
analysis of potential of mean force (PMF) for the last 50ns. The simulation time step was
2 fs. The total simulation time was approximately 34.5 µs. The PMFs were constructed
using the weighted histogram analysis method (WHAM) 258 in AMBER software package.
The last 50 ns of calculation was divided into 10 blocks each of 10 ns duration so that there
is overlap of time periods. The PMF values at each location of N terminal were evaluated
from histograms that were obtained from each interval using WHAM. The mean values
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and error bars were evaluated from these. Snapshots were taken from VMD software 134.
The density and position of the peptides were calculated using cpptraj tool 259 in AMBER.
The secondary structure analysis was performed using the DSSP module 260.
To elucidate the structure of the pore, the size of aggregate at different values of reaction
coordinate was calculated as well as the radius of water channel.
4.2.2

Aggregate size calculation

The size of aggregate was calculated based on the position of each peptide. The coordinates
of each residue from backbone were exported from the simulation result, the areas
surrounded by the peptides at different z coordinates were calculated and employed to
evaluate the equivalent radius of a circle of the same area.
4.2.3

Water channel radius calculation

Water channel radius was determined by counting the number of water molecules in the
center of the lipid bilayer corresponding to z coordinates from -5 to 5 Å in order to
characterize the pore. The space occupied by the water molecules was approximated as a
cylinder and the density of water molecules in the cylinder was considered to be the same
as that of bulk water. The radius was then calculated using the equation:

r=

F

MwN
N ap H

(1)

where r is the radius of the water channel , where M w is molecular weight of water and

N a is Avagadro number, N is the number of water molecules in the cylinder and H is the
height of the cylinder 252, 253.
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4.3
4.3.1

Results and Discussion
Free energy of peptide insertion for different cases

Schematic of potential of mean force profile for insertion of a peptide into a bilayer is
presented in Figure 4.1. Figure 4.1a depicts the positions of lipid heads, tails and inserted
peptide at different locations of free energy profile for insertion of a single peptide. Figure
4.1b depicts the insertion of a peptide into preexisting pores of different sizes. The
existence of an energy barrier when the N terminal of a peptide is close to the center of the
lipid bilayer can be clearly seen from the schematic. Figure 4.2a-e show the plot of
calculated potential of mean force versus different positions of the restrained N terminal of
the peptide inside the lipid bilayer. Comparison of PMF profiles for simulation time of 120
ns for all the cases (Figure 4.3) with the current results (simulation time of 150 ns) shows
negligible difference between the two thereby indicating that the system is close to
equilibrium. The free energy of the peptide increases when it is transferred from the top
leaflet reaching a maximum near the center of the bilayer and decreasing subsequently as
the peptide is inserted further into the bilayer. Consequently, there is a free energy barrier
of about 7.209±0.864 kcal/mol (see Figure 4.2a) for insertion of a single peptide into the
bilayer. Irudyam et al. 257 obtained a value of 13.20±0.80 kcal/mol for insertion of melittin
into POPC bilayer. The energy barrier is lower for our case of mixed bilayer (DOPC/DOPG)
because of net charge of the bilayer. Negatively charged DOPG phospholipid heads will
neutralize part of the peptide charge and thus reduce the free energy. The asymmetric PMF
profile is believed to be due to changes in the structure of the bilayer as a result of bending
of lipid heads due to electrostatic attraction. This effect may be enhanced in our case (mixed
lipid bilayer) as a result of more lipid bending due to net charge of the bilayer. It is
important to note that the free energy of the peptide decreases from surface state to
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transmembrane state by 0.084±0.120 kcal/mol. However, the rate of insertion would be
proportional to exp ( -Df max kT ) , Df max being the energy barrier. Similar plots of potential
energy of mean force for other cases (four, five, six and seven peptide aggregates) are
shown in Figures 4.2b-e. As shown in Figure 4.2f, the energy barrier is found to decrease
for insertion of peptide into a transmembrane peptide aggregate of larger size. Interestingly,
the energy barrier approaches zero (0.588±0.185 kcal/mol) for aggregate of six to seven
peptides. Figure 4.2f also shows that the free energy change ∆� for complete insertion from
surface state to transmembrane state is more negative for larger pore size thereby indicating
that larger pores will be more stable.
In order to better describe the energy profile, we adopt a three-region model of the lipid
bilayer based on the density profile (see Figure 4.4), similar to that of Marrink’s261 and
MacCallum’s262 work. Starting from the top leaflet of the lipid bilayer (~20Å), Region I
refers to the region of lipid heads from 20 Å to 10 Å. Region II starts from the interface of
top leaflet lipid heads and lipid tails (~10 Å) to the next interface of lower leaflet lipid
heads and lipid tails (~-10 Å). Region III is lipid heads of lower leaflet, starting from -10
Å to -20 Å. Transfer of a melittin molecule through Region I in general show a free energy
decrease indicating that the insertion of peptide through region I is favorable (Figure 4.2a).
Density profiles show that part of the hydrophobic residues of the peptide has inserted into
Region II (Figures 4.5a and 4.6a), which is hydrophobic environment. Similar results were
reported for pure POPC lipid bilayer

257

. When melittin is inserted through Region II, it

experiences an energy barrier of about 7.209 ± 0.864 kcal/mol at a location which
corresponds to a distance of around -4.52 Å from the center (see Figure 4.2a). As the
peptide is inserted through region II, lysine near the N-terminal (7_LYS) attracts oppositely
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charged lipid heads leading to their bending as can be seen from the peak in density profile
of charged residues at around -4.52 Å in Figure 4.5c and snapshot Figure 4.7c. This results
in an increase in free energy of bending. Interestingly, this lipid bending is predominantly
from the bottom leaflet and is more pronounced when the peptide is at -4.52 Å
corresponding to the energy barrier. The second energy minimum refers to the location (~18.12 Å) when melittin becomes perpendicular to the lipid bilayer, or in transmembrane
state. At this location, the decrease in free energy occurs due to (i) less lipid bending since
the charged residue (7_LYS) near N terminal is in Region III (corresponding to peak in
density distribution of charged residues around -15 Å as shown in Figure 4.5d), which is a
hydrophilic region and (ii) most part of hydrophobic residues stays in Region II.
It is important to notice that there exists multiple barriers and minimums when a single
melittin penetrates into a pore formed by an aggregate of peptides. For the case of 3 to 4
peptides, the first barrier occurs at 4.49 Å, which can be attributed to part of hydrophobic
residues insertion and bending of upper lipid head as evident from density profile (Figure
4.8b) and snapshot (Figure 4.9b). The secondary barrier is experienced by the peptide at a
location of -1.04 Å from the center. This barrier is higher than the first as a result of further
insertion of charged residue (7_LYS) and more bending of lipid heads. This difference can
be attributed to the difference in the environment experienced by an inserting peptide into
preexisting pore compared to pure bilayer. In addition, multiple free energy local maxima
and minima in case of peptide insertion into preexisting pore formed by peptide aggregates
(see Figures 4.2b-e) is believed to be due to discrete distribution of amino acid side chains
along the backbone. The interactions between sidechains of inserting peptide and the
sidechains belonging to the peptides in the preexisting pores are not evenly distributed
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along the reaction coordinate. Similar behavior was observed for the other cases which are
not presented here. It is important to note that the thinning of membrane as a result of
bending of lipid is more pronounced for the bottom leaflet especially for the case of
preexisting pores of multiple peptides. As a result, -20 Å refers to the aqueous medium on
the other side of the bilayer. In these cases, a steep increase in the free energy profile is
observed near -20 Å. This result is consistent with a separate study on the free energy cost
for one mellitin peptide diffusing out of a small membrane pore 252.
4.3.2

Insertion of single peptide in lipid bilayer without peptide aggregate

Figures 4.7a-d show snapshots of the conformations of peptide along with the lipid bilayer
at four different extents of insertion when the peptide is introduced from the top layer with
its N terminal restrained as described in the methods. When the peptide is at the top leaflet
parallel to the surface (~11.79 Å), it retained most of the helical structure. As the peptide
penetrated the bilayer, its orientation changed. Peptide is found to retain most of its helical
conformation at different orientations until it reached the bottom leaflet as can be seen from
Figure 4.7. When the peptide insertion is 0.52 Å (see Figure 4.7b), electrostatic attraction
between the N terminal and oppositely charged phospholipid heads at the upper leaflet led
to bending of the upper leaflet in the vicinity of N terminal. The hydrophobic parts of the
peptides (white part in Figure 4.7b) interact with the lipid tails whereas the hydrophilic
parts (green and blue part in Figure 4.7b) interact with water and lipid heads. This can be
also seen from the density profiles of water, lipid heads and lipid tail molecules, 6_LEU,
7_LYS, 8_VAL and 9_LEU (Figure 4.6).
Because of favorable interactions with water and lipid heads, 7_LYS is found to lie in
region I whereas the other three hydrophobic residues lie in region II due to stronger

73
hydrophobic interactions. When the peptide insertion is -4.52 Å (Figure 4.7c), the N
terminal reached the lower leaflet thereby causing bending of lower leaflet lipid heads in
its vicinity as is evident from lipid density profiles (see Figures 4.5 and 4.6). However, the
lipid heads in the upper leaflet did not bend. In addition, considerable number of water
molecules can be found in the vicinity of bent lipid heads though no water channel was
formed which can also be clearly seen from the snapshots (see Figure 4.7). When the
peptide insertion is -18.12 Å, the peptide becomes perpendicular to the lipid bilayer as can
be seen from Figure 4.7d.
4.3.3

Insertion of single peptide in lipid bilayer with peptide aggregates

Figures 4.9-12 show snapshots of the conformations of peptide along with the lipid bilayer
at four different extents of insertion when the peptide is introduced from the top layer with
its N terminal restrained into an existing aggregate consisting of three, four, five and six
transmembrane peptides respectively. Although there are preexisting peptides in the lipid
bilayer, the distribution of the inserting peptide residues is similar to the first case. For
example, when the insertion peptide is parallel to the bilayer, or at surface state, the
hydrophobic residues are closer to Region II while the charged residues all stay in Region
I (see Figure 4.8). When the transferred peptide is at the center of the bilayer, density profile
of 6_LEU, 8_VAL, and 9_LEU are still located in Region II whereas 7_LYS lie in Region
I (see Figure 4.13). Significant water concentration was observed for larger number of
peptides inside the aggregate (Figure 4.14). In addition, for complete penetration of
inserted peptide, water channel can be observed for the cases of four, five, six and seven
peptide aggregates. This can also be seen from the 2D water density profiles as shown in
Figures 4.15b-e. The variation of equivalent radius of aggregate opening (defined as radius
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of circle whose cross sectional area is equal to the area of the opening) with depths of
bilayer for different numbers of peptides in the aggregate is shown in Figure 4.16. The
equivalent radius of aggregate is found to be minimum at the center of the bilayer.
Therefore, in the cases in which peptide is inserted into three to six peptide aggregates, the
pore structure is found to be closer to paraboloid with the cross sectional area being
minimum at the center. This can be also seen from the snapshots (Figures 4.9-12). The
equivalent radius of water channel was calculated based on the total number of water
molecules in the central region of the opening as described in methods section. Figure 4.15f
shows the plot of water channel radius versus number of peptides in peptide aggregate. The
water channel radius is found to increase with aggregate size with this increase being more
pronounced from six to seven peptides in the aggregate consistent with 2D water density
profiles (Figure 4.15b-e). In addition, all the peptides, including the inserting peptide and
preexisting peptide, maintain over 30% helical structure as can be from Figure 4.17.
4.3.4

Free energy calculation based on mathematic model

We present a model for the prediction of energy barrier for peptide insertion into a pore.
While MD simulation is capable of providing rich information about pore formation, such
a mathematic model based on intermolecular interactions will be useful for efficient
analysis of nucleation of pores. Nucleation of pores involves several steps, such as,
adsorption of peptide onto lipid bilayer followed by surface diffusion and penetration into
preexisting pores of different sizes thereby leading to formation of pore of critical size. The
information on energy barrier for addition of a single peptide into a preexisting pore will
be necessary for the evaluation of rate of penetration of a single peptide and hence growth
rate of pores. Since radius of aggregate at the center is almost equal to the radius of water
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channel, and the water density profile indicates the presence of water in the regions in the
vicinity of top and bottom leaflets, the region inside the aggregate opening can be assumed
to be aqueous. We can estimate the free energy change for insertion of a peptide based on
energetic considerations. We employ a simplified approach to estimate the hydrophobic,
electrostatic and bending free energy when transferred from the surface to the pore. This
approach would provide a general correlation between the energy barrier for peptide
insertion and the size of peptide aggregate in the preexisting pore. An ideal toroidal pore
will consist of an aggregate of peptides with their hydrophilic side chains pointing inwards
into the aqueous pore and the hydrophobic side chains pointing outwards into the lipid tails.
Also, these peptides will not be close packed thereby allowing some negatively charged
phospholipid heads to bend into the inner lining of the pore in regions between peptides in
order to partly neutralize the positive charge of the peptides. The electrostatic attraction of
phospholipid heads with charged groups of peptides will lead to bending of peptides to
form a paraboloid pore as was shown by the pore structure obtained from MD simulation
(see Figures 4.9-12). This analysis makes the following simplifying assumptions, namely,
(i) the hydrophobicity of peptide is uniformly distributed along the peptide backbone (ii)
the charge density of cationic peptide is also uniform along its length (iii) electrostatic
repulsion among point charges distributed along the hydrophilic side groups inside the pore
is approximated as electrostatic interaction inside a cylindrical cavity with uniform
distribution of surface charges – such an assumption is reasonable for pore sizes much
larger than the debye length since the charges are in the hydrophilic side chains facing the
inside that are subjected to Brownian motion. The free energy change upon insertion of a
peptide into a pore consists of several contributions, namely, (i) free energy of bending of
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phospholipid heads (ii) electrostatic free energy resulting from confinement of charges
within the aqueous pore and (iii) hydrophobic free energy as a result of exposure of
hydrophobic side groups into the lipid environment Detailed discussion of these
contributions can be found elsewhere263, 264.
In an ideal pore, the radius of curvature of this paraboloid pore is taken to be t pore 2 , t pore
being the thickness of the bilayer. From geometric consideration, p t pore 2 = l0 , where l0
is the length of the peptide backbone (consisting of 26 amino acid side chains with the
spacing between them being 1.5×10-10 m). The schematic of an ideal paraboloid pore is
shown in Figure 4.18. The pore is symmetric about the central plane of the lipid bilayer
with the pore diameter being the smallest at the center, increasing with the distance from
the center and becoming the largest at the top and bottom leaflets. Because of the repulsion
between phospholipid heads, the center to center distance between two phospholipid heads
is greater than dh . Let this distance be a dh , a > 1 . Since the phospholipids are bent along a
circumference ( l + dh ) , l and dh being the length of the lipid tail and the diameter of the
phospholipid head respectively, the number of layers nlayers of phospholipids in a pore is
given by nlayers = p ( l + dh ) a dh . The diameter of a pore d pore at the center consisting of na
peptides

and

(

nb

phospholipids

(

per

peptide

is

given

by

263

) )

d pore ( na ,nb ) = na d pep + na nb nlayers dh p . If q is the net (positive) charge of the peptide
and qlipid is the net (negative) charge of phospholipid head, the total charge inside the pore

qnet is equal to naq - nanbqlipid . From geometric considerations, the radius of the pore r ( x )
at any depth x into the lipid bilayer is given by,
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otherwise

In our simulations, the potential of mean force was evaluated for insertion of a peptide into
a pore that can accommodate na peptides but consist only of na -1 peptides with a vacant
space for the insertion of additional peptide. Consequently, the paraboloid structure of the
pore is that for aggregate of na peptide thereby ensuring that the insertion of additional
peptide did not change the pore structure.
We are now interested in evaluating the change in free energy when a melittin molecule is
inserted to different extents of penetration into a pore consisting of an aggregate of melittin.
Understandably, the free energy change will depend on how far the melittin molecule is
inserted into an existing pore. It is assumed that the melittin that is inserted is in α helical
conformation within the pore. It is also assumed that the peptides belonging to the
aggregate that form the pore are also in α helical conformation. The change in hydrophobic
free energy Df hy ( x ) as a result of insertion of a peptide up to a depth x is given by,
Df hy ( x, na ) = g hb

l ( x)
L

(3)

In the above equation, g hb is the hydrophobicity of melittin, L is the total length of the
peptide backbone and l ( x ) is the length of the peptide inserted into the pore for a
penetration of

x

as given by,
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Similarly, the bending free energy can be calculated as follows. At any depth of insertion
x , the two principal radii of curvature for the bending of phospholipid head are r ( x ) , the

radius of the pore, and t pore 2 , the radius of the arc along which they are bent (see Figure

I

4.18). Consequently, the free energy Dfbend change due to bending of phospholipid heads
is given by,
2
æxæ 2
ö
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(5)

Confinement of positive peptide charges within the pore will result in an electrostatic
repulsion. These charges are in the hydrophilic side chains of the peptide and therefore are
distributed along the peptide backbone. These charges exhibit Brownian motion.
Consequently, it can be assumed that the charges are uniformly distributed in the inner pore
surface. Based on electrostatic interaction inside a charged cylindrical curved surface, the
electrostatic free energy of paraboloid surface is given by263, 265,

qnet ( na , nb ) e 2 é y I12 ( y¢ )
1 ù dl
¢
Df el ( x, na , nb ) = ò ò
dy
+
ê
ú dy dx¢
p ye r e 0 L2 ë ò0 y¢
2 û dx
0 k r ( x¢ )
x

2

¥

(6)

Therefore, the net free energy change Df ( x, na ) for extent of insertion x into a pore
consisting of na peptides is given by,

(

)

(

)

(

)

(

Δf x, na = Δf hy x, na + Δf bend x, na , nb + Δf el x, na ,nb

)

(7)
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where Df hy ( x, na ) is the hydrophobic interaction free energy, Dfbend ( x, na , nb ) is the
bending free energy, and Dfel ( x, na , nb ) is the electrostatic free energy. In the above, x
refers to the extent of insertion of the peptide, na and nb refer to the number of peptides in
the pore and number of bent phospholipid heads per peptide respectively. The detailed
derivation of these quantities is given in Appendix. The potential energy vs extent of
insertion as evaluated by equation (7) for three different number of peptides in the pore as
shown in Figure 4.19 exhibits an energy barrier of 16.76kT for insertion of peptide into a
pore consisting of 3 peptides which decreases to a value of 3kT for insertion into a pore
consisting of 4 peptides. For a pore consisting of 5 peptides, however, insertion of a peptide
does not experience any energy barrier. These results are consistent with the MD
simulation results reported earlier. Comparison of energy barriers obtained from MD
simulation with the model prediction for insertion of melittin into pore consisting of
different number of peptides is shown in Figure 4.20. The predicted energy barriers
decrease with number of peptides in the pore and eventually become zero for five peptides.
Even though the predicted energy barrier agrees reasonably well with the value obtained
from MD simulation for pore sizes of six and seven peptides, the predicted value is found
to be higher than MD simulation value for pore sizes of four and five peptides. The
discrepancy between MD simulation and model predictions can be attributed to the
simplifying assumptions with regard to uniform distribution of charges and hydrophobicity
as well as the shape of the paraboloid pore employed in the model for the evaluation of
these potentials. The energy barrier for insertion of a peptide into peptide aggregates of
different sizes is important in the characterization of rates of formation and dissociation of
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pores of different sizes and therefore in the evaluation of rate of growth of pores due to
nucleation.

4.4

Conclusions

MD simulation of insertion of a melittin molecule into a transmembrane pore consisting of
different number of peptides inside a DOPC/DOPG lipid bilayer to different extents of
insertion indicated that water channel formation occurs only for insertion into pores
consisting of four or more transmembrane peptides. The radius of water channel was found
to be larger for larger number of transmembrane peptides. The structure of the pore is found
to be paraboloid with the minimum radius being at the center of the lipid bilayer. Insertion
of peptide into a pore is found to be energetically favorable. However, a melittin molecule
had to overcome an energy barrier for its complete insertion into the pore. This energy
barrier is found to be highest for insertion into lipid bilayer in the absence of
transmembrane peptides and is found to decrease with number of transmembrane peptides
from three to six eventually approaching zero at sufficiently large number. Estimation of
free energy of a melittin molecule at different extents of insertion into an ideal paraboloid
pore accounting for different intermolecular interactions indicated the existence of an
energy barrier consistent with MD simulation results. Quantification of energy barrier for
peptide insertion is important for the evaluation of rate of formation of pores of different
sizes which is necessary for the evaluation of rate of nucleation of pores.
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4.5

Figures and Tables
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Figure 4.1 Schematic of potential of mean force profile for insertion of a peptide into a
lipid bilayer, (a) identifies different locations of the peptide inside the bilayer in PMF
calculations for insertion, energy barrier and transmembrane state in the free energy
diagram and (b) depicts the insertion of a peptide into a preexisting pore of different sizes.
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Figure 4.2 Potential of mean force as a function of extent of insertion of a single melittin
into a pore formed by melittin aggregates of different sizes, a: lipid bilayer (no melittin), b:
three melittin, c: four melittin, d: five melittin, e: six melittin and f: comparison of energy
barrier ∆�m\n and energy change ∆� from surface state to transmembrane state between
each case.
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Figure 4.3 Potential of mean force as a function of extent of insertion of a single melittin
into a pore formed by melittin aggregates of different sizes, a: lipid bilayer (no melittin), b:
three melittin, c: four melittin, d: five melittin, e: six melittin and f: comparison of energy
barrier ∆�m\n and energy change ∆� from surface state to transmembrane state between
each cases. These results are obtained from simulation upto 120 ns.

84

11

l

coordinate (A)

Figure 4.4 Region defined according to the density profile of mixed DOPC/DOPG lipid
bilayer. Region I: upper leaflet lipid head, Region II: lipid tails, Region III: lower leaflet
lipid head
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Figure 4.7 Snapshots of single peptide inserting into lipid bilayer –different extents of
insertion of the peptide, a: 11.79 Å, b: 0.52 Å, c: -4.52 Å, d: -18.12 Å. Color code: yellow:
DOPC lipid heads, pink: DOPG lipid heads, gray: lipid tails, cyan: water. Blue: charged
residues, green: polar residues and white: nonpolar residues.
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Figure 4.8 Density profile of single melittin at different locations of lipid bilayer when
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Figure 4.9 Snapshots of single peptide penetrating into a pore formed by aggregate of three
peptides, a: 11.99 Å, b: 4.49 Å, c: -6.21 Å, d: -15.34 Å. Color code: orange: preformed
transmembrane peptide aggregate; other color codes are the same as FIGURE 5.
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Figure 4.10 Snapshots of single peptide penetrating into a pore formed by aggregate of four
peptides, a: 10.09 Å, b: 0.97 Å, c: -5.87 Å, d: -15.05 Å. Color code: orange: preformed
transmembrane peptide aggregate; other color codes are the same as Figure 4.7.
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Figure 4.11 Snapshots of single peptide penetrating into a pore formed by aggregate of five
peptides, a: 11.31 Å, b: 1.49 Å, c: -3.64 Å, d: -13.36 Å. Color code: orange: preformed
transmembrane peptide aggregate; other color codes are the same as Figure 4.7.
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Figure 4.12 Snapshots of single peptide penetrating into a pore formed by aggregate of six
peptides, a: 11.38 Å, b: 0.07 Å, c: -5.11 Å, d: -15.72 Å. Color code: orange: preformed
transmembrane peptide aggregate; other color codes are the same as Figure 4.7.
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Figure 4.13 Density profile for single melittin at the center of lipid bilayer with different
number of preexisting peptides in the pore. (a) three, (b)four, (c) five, and (d) six.
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Figure 4.14 Density profile for single melittin at the surface of lipid bilayer with different
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5. IDENTIFICATION OF ANTIMICROBIAL PEPTIDES FROM
SOY PROTEIN 7S GLOBULIN

5.1

Introduction

Due to the rising concern of generation of multi-resistant bacteria, the discovery and
application of conventional antibiotics against pathogenic bacteria has decreased in recent
decades. Antimicrobial peptides (AMPs), as compared to the traditional antibiotics, own
the ability of targeting multiple pathogens without producing resistant. AMPs belong to a
large and varied class of relatively short peptides family, typically containing 10-15
residues

27, 266

. As part of the host-defense system in many living organisms, they are

capable of killing broad spectrum bacteria, including both gram-positive and gramnegative bacteria. This renders them of great interest as potential alternatives to traditional
antibiotics and highly relevant from a pharmaceutical perspective

267

. In the family of

AMPs, there are large number of peptides predominantly adopting an α helical secondary
conformation in the hydrophobic environment of lipid bilayer 268 and containing positive
charges. They disrupt or permeabilize the cell membrane by pore formation, leading to cell
lysis and death consequently 30, 269.
Current research of AMPs is mainly focusing on naturally occurring peptides, such as
melittin from bee venom 270, cecropin from insects or pig intestinie 271, 272, alamethicin from
the fungus Trichoderma viride 273, hispidulin from the medicinal plant Benincasa hispida
274

etc. There are also attempts to design synthetic peptides that exhibit antimicrobial

activity 275, 276. However, the resources of these AMPs are very expensive, infrequent, and
not easy to produce in large scale. Therefore, commercial-scale production platforms to
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produce AMPs are urgently needed. In this context, production of AMPs from soy protein
become an attractive, cost-saving alternative for commercial consideration, due to the
abundant and common properties of soy protein. In addition, the AMPs from edible soy
protein are considered to be “natural”, which are promising to replace antibiotics in human
health and animal feed. The application of these AMPs can be also expanded to food safety,
such as (i) antimicrobial coating in packaging film, and (ii) natural food additives. In this
research, a methodology for identification of peptide segments with antimicrobial activity
from soy protein β-conglycinin (7S) subunits is proposed. To the best of our knowledge,
this is the first study that developed a methodology to identify AMPs from natural protein
molecule. The proposed method avoids expensive trials and would therefore decrease the
cost of producing AMPs from any natural protein. 7S is one of the most abundant storage
proteins in soy, which constitute 30–46% of the total water-extractable proteins in soy 277.
7S has a large molecular mass of 180–210 kDa

278

and a compact globular structure at

physiological pH 279. It consists of three major subunits: α (67 kDa), α′ (71 kDa) and β (50
kDa) 280. In this chapter, 7S was chosen to be the target protein for screening AMPs.
It is well known that natural AMPs deactivate microorganisms by forming pores on their
cell membrane. This pore formation event starts by electrostatic attraction followed by
adsorption and penetration into cell membrane by peptides and has been subject to several
investigations 229, 281-284. Various experimental techniques, such as fluorescent 263, oriented
circular dichroism

174

, NMR spectroscopy

173

, and x-ray crystallography

272

, have been

employed to monitor pore formation, structure of the pore, secondary conformation of the
peptide, orientation of peptide and lipid, as well as thinning of the membrane. Studies using
model membranes have elucidated different mechanisms of pore formation by AMPs such
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as hydrophobic (barrel-stave) pore, hydrophilic (toroidal) pore, and micelle formation
(carpet mechanism) and have helped identify key factors that control pore formation

282

.

Molecular dynamics (MD) simulation, a technique in which the evolution of positions of
all atoms belonging to peptide when interacting with lipid bilayer accounting for
interatomic interactions such as van der Waals, electrostatic etc. has been employed to
evaluate the potential energy of interaction
orientation

287

, and lipids deformation

288

285

, peptide conformation

286

, peptide

. In order to predict antimicrobial activity of a

peptide, a combination of physicochemical properties and conformational features such as
size, charge, hydrophobicity, amino acid sequence, and secondary structure should be taken
into account. Physicochemical properties of some naturally occurring AMPs have been
reported before

96, 289-291

. Higher hydrophobicity would result in lower free energy of

penetration of peptide into the cell membrane. On the other hand, hydrophobicity should
not be so high as to make the peptide insoluble leading to its aggregation in aqueous
environment. Therefore, the hydrophobicity of the AMPs should be within a desirable
range as can be seen from the values for different naturally occurring AMPs

96, 289-291

.

Positive charges are another important character for AMPs to facilitate their attachment to
the anionic bacterial cell membrane. However, sufficiently high positive charge would
result in higher hydrophilicity thereby making it difficult for the peptide to penetrate into
the lipid bilayer. In addition, high charge will also result in high energy barrier for pore
formation because of electrostatic repulsion within the pore due to confinement of charge
263, 264

.

Several AMP prediction tools have been developed in recent decades

292-298

. Current

physicochemical prediction methods indicated that higher hydrophobicity would increase
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the peptides’ affinity to lipids 299 and higher charges can promote interaction with anionic
membrane component

299

. Most physicochemical prediction methods adopt the α-helical

peptide as the basis for their study. Consequently, another important parameter is
hydrophobic moment which is an index of α-helix formation: peptides with higher
hydrophobic moment may have an amphiphilic favorable α-helical structure 87, 300. Most of
current methods for prediction of antimicrobial activity are not mechanistic since they are
based on the comparison of amino acid composition, charge, helicity, and hydrophobicity
with corresponding properties of AMPs in the existing database. Consequently, these
methods are limited to identify AMPs with complex structure and lack of validation 301, 302.
In this chapter, we developed a methodology for identification of AMP segments from soy
protein 7S globulin based on (i) their physicochemical properties and (ii) their interaction
with mimic bacterial cell membrane. The effect of different physicochemical properties on
the interaction of these peptides with cell membrane is ascertained using MD simulation.
This proposed methodology is capable of accounting for interaction of AMP with the cell
membrane of a specific microorganism since the proposed methodology is mechanistic.
Therefore, the proposed methodology can be employed to identify an AMP targeted for
different microorganisms. We identified one AMP segment from 7S α subunit and
experimentally verified its antimicrobial activity against Listeria monocytogenes (L.
monocytogenes) F4244 and Escherichia coli (E. coli) O157:H7 EDL933. The method
described in this research can be also applied to identify AMPs from other inexpensive
proteins to produce value-added products from these proteins and eventually, help broaden
the application of AMPs.
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5.2
5.2.1

Material and Methods
Materials

Identified peptide segments were synthetized, purity >95% (GenScript, USA). L.
monocytogenes F4244 and E. coli O157:H7 EDL933, Trifluoroacetic acid (TFA) and
Dimethyl sulfoxide (DMSO) were from Sigma-Aldrich.
5.2.2

Selection of possible AMPs from soy protein 7S globulin

Possible AMPs segments were selected from three subunits from 7S: α (Uniprot: P13916),
α’ (PDB:1UIK) and β (PDB:1UIJ), based on the criteria of (i) the number of amino acids
(18-28), (ii) net charge (>+2), (iii) Eisenberg scale hydrophobicity

303

(>−0.30 kcal/mol)

and (iv) hydrophobic moment 99 (>+0.20 kcal/mol).
5.2.3 Description of the lipid bilayer system
The initial lipid bilayer structure for the simulation was built using the CHARMM-GUI
web tool

304

. The bilayer in the simulation was represented by mixed 1,2-Dioleoyl-sn-

glycero-3-phosphocholine

(DOPC,

neutral)/

1,2-di-(9Z-octadecenoyl)-sn-glycero-3-

phospho-(1'-rac-glycerol) (DOPG, negatively charged) in a 3:1 ratio bilayer. DOPC/DOPG
mixed bilayers are negatively charged membrane, mimicking bacterial membrane. The
peptide/lipid ratio was 6/128 with six peptides inside the lipid system. Chosen peptides
were placed (i) on the surface of lipid membrane to observe the interaction of peptide and
lipid membrane, (ii) inside the membrane in order to observe deformation of lipid
membrane and formation of water channel. 0.150 M KCl was added and the final system
was neutral. All-atom MD simulation was employed with Amber14 software package 305.
The snapshots were visualized using VMD software 134.
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5.2.4

Different initial structures

Surface and transmembrane MD simulation were performed for different initial structures
for all peptides that are investigated (7a16 and 7a187). Initial structures from four different
resources were involved in the MD simulation. The first and second initial structures were
obtained from online peptide structure constructor PEP-FOLD 306, 307. The two structures
were chosen as those with the largest structural difference (as quantified by RMSD), and
were coded as Model1 and Model2. The third initial structures, coded as Model 3, was
obtained from implicit MD simulation after 50 ns using AMBER14 software and AMBER
ff99SBildn force field, as dielectric constant set up to 20, which mimic the lipid
environment.
5.2.5

MD simulation setup

AMBER ff99SBildn force field 308 (employed for the peptides) and Lipid11 force field 309
(employed for lipid force field) were used and the combination of these two force fields
would be referred to hereafter as Amber force field. Careful minimization to remove bad
contacts and steric hindrances was performed before slowly heating the system to 303 K:
first, the configurational energy of the system was minimized by performing 2000 steps of
a steepest descent algorithm followed by 3000 steps of a conjugate gradient algorithm 310.
The protein-membrane system, then, was relaxed prior to running heating MD using
constant pressure (NPT) to reach the target temperature (303 K). During the heating, the
position of lipid atoms was kept fixed with harmonic constraints. A 5 ns MD simulation at
303 K with a NPT ensemble was performed to equilibrate the system followed by 50/100
ns production runs of constant surface tension “γ” (NPγT) simulation. Langevin dynamics
was employed with a collision frequency γ = 1 ps−1. Semi-isotropic pressure scaling was
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used to maintain the pressure at 1 atm with a constant surface tension value set to 15
dyn/cm. Nonbonded interactions were calculated with a cutoff at 10 Å; full electrostatics
was employed using the particle-mesh Ewald method. Covalent bonds involving hydrogen
atoms were held rigid with the SHAKE algorithm, allowing a 2 fs time step.
5.2.6

Bioassay and viability studies

The potential candidates of peptide fragments from soy protein for antimicrobial activity
that were identified using MD simulation were commercially synthesized (GenScript,
USA). 7a16 was dissolved in 20% DMSO solution and 0.1% trifluoroacetic acid (TFA).
Antimicrobial activity of synthesized peptide (SP) fragments was tested against L.
monocytogenes F4244 (Gram positive) and E. coli O157:H7 EDL933 (Gram negative)
bacteria by using spot-on-lawn test. The bacteria were stored as 10% frozen glycerol stocks
in deep-freezer at −80 °C. Prior to experiments, frozen stocks of bacteria strains were added
into a tube that contain 3.7% (w/v) brain heart infusion (BHI) and incubated at 37 °C for
24 h. Then 50 µL cultured bacteria were transferred to 3 mL buffer that contain 3.7% (w/v)
BHI and 0.8% (w/v) agar. Next, the above solution was poured to a petri plate followed by
exposing to selected SP of different concentrations (10 µL each spots). The petri plates
were incubated in 37 °C incubator overnight to observe the formation of inhibition ring.
Viability assay for the antimicrobial activity of 7a16 was performed in 96 well micro-titer
plate over a period of 7 h by measuring absorbance (wavelength = 595nm) every 30 min
using a microplate reader (Benchmark, BIO-RAD). 200 µL reaction volume was setup in
duplicate with sterile BHI broth inoculated with 5 × 107 cells of L. monocytogenes and E.
coli. For E. coli, 7a16 were added into the reaction volume at the concentration of 5, 2.5,
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1.25, 0.63, 0.32 and 0.16 mg/mL. For L. monocytogenes, 7a16 was added into the reaction
volume at the concentration of 2.3, 1.15, 0.58, 0.29, 0.15 and 0.08 mg/mL.

5.3
5.3.1

Results and Discussion
Identification of AMPs from soy protein

Initial screening of peptide segments belonging to soy protein subunits was undertaken
based on physicochemical properties such as total number of amino acids, hydrophobicity,
hydrophobic moment and charge. The criteria for screening was derived from the
physicochemical properties of many naturally occurring AMPs. Proposed mechanism of
pore formation by AMP in a cell membrane (lipid bilayer) 311 suggest that they should first
bind to the cell membrane and subsequently aggregate within the bilayer to form a
transmembrane pore. In order to exhibit antimicrobial activity, a peptide fragment should
satisfy both criteria, namely, (i) bind to membrane surface, and (ii) its aggregate should
form a pore. Therefore, a surface MD simulation of peptide fragment was first performed.
In this simulation, peptide fragments were placed on the surface and the evolution of their
center of mass was tracked to ascertain their ability to bind to the lipid bilayer. Those
peptide fragments were then subjected to transmembrane MD simulation in which four
molecules of the peptide were placed across the lipid bilayer with their hydrophilic side
chains facing inwards. These simulation results indicated the ability of peptides to form a
water channel across the membrane and hence a pore. The peptides that satisfy both criteria
are likely to exhibit antimicrobial activity.
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5.3.2

Selection of possible AMP segments from soy protein

Figure 5.1 shows an example of selecting possible AMP regions based on physicochemical
properties from 7S α’ subunit. The α’ subunit contains 414 amino acids; therefore, it would
have 394 peptide segments with 20 amino acids per peptide. The net charge,
hydrophobicity and hydrophobic moment were calculated for each peptide, and the results
are shown in Figure 5.1. Peptide segments in the red rectangular regions have net charge
≥2, hydrophobicity > -0.30 kcal/mol, and hydrophobic moment > 0.20 kcal/mol, which are
the criteria for selection of AMP that is based on properties of most naturally occurring
AMPs and therefore, are possible AMP candidates. One peptide from seven in the
rectangular regions was chosen for further investigation since their sequences are similar.
Possible AMP candidates from other soy subunits with different peptide lengths (20–30
amino acids) were calculated with the same selection criteria and the results are not shown.
Two possible AMP candidates (coded as 7a16 and 7a187) were selected from 7S for further
investigation, based on their physiochemical properties, namely, their sequence, net
charge, hydrophobicity and hydrophobic moment (Table 5.1).
5.3.3

Surface-membrane MD simulation

Surface-membrane MD simulation was performed to evaluate the potential antimicrobial
activity of peptides 7a16 and 7a187 by investigation of their interaction with lipid bilayer.
These simulations were performed for multiple initial conformations. Six molecules of a
peptide were placed on the top leaflet of a 3:1 DOPC/DOPG mixed lipid membrane (a
mimic of bacterial cell membrane). Here we present the results for one initial conformation
for illustrative purposes. The effect of different initial conformations on surface binding is
discussed in Section 5.3.5.1. Initial and final snapshots for 7a16 and 7a187 placed on the
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surface of mixed lipid membrane are shown in Figure 4.2 and the distance between center
of mass of peptide and lipid membrane over time are given in Figure 4.3. After 500 ns MD
simulation time, 7a16 did not leave the lipid membrane and their center of mass remained
inside the bilayer indicating thereby that these peptides penetrate the membrane. On the
other hand, MD simulation results show that only one out of four molecules of 7a187
remained inside the lipid bilayer. This indicates that 7a187 would prefer water
environment, and is not able to penetrate into the lipid membrane. Therefore, 7a187 does
not bind to the top leaflet of the lipid bilayer and hence is unlikely to exhibit antimicrobial
activity. To verify the antimicrobial activity of these two peptides, transmembrane MD
simulation was performed to further investigate peptide-lipid interaction.
5.3.4

Trans-membrane MD simulation

Transmembrane MD simulation was performed to investigate the formation of a water
channel (channel of water molecules across the bilayer as indicated by non-zero water
density) and bending of lipid heads. The purpose behind transmembrane simulation is to
ascertain the ability of transmembrane aggregates under ideal conditions to form water
channel. On the other hand, those peptides that do form water channel will have high
probability of antimicrobial action. Therefore, the proposed transmembrane simulation will
screen peptides that cannot form a pore. These simulations were performed for multiple
initial conformations. Here we present the results for one initial conformation for
illustrative purposes. The effect of different initial conformations on water channel
formation is discussed in Section 5.3.5.2. Six molecules of a peptide were initially placed
in the center of the lipid membrane, with hydrophilic residues facing inwards. Formation
of a water channel indicates a pore and therefore potential antimicrobial activity. Figure
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5.4 shows snapshots of MD simulation for the six peptides at 500 ns. Water channels as
well as bending of phospholipid heads can be observed for 7a16 and 7a187. Specifically,
for 7a16, the bent phospholipids heads protrude into the peptides, consistent with toroidal
structure 311. 7a187 tends to move to the lower membrane leaflet. The pore structure was
found to be disordered consequently.
Normalized density profiles of water, lipid head and peptide (Figure 5.5) clearly indicate
the formation of water channel and bending of lipid heads for 7a16, which is consistent
with the snapshot results (Figure 5.4). Side view of 2D density plots (Figure 5.6), clear
show the water channel for 7a16. Top views of water and peptide density profiles also
indicate pore formation. However, for 7a187, the peptides lost their original compact
position as indicated by their contours in lowest middle panel (Figure 5.6), and therefore
the water molecules do not form a stable continuous water channel. Since 7a187 does not
satisfy both criteria, viz. peptide-lipid binding and pore formation, it is not likely to exhibit
antimicrobial activity.
5.3.5

Effect of initial structures

5.3.5.1 Surface simulation
In this section, we compared the effect of initial structure on the simulation results. Two of
the initial structures of peptides were obtained from PEP-FOLD prediction (coded as
Model 1 and Model 2 respectively), whereas the third structure was obtained from implicit
solvent MD simulation (coded as Model 3/Implicit). The binding affinity of 7a16 for three
different initial structures were studied by performing MD simulation of six peptides that
are placed at the upper leaflet of the lipid bilayer. The main difference between these initial
structures are configuration and helicity. Model1 has a helicity of 55%, Model 2 has a
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helicity of 43%, and Model 3 has a helicity of 30%. The helicity is calculated by DSSP
method 260. Figure 5.7 shows the three initial peptide structures and snapshots of peptides
at 500 ns. From Figure 5.7, one can observe that the peptide remained inside the lipid
bilayer after 500 ns simulation for all the three cases.
The binding affinity for 7a187 for three different initial structures were studied by similar
MD simulations. Among these peptides, Model 1 has 95% helicity, Model 2 has 50%
helicity, and Model 3 has 20% helicity from implicit simulation. Figure 5.8 shows the
configuration of initial structure, initial position of peptides, and 500ns simulation results.
For Model 1 and Model 2, although part of peptides still interacted with lipid bilayer, most
part of peptides are above lipid heads, which is the aqueous environment. For Model 3,
peptides are all moved above the membrane, one of the peptide even leave the bilayer and
move into the aqueous solution. The results indicated that 7a187 are more favorable in
aqueous solution than inside the membrane.
The evolution of the distance between the center of mass of peptides and lipid membrane
as shown in Figure 5.9 further demonstrated that all three initial structures are able to bind
with the lipid bilayer with all peptides remaining inside the bilayer for 7a16, while 7a187
are more favorable to stay above the lipid heads indicating its unfavorable binding affinity.
Figure 5.10 shows the normalized density profile of the hydrophobic and hydrophilic
residues of the peptides placed on the upper leaflet of the bilayer for both 7a16 and 7a187.
All the peptides showed the hydrophobic residues distribution is closer to bilayer center
than hydrophilic residues. For Model 1 of 7a16 and 7a187, this phenomenon is the most
obvious: at around 16 Å from the lipid center of mass whereas the hydrophilic residues are
located at around 22 Å. For the Model 3 of 7a187, peptides moving into the water could
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also be captured as shown in Figure 5.10. These results demonstrate that the binding
affinity of peptides onto the top leaflet of lipid bilayer is insensitive to their initial
conformation.
5.3.5.2 Transmembrane simulation
Impact of initial structure of 7a16 and 7a187 were further validated through transmembrane
MD simulation. Figure 5.11 shows the snapshots for the remaining two different structures
inside DOPC/DOPG lipid bilayer after 500 ns simulation. From the snapshots, one can
observe that 7a16 induced significant lipid heads bending and water channel formation,
whereas 7a187 induced less lipid heads bending and less concentrated water channel
formation. 2D density plot of water and peptides are shown in Figure 5.12. For Model 2
and Model 3 of 7a16, the peptides are surrounded into a complete pore, while the water
channel is formed in the center of the pore. The third column of water density in xz plane
indicates the significant water channel formation for 7a16 as shown in Figure 5.12. For
7a187, Model 2 and Model 3 are slightly different. For Model 2, it seems there is a water
channel formation from both snapshots and 2D density profile (Figure 5.11 and 5.12),
however, the density distribution indicates some peptides alter their orientation from
vertical to parallel with lipid bilayer (Figure 5.12). The number of lipid heads bending into
the pore is also not significant as shown in the snapshot (Figure 5.11). For Model 3,
although it also showed water molecules through the membrane, both snapshots and water
density indicate the water molecules mostly existence around the peptides, instead of
forming a water channel in the center of the peptides aggregates. Therefore, Model 2 and
Model 3 of 7a187 also showed disability of forming pores and water channel inside the cell
membrane.
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It should be noted that, different initial structures of a peptide can result in different
evolution of its secondary conformations during MD simulation. In addition, the peptide
position inside lipid membrane can also be affected, for the reason that with different
structures, there is a different charge density over the length of the peptide. For example,
with a helical and bend structure, 7a16 is able to keep vertical inside lipid membrane since
its charged residues are almost evenly distributed over the peptide. On the other hand, with
a disordered structure, the charged residues could be accumulated on one side, thereby
resulting in excess electrostatic interaction which in turn would attract the peptide to either
lower or upper leaflet of the lipid bilayer. However, different initial structures yielded the
same qualitative features for the formation of water channel and deformation of lipid
membrane. In addition, the helicity is not a prerequisite for water channel and lipid head
bending. The result agrees with MD simulation investigation on pore formation by melittin
312

, which indicated that melittin lost its helicity during the pore formation but still water

channel formation and lipid heads bending were observed.
5.3.6

Bioassay and viability studies

As pointed out above, the peptides that satisfy (i) ability to bind to top leaflet of lipid bilayer
and (ii) ability for transmembrane peptides to form water channel are likely to exhibit
antimicrobial activity. 7a16 satisfied both criteria. In order to test the validity of proposed
methodology, we tested the antimicrobial activity of 7a16 and 7a187 against gram positive
L. monocytogenes F4244 and against gram negative E. coli O157:H7 EDL933 by spot-onlawn assay, as shown in Figure 5.13. Their susceptible MIC and inhibitory zone diameter
are given in Table 5.2. No inhibitory ring was observed for peptide 7a187, whereas 7a16
is able to inhibit the growth of both L. monocytogenes at concentration of 5.0 µM/mL and
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above, and E. coli at concentration of 19.8 µM/mL and above. Bacterial optical density
measurement (OD) for 7a16 also indicates that the peptides are more sensitive to L.
monocytogenes with a minimum inhibitory concentration (MIC) of 0.91 µM/mL as shown
in Figure 5.14. Experiments could not be performed at higher peptide concentration
because of limited solubility.
5.3.7

Comparison with online prediction

In general, predictions of antimicrobial activity by different online prediction tools did not
agree with our results (Table 5.3). Antimicrobial Peptide Database (APD)
Collection of Anti-Microbial Peptides (CAMP)

295

292

and

predictions for 7a187 as well as

Database of Antimicrobial Activity and Structure of Peptides (DBAASP) 294 did not agree
with our experiments. DBAASP, iAMP-2L

313

and AntiBP2

297

were unsuccessful in

predicting antimicrobial activity for 7a16.
The proposed methodology consists of three steps. The first prescreening step is based on
selection of peptides with physicochemical properties that are close to natural AMP. Based
on MD simulation that accounts for mechanistic peptide-lipid interaction, subsequent two
steps identify peptides (from prescreened candidates) that exhibit (i) binding affinity to
surface of lipid bilayer and (ii) ability of transmembrane peptide aggregates to form water
channel under ideal conditions. Consequently, the proposed method is feasible with respect
to its requirement of computational resources. The robustness of proposed methodology
was established by performing MD simulation for surface binding and water channel
formation for limited number of different initial conformations. The proposed method
identified the same peptides for antimicrobial activity from the list of candidates (from
initial screening) when AMBER or CHARMM36 force fields were employed in MD
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simulation, as indicated in our published paper

166

. Although the physicochemical

properties of 7a187 are similar to those of 7a16, high total charge of 7 for the former results
in it moving away from the top leaflet into the water phase in surface simulation (Figure
5.2). High total charge also leads to its movement to the lower leaflet in transmembrane
simulation (Figure 5.4), not conducive to water channel formation. Since adsorption of
peptide is the first step in its penetration into the cell membrane to form a pore, it is
important that the two criteria, namely, tendency to stay on the lipid surface in surface
simulation and water channel formation in transmembrane simulation be satisfied for
antimicrobial activity. Unlike the online prediction tools, this methodology accounts for
the effect of specific amino acid sequence of peptide on its interaction with cell membrane.
On the other hand, the current AMP prediction tools are statistical data based. Since APD
292

prediction is based on the assumption of helical structure, it does not give sufficient

weightage to the effect of charged residues and hydrophobicity on lipid-peptide interaction.
Since CAMP

295

and AntiBP2

297

predictions are based on existing antimicrobial peptide

database, they are not mechanistic. The DBAASP 294 tool uses an algorithm of prediction
based on charge density, hydrophobicity, amphipathicity, location of the peptide in relation
to membrane, propensities to disordered structure and aggregation but does not account for
the interaction of lipid head and water molecular with peptides in its prediction. iAMP-2L
313

takes physicochemical properties of each amino acids (such as hydrophobicity, pK1

(CCOOH), A pK2 (NH3), PI (25 °C) and molecular weight) into account in its fuzzy Knearest neighbor (FKNN) algorithm to predict antimicrobial activity and does not consider
structural features and amphiphilic characteristics. The main drawback of all these online
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prediction tools is that they often fail to predict antimicrobial activity of peptides that does
not have any similarity to existing peptides in their database.
The results show that 7a16 exhibit higher antimicrobial activity to L. monocytogenes. This
could be that L. monocytogenes a gram-positive bacterium, involves a single cytoplasmic
membrane, whereas gram-negative bacteria such as E. coli have an outer membrane and
an inner membrane, which could increase the difficulty of penetration of AMPs into the
bacterial cell membrane thereby resulting in lower antimicrobial activity.
We believe that our methodology is better than existing online AMP prediction tools since
it provides a detailed information on the effects of charge distribution, amino acid sequence
and secondary structure of peptide on its interaction with cell membrane, and has the
potential of predicting antimicrobial activity against a specific microorganism and more
importantly, it is feasible with respect to its requirement of computational resources. Our
methodology is validated by the fact that the antimicrobial activity of two peptides (7a16
and 7a187) as predicted by the proposed methodology, based on the ability of (i) surface
peptides to bind to the cell membrane and (ii) transmembrane peptides to form water
channels in the cell membrane, is consistent with the experimental measurements against
L. monocytogenes F4244 (gram-positive) and E. coli O157:H7 EDL933 (gram-negative).
The proposed methodology, therefore, can be applied to identify new sources of AMP from
several protein sources.
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5.4

Conclusions

In this chapter, we developed a methodology based on mechanistic evaluation of peptidelipid bilayer interaction to identify AMPs from soy protein 7S globulin. Initial screening
of peptide segments from soy β-conglycinin (7S) subunits was based on their
hydrophobicity, hydrophobic moment and net charge. Delicate balance between
hydrophilic and hydrophobic interactions is necessary for pore formation. High
hydrophobicity decreases the peptide solubility in aqueous phase whereas high
hydrophilicity limits binding of the peptide to the bilayer. Out of two candidates chosen
from the initial screening, one peptide (coded as 7a16) satisfied the criteria for
antimicrobial activity, viz. (i) lipid-peptide binding in surface state and (ii) pore formation
in transmembrane state of the aggregate. This method of identification of antimicrobial
activity via molecular dynamics simulation was shown to be robust in that it is insensitive
to the initial peptide structure. Their antimicrobial activity against L. monocytogenes and
E. coli was further confirmed by spot-on-lawn and OD test. Future work could focus on
improvement of the selection criteria and validation of this methodology on other protein.
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different starting location of 7S α’ subunit.
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7a187

500ns

Initial positions

7a16

Figure 5.2 MD simulation snapshots of six peptides placed on the top leaflet of 3:1
DOPC/DOPG bilayer for initial and 500 ns. Color code: yellow, DOPC lipid heads; pink,
DOPG lipid heads; deep blue, charged residues; green, polar residues; white, nonpolar
residues. Lipid tails and water molecules are not shown for clarity.

121

(a)

(b)

Figure 5.3 The evolution of distance between the center of mass of six peptides and lipid
membrane as obtained by surface-membrane MD simulation for 3:1 DOPC/DOPG mixed
lipid bilayer. The six peptides are denoted by different colors. (a) 7a16; (b) 7a187.
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Lipids

Water

7a187

7a16

Overview

Figure 5.4 Snapshots of transmembrane MD simulation at 500 ns for four peptides placed
across 3:1 DOPC/DOPG mixed lipid bilayer. Color code: grey, lipid tails; blue, water; the
other color codes are the same as that given in Figure 5.2.
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Figure 5.5 Normalized density profiles of six transmembrane peptides in 3:1 DOPC/DOPG
mixed membrane averaged from 300 ns to 500 ns: (a) 7a16, (b) 7a187. Solid line: water;
dashed line: lipid; dotted line: peptide. The inset in these figures give the normalized
density near the center of the bilayer in expanded scale.
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Peptide (xy plane)

Water (xz plane)

7a187

7a16

Water (xy plane)

Figure 5.6 2D density plot of six transmembrane peptides placed across 3:1 DOPC/DOPG
membrane. Density was averaged from 300 ns to 500 ns, showing water density (from top),
peptide density (from top) and water density (from side), respectively. The unit for
coordinate is Å. Color bar represents the number of atoms.
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Model 2

Model 3

500ns

Initial positions

Initial structures

Model 1

Figure 5.7 MD simulation snapshots of 7a16 with three different initial structures. Six
peptides were placed on the top leaflet of 3:1 DOPC/DOPG bilayer for initial and 500 ns.
Color cods are the same as Figure 5.2. Lipid tails and water molecules are not shown for
clarity.
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Model 2

Model 3

500ns

Initial positions

Initial structures

Model 1

Figure 5.8 MD simulation snapshots of 7a187 with three different initial structures. Six
peptides were placed on the top leaflet of 3:1 DOPC/DOPG bilayer for initial and 500 ns.
Color codes are the same as Figure 5.2. Lipid tails and water molecules are not shown for
clarity.

Distance (A)
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Time (ns)

Figure 5.9 The evolution of distance between the center of mass of six peptides and lipid
membrane as obtained by surface-membrane MD simulation for 3:1 DOPC/DOPG mixed
lipid bilayer. The six peptides are denoted by different colors. The dashed line indicated
the interface of the lipid and water environment. Three different initial structures obtained
from 7a16 and 7a187, implicit is Model 3.
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Figure 5.10 Normalized density profile of the hydrophobic and hydrophilic residues of the
peptides placed on the upper leaflet of the bilayer. Three different initial structures from
7a16 and 7a187: (a) Model 1; (b) Model 2; (c) Model 3 (Implicit).
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Figure 5.11 Snapshots of MD simulation of remaining structures of 7a16 and 7a187 at 500
ns for four peptides placed across 3:1 DOPC/DOPG mixed lipid bilayer. Color codes are
the same as Figure 5.2.
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Figure 5.12 2D density plot of four peptides averaged from 300 ns to 500 ns, showing water
density (from top), peptide density (from top) and water density (from side), respectively.
The unit for coordinate is Å. Color bar represents the number of atoms.
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Figure 5.13 Spot-on-lawn test of antimicrobial activity of 7a16 and 7a187 against L.
monocytogenes F4244 and E. coli O157:H7 EDL933. The inhibitory rings at different
concentrations are indicated by circles.
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Figure 5.14 Effect of different concentration of 7a16 on the growth of L. monocytogenes
F4244 and E. coli O157:H7 EDL933 with time. (a) UV absorbance of 7a16 against E. coli
O157:H7 EDL933. (b) UV absorbance of 7a16 against L. monocytogenes F4244.
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Table 5.1 Possible AMP candidates from 7S α’ subunit.
code

subunit

Sequence
Residues
H*
FQTLFKNQYGHVR
7a16
α’
20
-0.275
VLQRFNK
SVIVEISKKQIRELS
7a187
α’
21
-0.2733
KHAKSS
*H is hydrophobicity, µH is hydrophobic moment, C is net charge

µH

C

0.3257

+4

0.311

+3
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Table 5.2 Susceptible MIC of 7a16 and 7a187 against L. monocytogenes F4244 and E.
coli O157:H7 EDL933 obtained by spot-on-lawn assay.
L. monocytogenes
Susceptible
Susceptible
MIC (µM/mL) MIC (µg/mL)
7a16
7a187

5.0
>42.2

12.5
>100

Zone
Diameter
(mm)
7.5
Not
observed

E. coli
Susceptible
MIC
(µM/mL)
19.8
>42.2

Susceptible
MIC
(µM/mL)
50.0
>100

Zone
Diameter
(mm)
10.8
Not
observed
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Table 5.3 Comparison of experimental antimicrobial activity with predictions by online
AMP prediction tools.
Peptides

7a16
7a187

Experimental
results

Our
prediction

Online AMP prediction
APD
CAMP
DBAASP

0.91 µM/mL*
No

Yes
No

Yes
Yes

Yes
Yes

No
Yes

iAMP2L
No
No

AntiBP2
No
No

136

6. CHARACTERIZATION OF INTERACTION BETWEEN
CURCUMIN AND DIFFERENT TYPES OF LIPID BILAYERS BY
MOLECULAR DYNAMICS SIMULATION

6.1

Introduction

Natural antimicrobial molecules, such as enzymes 314-316, bacteriocins 317-319, essential oil
320-322

, organic acid 323, 324, and phenolic compounds 325-331, have attracted great attention in

controlling infectious food borne outbreaks in recent decades. Among these agents,
phenolic compounds showed capability of interaction with membrane by altering
properties of the cell 3-5, while the exact mechanism responsible for these altering abilities
remain

largely

unclear.

Therefore,

curcumin

(CUR

[1,7-Bis(4-hydroxy-3-

methoxyphenyl)-1,6-heptadiene 3,5-dione]), as a typical hydrophobic polyphenol
molecule extracted from Curcuma longa, was selected for investigation of its interaction
with lipid bilayers in this study.
CUR is widely used as a natural food coloring and seasoning from ancient times. It has two
aromatic groups with hydroxyl groups and other substituents at each end of the molecule,
and these two aromatic rings are linked by a diene chain, which is similar to the structure
of stilbenoids. As the active component of Curcuma longa turmeric, CUR was studied
worldwide and reported to possess multiple functions, including: antimicrobial

332-334

,

antioxidant 335-337, anti-Alzheimer’s 338-340, anticancer 341, 342, anti-inflammatory 343, 344 etc.
Although various studies have reported that CUR is able to inhibit the growth of several
microorganisms by targeting their cell membranes

345-348

, understanding of the detailed

interaction mechanism between CUR and cell membranes is still not adequate. Commonly
used experimental techniques for directly detecting membrane disruption include: (1)
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measurement of fluorescence intensity of the dye that leaked from cells or liposomes
345, 347

263,

, and (2) observation of the membrane structure change through scanning electron

microscopy (SEM)

345, 349

and transmission electron microscopy (TEM)

264, 348

. All-atom

molecular dynamics (MD) simulation provides an efficient way to understand the
interactions between molecules and lipid bilayer at an atomic level for timescales not
accessible by experiments and therefore complements experimental methods 350.
It is well known that cell membrane is very complex with heterogeneous architecture that
contains a variety of phospholipids, cholesterol, and membrane proteins. It is also known
that the lipid compositions vary with different bacterial strains, as a response to changing
environment, or to exposure to other molecules 351. Model lipid bilayer MD simulation has
been widely used for many years due to its capability of providing feasible insights for
understanding the atomic interaction. Simulations of model lipid bilayer not only greatly
reduced the complexity of structure construction, but also provides us clearer data
interpretation to compare with experimental results. Systematic understanding of the effect
of lipid properties on the interaction of molecules with lipid bilayer is important. On the
other hand, studying complicated lipid bilayer is necessary to understand the function of
drug in a more realistic system.
In this work, we investigated the interaction of CUR with different lipid bilayers through
MD simulations: (1) lipids with various size and charge on lipid heads:
phosphatidylcholine (PC) vs. phosphatidylethanolamine (PE) vs. phosphatidylglycerol
(PG), (ii) lipids with different degrees of saturation in lipid tails: 1,2-dioleoyl- (DO) vs. 1palmitoyl-2-oleoyl- (PO) vs. 1,2-dipalmitoyl- (DP), (iii) mixed model lipid bilayer: 1Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) / 1-palmitoyl-2-oleoyl-sn-
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glycero-3-phosphoglycerol (POPG) with ratio of 3:1 to mimic bacteria cell membrane, and
(iv) realistic microorganism cell membrane systems: E. coli and yeast cell membrane. The
results obtained from this study will not only provide us specific insights for interaction of
curcumin and different bilayer systems, but also give us a more generalized idea for
choosing lipid bilayer based on simulation parameters in the future.

6.2
6.2.1

Material and Methods
System description

We conducted MD simulations of CUR in six different model membranes (consisting of
pure POPE, POPG, 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2Dioleoyl-sn-glycero-3-phosphocholine

(DOPC),

1,2-Dipalmitoyl-sn-glycero-3-

phosphoethanolamine (DPPE), and a mixture of POPE/POPG with ratio of 3:1) and two
realistic membrane systems (E. coli membrane consisting of 1,2-dipalmitoyl-1’-palmytoil2’-cis-9,10-methylenehexadecanoyl-cardiolipin (PMCL2), 1,2-1’,2’-tetra-hexadecenoylcardiolipin (TXCL2), 1,2-dipalmitoleic-phosphatidylethanolamine (DXPE/DYPE), 1,2dipalmitoyl-phosphatidylethanolamine

(DPPE),

and

1,2-dioleoyl-sn-glycero-3-

phosphoethanolamine-N-(1-pyrenesulfonyl) (PYPE); yeast membrane consisting of
DOPC, POPE, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (POPA), 1-palmitoyl-2oleoyl-sn-glycero-3-phospho-L-serine

(POPS),

1,2-dipalmitoyl-sn-glycero-3-

phosphocholine (DPPC) and cholesterol). Detailed information of lipid membrane
compositions was listed in Table 6.1. The E. coli membrane system is almost the same as
that employed by Wu et al

352

, with the only difference of 1-palmytoil-2-cis-9,10-

methylenehexadecanoyl-phosphatidylethanolamine (PMPE) replaced by PYPE. Yeast
membrane system contains the same components as that employed by Sunhwan et al 353,
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which has been reported existing similar properties compared to experimental results. The
structure of CUR is shown in Figure 6.1

354

. The initial CUR-membrane systems were

constructed using CHARMM-GUI’s Membrane Builder module (http://www.charmmgui.org/?doc=input/membrane ) 355.
Initial structure of CUR corresponding to lipid bilayer was shown in Figure 6.2. CUR was
initially placed both parallel and perpendicular to the lipid bilayer respectively. The closest
distance between CUR atom and one of the bilayer leaflets was about 1 nm (Figure 6.2a
and 6.2b). For E. coli and yeast membrane system, CUR was additionally placed in
transmembrane orientation (Figure 6.2c). 3 nm minimum height of water was added on
both top and bottom of the system to simulate a fully hydrated bilayer system. TIP3P water
model was used 140. A 0.15 M salt (both potassium and chloride were added) concentration
was set by mimicking the physiological conditions, and the final system was neutral in
charge. CHARMM36 force field was employed for lipid

356

, CUR and all the other

molecules 357.
6.2.2

Molecular dynamics simulations

All simulations were performed with both GROMACS (version 5.1.1)

358

and NAMD

(version 2.10) 135. Simulations performed with NAMD were used to monitor the insertion
of CUR, whereas GROMACS simulation results were used for analyzing behavior of CUR
inside lipid bilayer analysis.
In NAMD simulation, periodic boundary conditions were applied in all directions. In all
simulations, the cut-off distance for the Coulomb and van der Waals interactions was set
to 1.2 nm. Coulomb interactions were calculated by the Particle Mesh Ewald (PME)
method

359

. The temperature was maintained at 303.15K, which is above the gel-liquid
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transition temperature of 298.15K for POPE, 275.15K for POPG, 275.15K for POPC,
256.15K for DOPC, and below 336.15K for DPPE. The pressure was maintained at 1atm.
The constant temperature was controlled by Langevin dynamics, and constant pressure was
controlled by Nose-Hoover Langevin piston method

360

. The simulation was performed

with minimization of 50000 steps, equilibrium of 5ns, followed by production of 200ns.
First 100ns of simulation were taken for analysis of insertion of CUR into the bilayer.
GROMACS simulation setup was similar to NAMD simulation. Periodic boundary
conditions and PME method were also applied in the simulations. The reference
temperature was set at 303.15K using Nose-Hoover extended ensemble thermostat, and the
reference pressure was set at 1 atm, coupled with semi-isotropically using the ParinelloRahman barostat 361 and a time constant of 5 ps. The bonds with H-atoms were constrained
using the LINCS algorithm 362. The simulation was performed with minimization of 50000
steps, equilibrium of 5ns, followed by production of 1000ns. First 100ns of simulation were
taken for analysis of insertion of CUR into the bilayer, and the last 300ns were used for
analysis of CUR inside the bilayer. The summary of all simulation times was shown in
Table 6.2.
6.2.3

Data analysis

Radial distribution function (RDF) and number of hydrogen bond were calculated through
the implementation in VMD134. Order parameter (SCD) and area per lipid (APL) were
calculated using the membrane plugin

363

implemented in VMD. Bilayer thickness was

defined as the distance between peaks of the phosphate atoms calculated from density
profile. Density profile, lateral diffusion and potential energy were calculated using
gmx_tools (gmx_density, gmx_msd, gmx_rerun) implemented in GROMACS.
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6.3
6.3.1

Results and Discussion
Insertion of curcumin into model lipid bilayer

The snapshots of simulation systems with CUR and different lipid bilayers after 1000ns
are shown in Figure 6.3 and 6.4. CUR is found to insert into most of lipid bilayers except
DPPE bilayer. Simulation results show that CUR could insert into model lipid bilayer
within a few hundred nanoseconds (Table 6.3). DPPE bilayer (transition temperature:
336.15K) is found to be in gel phase at the simulation temperature (303.15K), as a result,
the lipid tails are not flexible to accommodate CUR. Consequently, CUR cannot be inserted
into DPPE bilayer up to 200 ns simulation. For other lipid bilayers, CUR stays in the lipid
tails region, close to the interface of lipid head and lipid tail, which is the glycerol region.
Karewicz A el al

364

observed similar phenomenon through the fluorescence quenching

experiment, which is consistent with our simulation results. It is also evident that CUR
could interrupt membrane and may change some properties of lipid bilayer as shown in
Figure 6.3. For example, bending of upper leaflet lipid heads occurs in POPC bilayer
induced by the insertion of CUR (Figure 6.3c). Time evolution (only the first hundred
nanoseconds are shown for clarity) of center of mass of CUR interacting with different
lipid bilayers are shown in Figure 6.5, where the black arrows indicate insertion of CUR
into lipid bilayer. The permeation of CUR into the lipid bilayer is favored and occurs within
hundred nanoseconds timescale. The initial orientation has no impact on both insertion
time and insertion terminal of CUR into model lipid bilayer (Table 6.3 and 6.4). It is also
found that DOPC and POPE/POPG bilayers are relatively easier for CUR insertion as
shown in the insertion time comparison (Table 6.3). The number of hydrogen bonds
between CUR and water, and between CUR and lipid bilayer is monitored during the
insertion of CUR (Figure 6.6). As CUR inserts into the bilayer, the number of hydrogen
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bonds of CUR and water decreases, while that between CUR and lipid bilayer increases.
After insertion, CUR stays inside lipid bilayer, below the phosphate lipid head, suggesting
hydrophobic interaction also plays an important role during this process. We also
calculated the time evolution of the positions of O1 and O5 with respect to the center of
lipid bilayer. The end (either O1 and O5) that first inserts into lipid bilayer in different
trajectories are listed in Table S2. Not surprisingly, results show that there’s no clear
preference for insertion of either end considering the symmetric structure of CUR.
6.3.2

Position of curcumin inside model lipid bilayer

In this section, we characterize the binding position of CUR within lipid bilayer for the last
300ns of 1000 ns simulation trajectory. The number density profiles of CUR, water and
phosphate as a function of distance to bilayer center are shown in Figure 6.7. CUR
distribution is in the range of 0.5-2 nm to bilayer center, which is mostly below phosphate
lipid head. This result is consistent with both earlier experimental and simulation results
364-366

. CUR also stays in one of the leaflets without moving through to the other leaflet,

which implies existence of an energy barrier for penetration through the lipid bilayer. CUR
distributions in POPE and POPE/POPG are found to be wider than the other three lipid
bilayers, which indicates the movement of CUR is more flexible in POPE and POPE/POPG
bilayers. Phosphate peak of POPE (located at ~2.162 nm) is the narrowest compared to the
other lipid bilayers. The breadth of the peaks increases in the order of POPE/POPG mixed
membrane (located at ~2.106 nm) < DOPC (located at ~1.835 nm) < POPC (located at
~1.839 nm) < POPG (located at ~1.878 nm). The widths of these peaks are related to
rigidity of lipid as discussed below. The peak of CUR distribution with respect to the
distance to bilayer center is the largest (~1.410 nm) in POPE, with this distance being
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similar in other bilayers (POPE/POPG: 1.190 nm, POPC: 1.138 nm, POPG: 1.225 nm and
DOPC: 1.136 nm). Penetration of water molecules into lipid tail region also strongly
depends on the lipid types. Figure 6.7 displays that water distributions extend closest to
bilayer center in POPC and POPG bilayers, followed by DOPC, POPE/POPG, and POPE
bilayer.
6.3.3

Orientation of curcumin in model lipid bilayer

In order to describe the orientation of CUR in lipid bilayer, we calculated the tilt angle of
CUR from the normal to the lipid bilayer for the last 200ns out of 1000ns simulation. The
tilt angle refers to the angle between the vector (from O1 to O5 on CUR) and the normal
vector to lipid bilayer. If the calculated value is 0°-60° and 120°-180°, it refers to CUR
perpendicular to bilayer normal; if the tilt angle is 60°-120°, CUR takes parallel orientation
to bilayer normal as shown in Figure 6.8.
Tilt angle probability of CUR inside different model lipid bilayers is shown in Figure 6.9a.
The results show that CUR tends to be parallel to the lipid bilayer predominantly, which
means the tilt angle of CUR is mostly from 60° to 120°. The angle distribution of CUR in
POPC, POPG and DOPC are similar whereas the probabilities of parallel orientation are
all above 0.8. Compared to CUR tilt angle in POPC, POPG, and DOPC bilayer systems
(0.19, 0.20 and 0.17, respectively), the probabilities of perpendicular orientation in POPE
and POPE/POPG lipid bilayer increase to 0.37 and 0.27, respectively. To explain this
interesting behavior, we analyzed solvation properties of CUR in lipid as well as its
interactions with both water and lipids. The RDF of the oxygen atoms of the solvent
molecules with respect to the oxygen of CUR molecule in different lipid bilayers was
shown in Figure 6.10. It is found that CUR in POPG, POPC, and DOPC bilayers has
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relatively higher solvation than POPE and POPE/POPG bilayers. Additionally, the first
solvation shell peak appears at the distance of 0.36 nm from the distance of oxygen atom
of CUR in all the lipid bilayers. Therefore, number of water molecules within 0.36 nm of
CUR is compared for different types of lipid bilayers in Figure 6.9b. In POPE and
POPE/POPG lipid bilayer, number of water molecules is higher in perpendicular
orientation (3.37 and 2.76 respectively) than parallel orientation (2.69 and 2.71
respectively). While in other three bilayers, number of water molecules around CUR is
higher in parallel orientation than perpendicular orientation. This implies that the solvation
of CUR is dependent on the structure and property of lipid bilayer. With the presence of
POPE, solvation of perpendicular orientation is higher than parallel orientation.
Different components of interaction energy between CUR and membrane, CUR and water
are shown in Figure 6.11 and their differences between parallel and perpendicular
orientations are given in Figure 6.12. Positive value indicates a specific energy component
is stronger for CUR in perpendicular orientation than in parallel orientation, while negative
difference suggests an opposite effect. Interestingly, only POPE system shows positive
differences in both short-range electrostatic and LJ interactions between CUR and water.
This is consistent with the observation of higher water hydration number for CUR in
perpendicular orientation in POPE bilayer. In contrast, parallel orientation is more
favorable in DOPC bilayer, presumably due to the stronger CUR and water interactions
when CUR aligns parallel to the membrane surface. In addition, LJ interaction of CUR
and lipid in POPE system is negative (-4.435 kcal/mol), while this value becomes positive
in other cases, particularly in DOPC bilayer. Such large positive LJ energy is likely related
to the insertion depth of CUR in different systems. Indeed, CUR in perpendicular
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orientation inserts deeper than that in parallel in DOPC, while the distances between the
center of mass and lipid center are similar in both orientations in POPE (Figure 6.13).
6.3.4

Effect of curcumin insertion on the bilayer thickness and area per lipid for
model lipid bilayers

Effect of CUR insertion on the bilayer thickness and area per lipid (APL) for different types
of model lipid bilayers are evaluated in Figure 6.14. Bilayer thickness is defined as the
distance between two phosphate peaks. In the absence of CUR, bilayer thickness decreases
in the order: POPE/POPG (4.238 ± 0.091 nm) to POPE (4.206 ± 0.117 nm), POPC (4.005
± 0.068 nm), DOPC (3.956 ± 0.060 nm) and POPG (3.942 ± 0.051 nm). These values are
in good agreement with reported simulation

367-369

and the experimental results

370, 371

.

Although not significant, insertion of CUR causes membrane thickness to increase in POPE
bilayer (4.231 ± 0.093 nm), whereas thinning of membrane occurred for all other bilayers
(POPE/POPG: 4.110 ± 0.078 nm, POPC: 3.906 ± 0.096 nm, POPG: 3.670 ± 0.048 nm, and
DOPC: 3.843 ± 0.088 nm). Membrane thinning induced by CUR insertion has been
reported previously. Huang et al 365 measured the thickness change of DOPC bilayer as a
function of the CUR/lipid ratio. Their results showed that there is a non-linear membrane
thinning effect by CUR. Ng et al reported that the thickness of POPE increased when
assembled with an adenosine A2a receptor protein during MD simulation, which is similar
to our simulation results 372. In the absence of CUR, APL increase from POPE (0.5517 ±
0.0054 nm2) to POPE/POPG (0.5748 ± 0.0072 nm2), POPC (0.6331 ± 0.0054 nm2), POPG
(0.6625 ± 0.0024 nm2) and DOPC (0.676 ± 0.0068 nm2). Our results are consistent with
reported both experimental results

373-375

and simulation results

376, 377

. Insertion of CUR

causes APL to increase (POPE: 0.5651± 0.0081 nm2, POPE/POPG: 0.5848 ± 0.0077 nm2,
POPC: 0.6482 ± 0.0099 nm2, POPG: 0.6825 ± 0.0120 nm2, and DOPC: 0.6818 ± 0.0134
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nm2), and this increase is significant in POPG lipid bilayer. Sun Y et al

378

reported the

responses of individual giant unilamellar vesicles (GUVs) to the binding of CUR from
solution. Their results indicated an increase in the fractional area of DOPC in GUVs due
to CUR binding, which is also consistent with our simulation results.
6.3.5

Order parameter of different model lipid bilayers in the absence of curcumin

Comparison of SCD for different lipid bilayers are shown in Figure 6.15. SCD of sn1 (chain
1) for POPE is the highest, followed by POPE/POPG, POPC, POPG and DOPC. SCD of
sn2 (chain 2) for POPE is also highest, following by POPE/POPG, POPC, DOPC and
POPG. CUR insertion causes an increase in the order parameter for POPE, and a decrease
for the other four bilayer systems. These differences are significant in POPE and POPG
bilayer systems. Similar increase in order parameter was reported for DMPC bilayers.
Barry J et al

379

measured two dimensional proton detected local field (PDLF) spectra

which showed that CUR increased the overall order of the DMPC membrane. CUR
introduced disorder in 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) through
infrared spectroscopy was also reported before

380

, which is similar to our simulation in

POPC and POPG bilayers.
6.3.6

Effect of curcumin insertion on the lateral diffusion coefficients of different
model lipid bilayers

Lateral diffusion coefficients (DL) of different lipid bilayers are calculated both in the
absence as well as in the presence of CUR. DL for POPE and POPE/POPG are lower than
POPC, POPG, and DOPC bilayer (Figure 6.16). The values are in the similar range as
earlier reported simulation results 381. Insertion of a single CUR induced the DL to increase
in all the membranes, and this increase is significant only for POPE/POPG bilayer. The
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lateral diffusion of CUR in POPE/POPG is the highest (0.034 ± 0.006 10-8 cm2s-1),
followed by POPE (0.025 ± 0.003 10-8 cm2s-1), POPC (0.021 ± 0.005 10-8 cm2s-1), POPG
(0.014 ± 0.003 10-8 cm2s-1), and DOPC (0.008 ± 0.002 10-8 cm2s-1). Filippov, et al

382

employed 1H NMR diffusometry to explore the lateral diffusion in planar-oriented bilayers
of dimyristoylphosphatidylcholine (DMPC) and DOPC at CUR concentration from 0 to 40
mol %. Their results indicated CUR could cause a decrease on the DL of both DOPC and
DMPC at concentration of ~7 mol %. It is understandable then the effect of single CUR on
the DL of lipid bilayer in our simulation is not that significant. Please note that DL
calculation based on periodic boundary condition may cause large error 383.
6.3.7

Insertion of curcumin into an E. coli inner membrane and yeast membrane

In nature, bacterial cell membrane is far more complicated than these model lipid bilayers.
For example, E. coli is a Gram-negative bacterium, which contains both outer membrane
and inner membrane. Outer membrane usually contains one layer of linked
lipopolysaccharides (LPS) and one layer of phosphate lipids. Inner membrane is usually
negatively charged mixed lipid bilayer. As a bacteria, E. coli could increase its osmotic
stress tolerance by increase in its cardiolipin (CL) content
staining E. coli by fluorescent lipophilic dyes

385, 386

384

. Observation of selective

through fluorescence microscopy

indicated the existence of CL lipid in E.coli polar and septal membrane regions. Although
MD simulations have been employed to investigated the differences of the interaction of
molecules with various mixed lipid bilayers (POPE/POPG
and POPC/POPG

166, 388

377, 387

, DOPC/DOPG

175, 250

,

) previously, while these mixed bilayer were used to mimic

bacterial cell membrane; it is also necessary and important to characterize the interactions
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between molecules with more realistic lipid bilayers. Therefore, interactions of CUR and
realistic cell membrane were investigated and discussed in this section.
In the absence of CUR, order parameter for different lipids in E. coli membrane (discussed
below) and electron density profile for different compositions in yeast membrane (Figure
6.17) are consistent with reported results 352, 355, indicating the membrane systems are well
equilibrated in our simulations.
Like other model lipid bilayers, CUR can insert into E. coli and yeast membrane within
hundred nanoseconds easily (Table 6.3) The insertion time of CUR into E. coli and yeast
is close to that into POPE/POPG and DOPC bilayers, and there is also no preference for
insertion terminal of CUR into these membranes (Table 6.4). After insertion, CUR stays
inside the lipid tails region of lipid bilayer as shown in Figure 6.18. Density profile of CUR
also indicates that CUR mostly stay in the region from 0.5-2 nm under the lipid heads,
close to the glycerol group region as shown in Figure 6.19. It also shows that E. coli
membrane has thinner membrane thickness than yeast membrane (Figure 6.19), which
result in a closer distance of CUR to bilayer center in E. coli membrane (~1.25nm) than
yeast membrane (~1.45nm).
To further characterize the behavior of CUR in these two bilayers, orientation of CUR and
hydration numbers around the oxygen of CUR are calculated and shown in Figure 6.20.
CUR also predominantly adopts a parallel orientation in both E. coli and yeast membranes
(Figure 6.20a), which is similar to that in model lipid bilayers described previously (section
3.3). More specifically, CUR in yeast membrane (~0.32) has relatively higher probability
of perpendicular orientation than in E. coli membrane (~0.22), this probability is very close
to the model lipid bilayers consisting of POPE (both POPE and POPE/POPG bilayers).
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The solvation behavior of CUR in E. coli and yeast bilayers are also calculated to further
explore the effect of CUR orientation. The first solvation shell appeared at the distance of
0.36 nm of the oxygen of CUR as shown in the RDF of oxygen of water with respect to
oxygen of CUR (Figure 6.21). Therefore, hydration numbers within 0.36 nm of the oxygen
of CUR in both E. coli and yeast membranes are compared in Figure 6.20b. The results
indicate CUR in both E. coli and yeast membranes have similar solvation behavior with
POPE and POPE/POPG bilayers: the hydration number of CUR with perpendicular
orientation is higher than that with parallel orientation. The existence of PE lipids in
microbial cell membrane, therefore, plays an important role in influencing its behavior.
SCDs for each acyl chain of PMCL2, TXCL2, PYPE, DYPE and DPPE in E. coli
membrane systems are shown in Figure 6.22, consisting with Wu et al’s work 352. The order
parameters for all the lipid molecules are lower than 0.3 indicating that the membrane is in
liquid phase. Compared to membrane only (in the absence of CUR), CUR insertion led to
PYPE and DYPE being more disordered, while there was no significant effect on SCD for
PMCL2, TXCL2 and DPPE. The SCDs of DOPC and POPE in the presence of CUR in
both yeast and pure membrane are compared in Figure 6.23. The order parameters of POPE
and DOPC in yeast membrane without CUR are significantly higher than those in pure
membrane, indicating thereby that the lipid bilayer is more ordered in yeast membrane.
Such a behavior is likely due to the presence of cholesterol, since cholesterol is well known
to induce chain order for many phospholipids

389-391

; this behavior is evident in our

simulation as well (Figure 6.23). The SCD for POPE is significantly lower for membrane
in the presence of CUR, while CUR has no significant effect on the SCD of DOPC
membrane. The SCD for both chain 1 and chain 2 of DPPC were significantly lower for
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membranes in the presence of CUR, and no significant effect on chain order in POPA and
POPS membrane (Figure 6.24).

6.4

Conclusions

CUR is a widely used natural food ingredient with known membrane activity, but the
details of molecular mechanisms remain poorly understood. This manuscript investigates
the molecular interactions between CUR and different types of lipid bilayers through
microsecond MD simulation. Results indicate that CUR could easily insert into lipid
bilayer in nanoseconds scale and stay inside. CUR is found to stay in the lipid tails region,
close to the interface of lipid head and lipid tail, which is the glycerol region. Parallel
orientation is found to be more probable than perpendicular for CUR in all bilayers as well
as in E. coli and yeast bilayer systems. Insertion of CUR results in membrane thinning with
a corresponding increase in area per lipid. CUR interaction with E. coli and yeast cell
membranes are quite similar to that with POPE/POPG mixed bilayer. The results from
these simulations can provide insights into the possible differences in antimicrobial activity
of CUR against different types of microorganisms, and the interaction of multiple CUR
molecules with lipid bilayers will be a future research direction.
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6.5

Figures and Tables

Figure 6.1 Structure of CUR. Color code: cyan: carbon, red: oxygen, and white: hydrogen.
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Figure 6.2 Initial position of CUR at different location of lipid bilayer. (a) Parallel, (b)
perpendicular, and (c) transmembrane. Color code: cyan: carbon, red: oxygen, white:
hydrogen, brown: phosphate, water molecules are not shown for clarity.
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Figure 6.18 Snapshots of CUR inside realistic membrane after 1000 ns with different initial
structure: (a, d) parallel, (b, e) perpendicular, and (c, f) transmembrane. Color code:
PMCL2: tan, TXCL2: pink, DPPE: purple, DYPE: green, PYPE: cyan, CHL: green, DOPC:
silver, POPE: pink, POPS: cyan, POPA: purple, DPPC: lime.
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Figure 6.23 Comparison of SCDs for different acyl chains in POPA, DPPC, POPE, DOPC,
and POPS in yeast membrane system. Color codes: dash line: bilayer without curcumin,
solid line: bilayer with curcumin, black: chain 1, red: chain 2.

174
0.5
0.4

(a) cha inl

0.5

yeast_POPE - CUR_yeast_POPE - POPE - -

0.4

(b) cha in2

yeast_POPE - CUR_yeast_POPE - POPE - -

0.3

0.3
C)

C)

u

u

l/l

l/l

0.2

0.2

0.1

0.1

00

5

0.5

(c) chainl
0.4

10

Carbon index

15

00

20

5

10

15

20

Carbon index

0.5

yeast_DOPC - CUR_yeast_DOPC - DOPC - -

(d) chain2
0.4

yeast_DOPC - CUR_yeast_DOPC - DOPC - -

0.3

0.3
C)

C)

u

u
l/l

l/l

0.2

0.2

0.1

0.1

00

5

10

Carbon index

15

20

00

5

10

15

20

Carbon index
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Table 6.1 System information of lipid bilayers
Model lipid bilayers
Charge

Tail Info. [sn1/sn2]

POPE
POPG
POPC
DOPC
DPPE

0
-1
0
0
0

16:0 / 18:1
16:0 / 18:1
16:0/18:1
18:1/18:1
16:0 / 16:0

Lipid Type

Charge

Tail Info. [sn1/sn2]

Head Info.

Transition Temperature

Number
of lipid

POPA
POPS
POPE
DOPC
DPPC
CHL

-1
-1
0
0
0
0

16:0 / 18:1
16:0 / 18:1
16:0 / 18:1
18:1/18:1
16:0 / 16:0
Not applicable

Phosphatidic acid
Phosphatidylserine
Choline (NH3)
Choline (N(CH3)3)
Choline (N(CH3)3)
Sterols

28°C (301.15K)
14°C (287.15K)
25°C (298.15K)
-17°C (256.15K)
41°C (314.15K)
Not applicable

20
10
60
100
20
60

Lipid Type
POPE
Lipid Type
PMCL2
TXCL2
DYPE
DPPE
PYPE

Head Info.

Transition Temperature

Number
of lipid
128
128
128
128
128

Lipid Type

Choline (NH3)
25°C (298.15K)
Glycerol((OH)2)
-2°C (275.15K)
Choline (N(CH3)3)
-2°C (275.15K)
Choline (N(CH3)3)
-17°C (256.15K)
Choline (NH3)
63°C (336.15K)
Mixture lipid bilayer
Number of lipid
Lipid Type
Number of lipid
Total number of lipid
96
POPG
32
128
E. coli membrane 352
Charge
Tail Info. [sn1,sn2/sn3,sn4]
Head Info.
Number of lipid
-2
16:0,16:0 / 16:0,16:0
(PO4)2OH
48
-2
16:1,16:1 / 16:1,16:1
(PO4)2OH
18
0
16:1 / 16:1
Choline (NH3)
12
0
16:0 / 16:0
Choline (NH3)
6
0
16:0 / 16:1
Choline (NH3)
6
355
yeast membrane
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Table 6.2 Details of simulation time
CUR Orientation
Parallel
Perpendicular
Transmembrane
Control

POPE
1000ns
1000ns

POPG
1000ns
1000ns

300ns

300ns

GROMACS
POPC DOPC
1000ns 1000ns
1000ns 1000ns
300ns
300ns
NAMD
POPC DOPC
200ns
200ns
200ns
200ns

POPE/POPG
1000ns
1000ns
300ns

E. coli
1000ns
1000ns
1000ns
300ns

Yeast
1000ns
1000ns
1000ns
300ns

CUR Orientation
POPE POPG
POPE/POPG DPPE E. coli
Yeast
Parallel × 3*
200ns
200ns
200ns
200ns 300ns
300ns
Perpendicular × 2**
200ns
200ns
200ns
200ns 300ns
300ns
Transmembrane
300ns
300ns
Control
200ns
200ns
200ns
200ns
200ns
200ns 300ns
300ns
*Three independent MD runs with different random seed; **two independent MD runs with different random
seed.
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Table 6.3 Insertion time of curcumin for different simulations

I Insertion time (ns)

GROMACS

Repeat

MD1

MD2

POPE
POPE/POPG
POPC
POPG
DOPC
DPPE
E. coli
yeast

63
5
42
32
23

5
24
4
78
7

40
5

8
13

NAMD
MD3
5
3
70
28
1
10
7

MD4
46
13
62
65
2.7
42
52

MD5
94
18
11
6
6
50
44

MD6
75
58
49
35
112
80
2

MD7
1
20
42
113
11

I
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Table 6.4 Insertion terminal of curcumin for different simulation

I

Insertion terminal
Repeat

GROMACS
MD1
MD2

MD3

MD4

NAMD
MD5

I
MD6

POPE
O1*
O5**
O1
O1
O1
O5
POPE/POPG
O1
O5
O1
O5
O1
O5
POPC
O1
O1
O1
O5
O1
O5
POPG
O5
O5
O5
O1
O5
O1
DOPC
O1
O5
O5
O1
O1
O5
DPPE
E. coli
O5
O5
O5
O5
O1
O1
yeast
O5
O1
O5
O1
O5
O1
* Insertion terminal is on the side of O1 of CUR; ** insertion terminal is on the side of O5 of CUR.

MD7
O1
O5
O1
O5
O1
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7. PORE FORMATION BY CURCUMIN ON BACTERIAL AND
LIPOSOME MEMBRANES

7.1

Introduction

Rhizome turmeric (Curcuma longa) is commonly used as both spice and pigment in foods
because of its characteristic taste and yellow color 392. Since turmeric has been used in Asia
as medicine for thousands of years because of its perceived health benefits, it is being
widely investigated in recent decades for its potential as a bioactive agent in
pharmaceuticals, foods, and cosmetic products 393, 394. One of the most biologically active
component within turmeric is curcumin (CUR [1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6hepadiene-3,5-dione]). This polyphenolic compound containing a variety of biological
activities has been gained significant attention of research all over the world 334, 344, 395, 396.
The reported biological activities of CUR include antimicrobial 396, antioxidant 335, 337, antiinflammatory 335, 343, anticancer 342, anti-Alzheimer’s 339, 397, improving wound healing 398,
399

etc. In addition, CUR has synergistic effect with antibiotics 400, 401. A typical structure

of CUR is shown in Figure 7.1. H-bond doner, phenolic hydroxyl groups are believed to
be the functional groups

402

. Low solubility and bioavailability became the main reasons

for which CUR cannot widely used, and several investigations about increasing the
solubility and bioavailability of CUR have been reported 395, 403-406.
Among the various functions of CUR, antimicrobial activity of CUR has been fully
investigated 396, 407. Several investigations discussed the antibacterial mechanism of CUR
through various experiment techniques. P Tyagi, et al

345

) employed fluorescence dye

leakage from Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli), and
scanning electron microscopy (SEM) to indicate the disruption of bacterial cell membrane
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(S. aureus) by CUR. RK Basniwal, et al

403

characterized the integrity of bacterial cell

membrane (S. aureus) by CUR nanoparticle through transmission electron microscopy
(TEM). Lee DG et al 408 reported that CUR could induce E. coli cell membrane damage at
relatively high concentrations, and stimulate E. coli cell to display various apoptotic
markers such as reactive oxygen species (ROS) accumulation, membrane depolarization,
and Ca2+ influx at minimum inhibition concentration (MIC). CUR may also cause the
membrane thinning when interacting with lipid bilayer

365

. CUR was also reported to

exhibit inhibition of the growth of fungal cell (Candida albicans) by disruption of their
plasma membrane
biofilm

409

347

. It was also proposed that CUR may inhibit formation of bacterial

, and target the Ftsz protofilaments, which are responsible for the bacterial

cytokinesis, by inhibiting the assembly of FtsZ protofilaments and increasing the GTPase
activity of FtsZ protofilaments 410.
Listeria monocytogenes (L. monocytogenes) is a gram-positive bacterium, containing a
thick peptidoglycan layer in the bacterial cell wall. As one of the most virulent foodborne
pathogens, L. monocytogenes could cause 20 to 30% of mortality among food borne
listeriosis infections

411

. For gram positive bacteria, cell wall plays an important role in

supporting and protecting the cell from outside environment. The main content of cell wall
is peptidoglycan, consisting of sugars (N-acetylclucosamine NAG and N-acetylmuramic
acid NAM) and amino acids (L-alanine, D-glutamine, L-lysine, and D-alanine) that forms
a mesh-like layer outside the plasma membrane, with a thickness of around 20-80 nm 412.
Escherichia coli (E. coli) is a gram-negative bacterium, containing an inner cell membrane,
a thin peptidoglycan cell wall, and an outer membrane. Although most E. coli strains are
harmless, some serotypes of E. coli, such as E. coli O157:H7, can cause food poisoning 413.
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For gram negative bacteria, the outer membrane consists of lipopolysaccharide (LPS,
acting as endotoxin), porins, and lipid bilayer. These two bacteria are used as model
bacteria for investigation in this manuscript.
Although the antimicrobial activity of CUR against L. monocytogenes and E. coli has been
demonstrated, the mechanism study of CUR with these two bacteria are still not fully
understood. The results of our investigation on the interaction of CUR and model lipid
bilayers and E. coli membrane through molecular dynamics (MD) simulation, as reported
in chapter 6, indicated that CUR could easily be inserted into the bilayer and remain in the
lipid tails region by adopting a predominantly parallel orientation. To further explore the
mechanism of CUR interacting with cell membrane, we did following studies: (1)
verification of the antimicrobial activity of CUR against L. monocytogenes and E. coli, (2)
the change in cell structure due to the presence of CUR, (3) dye leakage from liposome
subjected to CUR treatment, and proposed possible mechanism of membrane disruption by
CUR.

7.2
7.2.1

Material and Methods
Materials

CUR from Curcuma longa (Turmeric) was purchased from Sigma-Aldrich with 94% purity.
Brain Heart Infusion (BHI) and agar was purchased from Neogen Corp., Lansing MI. 1,2Dimyristoyl-sn-glycero-3-phosphorylcholine (DMPC), Cholesterol, and dihexadecyl
hydrogen phosphate (DHP) with 99% purity were purchased from Avanti Polar Lipids,
Alabaster AL.
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7.2.2

Bacteria and growth conditions

L. monocytogenes F4244 and E. coli O157:H7 EDL933 were used to represent Grampositive and Gram-negative foodborne pathogens, respectively. All bacteria cultures were
stored as 10% frozen glycerol stocks in deep-freezer at −80 °C. Prior to experiments, frozen
stocks were streaked in BHI broth and incubated at 37 °C for 16 h, followed by propagation
in fresh BHI broth at 37 °C for another 16 h to get ~109 CFU/mL bacterial culture.
7.2.3

Bioassay and viability test of CUR in vitro

The antimicrobial activity and minimum inhibition concentration (MIC) of CUR were
determined by spot-on-lawn and broth dilution method

166, 414

. For spot-on-lawn method,

50 µL of bacterial culture was added into 3 mL buffer containing 3.7 % (w/v) BHI and 0.8 %
(w/v) agar solution. The above bacteria solution was then poured onto a petri dish
(Fisherbrand, Fisher Scientific Company LLC, Pittsburgh, PA, USA) followed by exposure
to CUR with different concentration (10 µL each spot). For broth dilution method, the
bacterial culture was diluted to 107 CFU/mL in BHI, and 100 µL of the diluted culture was
added into wells of a 96-well microtiter plate (Falcon, Becton Dickinson Labware, Franklin
Lakes, NJ, USA). CUR solution was prepared with concentration of 2500 µg/mL that was
further diluted in series from 2500 to 19.53 µg/mL. 200 µL of the reaction solution in each
well were incubated at 37 °C for 8 h. The MIC was defined as the lowest antimicrobial
concentration that resulted in an optical density change at 590 nm (ΔOD590 nm) of < 0.05.
7.2.4

Transmission electron microscopy (TEM)

L. monocytogenes F4244 and E. coli O157:H7 EDL933 cells (~109 CFU/mL) treated with
CUR for 2 h or untreated (PBS only) were obtained by centrifugation. The cell was then
fixed in 5% glutaraldehyde fixative solution (1:1). The sample solution was then washed

183
with 0.1M cacodylate buffer at pH 6.8, followed by two washes with DI water. The cells
were embedded in 1.5% agarose (low temp. gelling), processed, dehydrated and sectioned
to observe under a FEI/Philips CM-10 transmission electron microscope (FEI Company,
Hillsboro, OR) using an accelerating voltage of 80 kV 415. High magnification (34, 000×)
images at five different microscopic fields were captured to show the structural damage to
the cell membrane.
7.2.5

Liposome preparation

Liposome consisting of DMPC, cholesterol, and DHP in a molar ratio of 5:4:1 and with
entrapped dye (calcein) was prepared using protocol described elsewhere 263, 416-419. Briefly,
100 µL of lipid stock solution (DMPC, cholesterol, and DHP in a molar ratio of 5:4:1 416
in chloroform) was dried under N2 to form a thin film in a glass vial. 1 mL of calcein (50
mM) in 0.02 M phosphate buffer at pH 6.0 was then added into the lipid film before
liposome formation. The suspension was vortexed for several minutes and then allowed to
rest for 30 min to form large unilamellar, dye-encapsulating vesicles. The vesicle
suspension was then forced through a polycarbonate filter (size = 1000 nm) using an
extruder for fifteen times to form uniform unilamellar liposomes. The diameter of the
liposomes was measured by laser light scattering (Zetasizer nano series, Malvern
Instruments, Worcestershire, UK). Free dye was removed by dialysis using a membrane
with a molecular weight cutoff of 10000 (Spectrum Laboratories, Inc. Rancho Dominguez,
CA, USA) overnight. To avoid photo-bleaching, liposomes were stored in a dark
environment at −4 °C until further use.
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7.2.6

Fluorescence measurement

The fluorescence of the released dye was measured with a spectrofluorometer (Flex Station
II, Molecular Device) at an excitation wavelength of 490 nm and an emission wavelength
of 520 nm. All experiments were conducted at 25°C which is above the phase transition
temperature for DMPC–cholesterol mixtures of cholesterol concentration above 12.5 mol%
420

. The intensity of calcein was normalized based on the equation:
𝐶𝑎𝑙𝑐𝑒𝑖𝑛 𝐿𝑒𝑎𝑘𝑎𝑔𝑒 (%) = 100×(𝐹 − 𝐹T )/(𝐹z − 𝐹T )

where 𝐹 is the fluorescent intensity achieved after addition of CUR, 𝐹T is the fluorescence
intensity with the presence of CUR, and 𝐹z is the fluorescence intensity with addition of
Triton X-100, which fully ruptures the liposome
7.2.7

421

.

Molecular dynamics simulation

Two different lipid bilayer systems: a pure 1-palmitoyl-2-oleoyl-sn-glycero-3phosphoethanolamine (POPE) lipid bilayer with 64 lipids per lipid bilayer and a total of
6199 water molecules, and a E. coli lipid bilayer with 48 1,2-dipalmitoyl-1’-palmytoil-2’cis-9,10-methylenehexadecanoyl-cardiolipin (PMCL2), 18 1,2-1’,2’-tetra-hexadecenoylcardiolipin (TXCL2), 12 1,2-dipalmitoleic-phosphatidylethanolamine (DXPE/DYPE), 6
1,2-dipalmitoyl-phosphatidylethanolamine

(DPPE),

6

1,2-dioleoyl-sn-glycero-3-

phosphoethanolamine-N-(1-pyrenesulfonyl) (PYPE) and a total of 8736 water molecules,
were obtained from our previous work (see chapter 6). A CUR molecule was then placed
at 32 different positions along z coordination of these two lipid bilayers to generate a total
of 32 restrained systems respectively. These positions of CUR were uniformly distributed
from aqueous solution (~ 3 nm) to the center of lipid bilayer (~ 0 nm). During these
simulations, CUR was restrained at each location with a force constant of 1000
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kcal/mol/nm2. The potential of mean force (PMF) of CUR along z coordinate was
calculated using the WHAM tool 258 embedded in GROMACS software 358. CHARMM36
force field

422, 423

was employed for both CUR, lipids and all the other molecules in the

systems. Periodic boundary conditions and Particle Mesh Ewald (PME)

359

method were

applied in the simulations. Umbrella sampling (US) simulations at 303.15K were
conducted for 250 ns for each conformation, while the last 100ns were used for free energy
calculation.
Another unbiased MD simulation was also performed to investigate the behavior of CUR
oligomers. In this simulation, 16 CUR molecules were placed on the surface a POPE lipid
bilayer, with parallel orientation to each other and lipid bilayer. Similar to our previous
simulation setup, Periodic boundary conditions and PME method were also applied in this
simulation. The reference temperature was set at 303.15K using Nose-Hoover extended
ensemble thermostat, and the reference pressure was set at 1 atm, coupled with semiisotropically using the Parinello-Rahman barostat 361 and a time constant of 5 ps. The bonds
with H-atoms were constrained using the LINCS algorithm

362

. The simulation was

performed with minimization of 50000 steps, equilibrium of 5ns, followed by production
of 1000ns.

7.3
7.3.1

Results and Discussion
Antimicrobial activity of CUR against L. monocytogenes and E. coli

CUR dissolved in different concentrations of Dimethylformamide (DMF: 100%, 50%,
20%, and 0) was spread onto the agar plate that had been inoculated L. monocytogenes and
E. coli with half serial dilution. The inhibition ring of CUR against these two bacteria are
shown in Figure 7.2. When L. monocytogenes F4244 exposed to different concentrations
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(from 7.8125 µg/mL to 1000 µg/mL) of CUR in different solvation (DMF concentration),
the minimum concentration of CUR at which it could form clear zone was 125 µg/mL for
100% DMF, 250 µg/mL for 50% DMF, none for 20% DMF and water, respectively (upper
row of Figure 7.2). However, E. coli O157:H7 exposed to CUR in 100% DMF showed
zone of inhibition (ZOI) at 7.8125 µg/mL which was larger than that for control treatment
(DMF only in the center), thus indicating synergistic effect of both CUR and DMF. CUR
dissolved in 50% DMF showed ZOI at 250 µg/mL, and none for 20% DMF and water,
respectively (lower row of Figure 7.2).
MIC of CUR against L. monocytogens and E. coli were determined through broth
macrodilution using half serial dilution; the absorbance of cell density was scaled for
comparison. Compared to control (listeria in the absence of CUR), CUR treatment could
increase the lag time of growth of L. monocytogenes (Figure 7.3a). CUR completely
inhibited growth of L. monocytogenes above a concentration of 78 µg/mL as can be seen
from Figure 7.3a. CUR exposed to E. coli showed no inhibition below 19.53 µg/mL (Figure
7.3b). As CUR concentration increased, the inhibition effect increased. When CUR
concentration was above 156 µg/mL, E. coli was completely deactivated as shown in
Figure 7.3b. In addition, CUR treatment in E. coli showed another interesting phenomenon:
the absorbance of high CUR concentration treatment decreased with time, which may
indicate that CUR was solubilizing E. coli. While this behavior was not observed for L.
monocytogenes, it also implied that CUR deactivate these two bacteria with different
mechanisms.
It has been reported that CUR dissolved in DMSO was able to inhibit growth of L.
monocytogenes and E. coli with MIC of 125 µg/mL and 250 µg/mL respectively 424, CUR
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dissolved in acetone showed MIC against L. monocytogenes and E. coli with 250 µg/mL
425

, CUR dissolved in ethanol could inhibit E. coli with concentration of 163 µg/mL 426. In

addition, curcuma longa turmeric extracted using different solvent (such as methanol, ethyl
acetate, hexane and methanol) showed a wide range of MIC against both gram positive and
gram negative bacteria 427-429. MIC of 78 µg/mL for L. monocytogenes and 125 µg/mL for
E. coli in our investigation fall within the range of MIC values reported by others.
7.3.2

TEM of CUR on L. monocytogenes

L. monocytogenes and E. coli cell structure under CUR treatment were observed with TEM.
In the absence of CUR, L. monocytogenes showed intact cellular architecture with uniform
cytoplasmic distribution and highly contrasting cell wall (Figure 7.4). Compared to control,
CUR treatment on L. monocytogenes could cause membrane disruption as shown in Figure
7.5. Four replicate fields showed similar results, around half of bacterial cell structure were
damaged, including cell wall breakup and leakage of cell content. Figures 7.5b and 7.5c
show two disrupted examples. Damage of the cell structure may either involve breakup of
the cell wall, followed by escape of the cell (Figure 7.5d) or breakup of the cell membrane
(Figure 7.5e and 7.5f), followed by leakage of the intra cellular matter. The results showed
in this section indicate CUR could disrupt both cell wall and cell membrane of grampositive bacteria. This mode of action to disrupt cell membrane is similar to that of
antimicrobial peptides as demonstrated through TEM technique 264.
7.3.3

TEM of CUR on E. coli

E. coli in the absence of CUR also showed intact cell architecture with uniform cell content
and highly contrasting cell membrane (Figure 7.6), similar to other’s observation

430

.

Compared to control E. coli, CUR treatment on E. coli could also cause damage of cell
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structure as shown in Figure 7.7. Four independent replicate fields showed similar results.
Unlike treatment of L. monocytogenes, damaged cell became small micelle structures with
the size range of 100-200 nm. Figure 7.7d showed that, the broken membrane of the cell
diffuses into the aqueous medium and are probably solubilized by the micelles. This seems
to suggest that membrane disruption for E. coli by CUR is by carpet mechanism.
7.3.4

Dye leakage of CUR on DMPC/cholesterol liposomes

Due to self-quenching ability, calcein has been widely used as a fluorescence probe 431-435.
We employed calcein encapsulated in DMPC/cholesterol liposome to monitor leakage of
the dye due to CUR treatment. Figure 7.8 showed that with CUR treatment, calcein leaked
out very quickly within minutes. The fluorescence intensity kept relatively constant within
tested time. Unlike antimicrobial peptides (AMPs, such as melittin 263) treatment, there is
no lag time for membrane disruption, only “all-or-none” disruption. This implied the
mechanism of membrane disruption by CUR may be carpet model, which only happens
when the concentration of treated molecule is high enough to result in solubilization of
membrane by CUR micelles as explained earlier (see Figure 7.7d). The fluorescence dye
leakage reached maximum when the CUR/lipid ratio was above 1000 as shown in Figure
7.9.
Carpet model is originally proposed by Shai 436 for membrane disruption by AMPs which
is based on detergent model

437-439

and interfacial activity model

437

. In carpet model,

AMPs firstly accumulate on the surface of the membrane with a parallel orientation to the
lipid bilayer; when the peptide sufficiently covers the membrane surface, like a “carpet”,
permeabilization of the membrane occurs.
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7.3.5

Partition of CUR into lipid bilayer through MD simulation

In this section, we used all-atom explicit solvent MD simulation to compute the potential
of mean force (PMF) of CUR to both POPE and E. coli lipid bilayer. The PMF results and
corresponding number density profiles of phosphate were shown in Figure 7.10. For POPE
lipid bilayer, the PMF profiles indicated that CUR inserts into the bilayer, partitioning
inside the lipid head groups, which is close to the glycerol region. The free energy change
ΔGwat (from the solution to the minimum) of CUR insertion to POPE bilayer is 4.989 ±
0.731 kcal/mol. The free energy change ΔGthro (from PMF minimum to the barrier near
bilayer center) of CUR to POPE bilayer center was 4.070 ± 1.155 kcal/mol. The minimum
of PMF appeared at 1.456 nm from POPE bilayer center, which is consistent with the
density profile of CUR location (shown in Chapter 6). For E. coli membrane system, the
PMF profiles showed that CUR could insert into the bilayer stronger than POPE bilayer,
with a free energy change ΔGwat of 6.637 ± 0.371 kcal/mol. The free energy change ΔGthro
of CUR from PMF minimum to E. coli bilayer center is 3.963 ± 0.221 kcal/mol. The
minimum of PMF appeared at 1.092 nm from bilayer center in E. coli bilayer system, which
is also consistent with the density profile of CUR location (shown in Chapter 6).
We also performed MD simulation of multiple CUR molecules partitioning into POPE
lipid bilayer. The initial and final snapshots of simulation systems are shown in Figure 7.11.
The results indicated that, instead of staying near the top leaflet of lipid bilayer, some CUR
molecules in the aggregate could penetrate through the bilayer center, and stay near the
bottom leaflet in the lipid tails region. CUR stayed near the surface of bilayer were mostly
parallel to membrane, and the orientation changed to perpendicular as CUR transferred to
the bilayer center. Unlike antimicrobial peptides, CUR permeation into lipid bilayer did
not introduce significant water molecules into the bilayer, therefore no water channel pore
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formation occurred during this procedure. This result also implied that, the ΔGthro for CUR
penetration through bilayer center could be overcome as number of CUR increased.
7.3.6

Mechanism of pore formation on L. monocytogenes and E. coli by CUR

L. monocytogenes and E. coli treated by CUR resulted in different membrane disruption
architectures indicating that two different mechanisms of pore formation were induced by
CUR. Since L. monocytogenes belong to gram-positive bacteria, it contains a cell wall with
thickness of 20-80 nm that cover the cell membrane. Peptidoglycan, the component of cell
wall, is a polymer consisting of alternating amino sugars, namely N-acetylglucosamine
(NAG) and N-acetylmuramic acid (NAM). Each NAM is attached to a short amino acid
chain, containing alanine, glutamine, lysine etc. It has been shown that CUR was able to
form hydrogen bond with protein through numerous amino acids

440

, including alanine,

glutamine, leucine, aspartic acid, methionine etc. Therefore, CUR has high potential to
interact with peptidoglycan. Saturated binding of CUR into peptidoglycan may cause the
collapse of cell wall architecture. In addition, as shown before, CUR could bind cell
membrane and partition into the lipid tails region close to the glycerol region. As number
of CUR molecules inside the bilayer increased, they will transfer through the bilayer center
and span the cell membrane, which may alter properties of cell membrane such as thickness,
order parameter, and lateral diffusion, finally disrupt the cell membrane. This sequence of
events is also shown in Figure 7.12.
Instead of containing a thick cell wall, E. coli contains a relatively thin cell wall with a
thickness of 7-8 nm. Additionally, there is an outer membrane that contains
lipopolysaccharides (LPS, which consists of lipid A, core polysaccharide, and O antigen)
in its outer leaflet and phospholipids in the inner leaflet. Self-assembly of CUR and
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polysaccharides has been reported by numerous studies 406, 441, 442. The hydrophobic part of
polysaccharides provides a favorable binding site for CUR. Therefore, CUR is believed to
interact with both outer membrane and inner membrane of E. coli. CUR may target the cell
membrane similar to carpet model

443

or detergent disruption mechanism

444

and form

micelles as suggested by TEM images (Figure 7.7). Both carpet model and detergent model
require a relatively high concentration of treated molecules. When CUR interacts with
membrane of E. coli, insertion of CUR would cause a large increase in the curvature of the
outer bilayer. This leads to the formation of a lipid-CUR mixed micelle followed by
shedding from the bilayer and disrupting the membrane. Eventually, these micelles
aggregate to form larger micelles. This sequence of events is shown in Figure 7.13.
It is well known that cell membrane is very complex with heterogeneous architecture that
contains a variety of phospholipids, cholesterol, and membrane proteins. It is also known
that the lipid compositions vary with different bacterial strains, as a response to changing
environment, or to exposure to other molecules

351

. Therefore, the different mechanisms

mentioned above could be attributed to the difference between lipid components,
membrane proteins, and cell walls. A detailed investigation of CUR: interaction of CUR
with peptidoglycan of gram-positive bacteria and outer membrane of gram-negative
bacteria would be required to further validate these hypotheses.

7.4 Conclusions
The antimicrobial activity of CUR against L. monocytogenes and E. coli were validated in
this study, the MICs of CUR were 78 µg/mL for L. monocytogenes and 156 µg/mL for E.
coli respectively. TEM images of L. monocytogenes treated with CUR suggested that
disruption occurred on both cell wall and cell membrane, whereas TEM of E. coli treated
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with CUR suggested that membrane solubilized into lipid-CUR micelles. Fluorescence dye
leakage from artificial liposome treated with CUR indicated that mechanism of cell
deactivation is “all-or-none” carpet model. There is an energy barrier for CUR insertion
across the bilayer center which could be overcome when multiple CUR interacted with
lipid bilayer. Two different mechanisms were then proposed to explain the interaction of
CUR and Gram positive and Gram negative bacterial cell membranes.
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7.5

Figures and Tables

HO

Figure 7.1 Structure of CUR.

OH

194
100% DMF

50% DMF

20% DMF

Water

Figure 7.2 Antimicrobial activity of CUR on agar plate against L. monocytogenes and E.
coli when dissolved in different solvent. Concentrations of CUR on the plate: 1000 µg/mL,
500 µg/mL, 250 µg/mL, 125 µg/mL, 62.5 µg/mL, 31.25 µg/mL, 15.625 µg/mL, 7.8125
µg/mL, and control (solvent) in the center.

195
1

1

(b) E.coli

(a) Liste1·ia
-+-2500.00

0.8

-+-2500.00

0.8

-+-1250.00

-+-1250.00
~0.6

-+-625.00

.,=

-+-312.50

§

0.4

-+-156.25

g0.6

-+-625.00

.,=

-+-312.50

.,,

§

0.4

-+-156.25
-+-78.13

-+-78.13
0.2

-+-39.06
-+-19.53

0
0

2

4
Time (h)

6

8

-+-listuia

0.2

-+-39.06
-+-19.53

0
0

2

4
Time (h)

6

8

-+-E.coli

Figure 7.3 Absorbance of growth of bacteria treated by CUR. (a) L. monocytogens and (b)
E. coli. The units of CUR concentrations are µg/mL.
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Figure 7.4 L. monocytogenes in the absence of CUR
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Figure 7.5 L. monocytogenes with the presence of CUR
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Figure 7.6 E. coli in the absence of CUR.
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Figure 7.7 E. coli with the presence of CUR.
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Figure 7.8 Calcein leakage from liposome with CUR treatment at different concentrations.
(a) CUR dilution with DMF, and (b) dilution with water. The first concentration (300
mg/mL dissolved in DMF) are the same line in both plots for comparison.
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(c)

Figure 7.11 Snapshots of POPE membrane system with multiple CUR molecules. (a) and
(c) are initial structure of top view and side view respectively; (b) and (d) are simulation
after 1 µs of top view and side vies respectively. (e) is the same as (d) while water
molecules are shown additionally. Color code: brown sphere: phosphate, colorful licorice:
different CUR molecules, and red particles: oxygen of water molecules.
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Figure 7.12 Proposed mechanism of L. monocytogenes membrane disruption by CUR.
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Figure 7.13 Proposed mechanism of E. coli membrane disruption by CUR.
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8. DYE LEAKAGE OF LIPOSOME BY MELITTIN AND ITS
MUTANTS

8.1

Introduction

Antimicrobial peptides (AMPs) are small peptides that can deactivate microorganisms by
disrupting their cell membrane. These peptides share some common features, such as 2040 amino acids, positively charged, and amphiphilic structured with hydrophobic and
hydrophilic amino acids 6. AMPs have raised broad research interest due to their ability of
combating antibiotic resistance and potential of replacing antibiotics 445. Natural AMPs are
mostly isolated from animals and insects, which cause the producing cost very expensive.
In addition, toxicity issues of some AMPs cannot be ignored and become an obstacle for
application in agricultural, food, and pharmaceutical areas. Design of synthesized AMPs
based on natural AMPs to minimize toxicity is therefore necessary and urgent.
To design synthesized AMPs with higher efficiency, understanding the mechanism of
AMPs interacted with cell membrane is needed. Several general mechanisms have been
proposed to describe the action of AMPs on cell membrane, namely ‘carpet model’, ‘barrel
stave model’ and ‘toroidal pore model’ 173, 446, 447. After binding to the negatively charged
bacterial cell membrane due to electrostatic attraction, AMPs will aggregate and form pores
on cell membrane, aligning their hydrophobic residues towards lipid core region and
hydrophilic residues towards the interior of the pore. The structure properties of AMPs
could determine their action mode on cell membrane. Among the structure properties, net
charge and hydrophobicity of AMPs were reported to play important roles that influence
their antimicrobial activity

448

. It has been shown that electrostatic interaction results in

initial binding of AMPs onto the bilayer surface, while hydrophobicity controlled other

207
structure parameters

449

. Optimal balance between net charge and hydrophobicity was

essential for maintaining the antimicrobial activity of AMPs.
Melittin is a well-known AMP that exhibit both antimicrobial activity and strong toxicity.
It has been reported that at lower concentration, melittin disrupted cell membrane by
adopting ‘toroidal pore’, which means the pore is consisting of both peptides and bending
of lipid heads 450. Previously, we designed two mutants of melittin in order to investigate
the effect of net charge and hydrophobicity on the antimicrobial activity of melittin

264

.

One mutant (I17K) replaced the 17th isoleucine with lysine to increase the charge and
decrease the hydrophobicity, the other (G1I) replaced the 1st glycine with isoleucine to
increase the hydrophobicity. The results indicated that, although the antimicrobial activity
decreased compared to native melittin, both mutants showed significant decrease in
toxicity. TEM images showed that these peptides disrupted the bacteria by forming pore
on their cell membrane 264.
To further characterize the pore formation activity of these peptides, we employed
fluorescence dye leakage from liposome in this study. Although formation of pores in both
bacterial cell membrane and liposomes have been investigated by numerous techniques,
including fluorescence
crystallography

229

451

, oriented circular dichroism

, and quartz crystal microbalance

229

452

, NMR spectroscopy

173

, X-ray

, fluorescence dye leakage from

liposome is a well-established technique for investigating property of cell membrane.
Liposome was made from model lipid bilayer. Even though the model lipid bilayer is not
a true representation of bacterial cell membrane in that it lacked the complexity of a real
lipid bilayer, leaflet asymmetry, and membrane proteins, the validity of these simple
models has been shown by Faust JE et al

453

. They found that AMP induced membrane
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permeation could be reproduced in both E. coli membrane and model lipid bilayer, which
provided a strong support for using model membranes to study the molecular interactions
of AMPs with bacterial membranes.
Therefore, in this chapter, we compared the membrane permeability of melittin and its
mutants through dye leakage experiments in model lipid bilayers. The time dependent
fluorescence dye leakage from liposomes treated with AMPs were monitored at different
peptide concentrations. Kinetics of dye leakage were compared for both native melittin and
its mutant variants. This study will shed light on the effect of net charge and hydrophobicity
on pore formation efficiency, and provide insights for the design of novel synthesized
AMPs.

8.2
8.2.1

Materials and Methods
Materials

Melittin was purchased from Sigma-Aldrich with 85% purity. Mutant of melittin (G1I and
I17K) were synthesized with 95% purity by GenScript, Piscataway NJ. 1,2-Dimyristoylsn-glycero-3-phosphorylcholine (DMPC), Cholesterol, and dihexadecyl hydrogen
phosphate (DHP) with 99% purity were purchased from Avanti Polar Lipids, Alabaster AL.
8.2.2

Information of melittin and its muatants

The information of melittin and its mutant used in this study were listed in Table 8.1.
Compare to native melittin, G1I replaced the first residue glycine with isoleucine, which
resulted in an increase on hydrophobicity; I17K replaced the 17th residue isoleucine with
lysine, which resulted in an increase on net charge and decrease on hydrophobicity.
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8.2.3

Liposome preparation

Preparation of liposome encapsulated fluorescence dye (calcein) used protocol described
elsewhere

263, 416-419

. Briefly, 100 µL of mixed lipid stock solution consisting of DMPC,

cholesterol, and DHP in a molar ratio of 5:4:1 416 in chloroform was dried under N2 to form
a thin film in a glass vial. 1 mL of calcein (50 mM) in 0.02 M phosphate buffer at pH 6.0
was then added into the dry lipid film. The suspension was vortexed several minutes and
allowed to stand for 30 min to form large unilamellar encapsulating calcein. The vesicle
suspension was then forced through a polycarbonate filter (size = 1000 nm) using an
extruder for fifteen times to form uniform unilamellar liposomes. The size of extruded
liposomes was measured by Zeta sizer (Malvern Instruments, Worcestershire, UK). The
free calcein was washed by dialysis through a membrane with a molecular weight cutoff
of 10000 (Spectrum Laboratories, Inc. Rancho Dominguez, CA, USA) overnight. The
liposome was stored in a dark environment at −4 °C to avoid photo-bleaching until further
use.
8.2.4

Fluorescence measurement

The fluorescence of the released dye was measured with a spectrofluorometer (Flex Station
II, Molecular Device) at an excitation wavelength of 490 nm and an emission wavelength
of 520 nm. All experiments were conducted at 25°C which is above the phase transition
temperature for DMPC–cholesterol mixtures of cholesterol concentration above 12.5 mol%
420

. To compare the intensity, intensity of calcein was normalized based on the equation

showed below:
𝐶𝑎𝑙𝑐𝑒𝑖𝑛 𝐿𝑒𝑎𝑘𝑎𝑔𝑒 ( %) = 100×(𝐹 − 𝐹T )/(𝐹z − 𝐹T )
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where 𝐹 is the fluorescent intensity achieved after addition of CUR, 𝐹T is the fluorescence
intensity with the presence of CUR, and 𝐹z is the fluorescence intensity with addition of
Triton X-100, which makes the liposome fully ruptured 421.

8.3
8.3.1

Results and Discussion
Membrane permeation induced by Melittin and its mutants

Calcein leakage from liposome treated by melittin and its mutants as a function of time are
shown in Figure 8.1. Results showed that both melittin and its mutants could cause
concentration dependent calcein leakage from liposome vesicles. The dye leakage occurred
when the concentration of peptide was above a critical value. There was a lag time before
dye leakage for all the peptides, the lag time decreased as peptide concentration increased.
The fluorescence intensity reached an equilibrium state after several minutes. The time to
reach equilibrium was found to be smaller at higher peptide concentration. Similar behavior
of calcein leakage from PE/PG liposome had been reported before by Som A et al who
showed that a synthesized AMP (SAMP3) could cause concentration dependent dye
leakage with time evolution

454

. According to Figure 8.1, it should also be noted that the

shapes of fluorescence intensity were slightly different for each peptide, which indicated
the important roles of net charge and hydrophobicity.
8.3.2

Dye leakage properties for Melittin and its mutants

It could be observed that the slopes of fluorescence intensity vs time were different for all
the peptides. The rate of pore formation could be represented by the inverse of time
constant 𝑇𝐴𝑂 for the fluorescence intensity to reach the equilibrium state as explained in
caption to Figure 8.1, were compared for these peptides in Figure 8.2. Fitted equation of
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each peptides are shown in Table 8.2. The slope of fitted equation was the rate of pore
formation. It showed that melittin had the highest rate of pore formation with 0.0536 s-1,
followed by G1I (0.0281 s-1) and I17K (0.0226 s-1). This order was consistent with their
antimicrobial activity (melittin > G1I > I17K).
The lag time is determined as the time at which the fluorescence intensity started to increase
(after peptide was added). The lag time for these three peptides are compared in Figure 8.3.
The lag time plots showed that at lower peptide concentration, the lag time increased
dramatically; at higher peptide concentration, this value asymptotically approached zero.
Interestingly, the results also indicated that melittin has the lowest lag time, followed by
G1I and I17K, which is also consistent with their antimicrobial activity.
The initial rate of dye leakage was calculated from the slope of linear fit of fluorescence
intensity vs time soon after lag time (see Figure 8.4). as a function of peptide concentration
as shown in Figure 8.4. The results indicated the rate of dye leakage was strong positively
correlated with peptide concentration. The slope of melittin fitted line has the highest slope
(2.1883), followed by G1I (1.3403) and I17K (1.2444). This property was also consistent
with the antimicrobial activity of these peptides. It is also noted that, at the same rate of
dye leakage, melittin required highest peptide concentration, followed by G1I and I17K.
This could be explained by the effect of charge and hydrophobicity: higher charge and
lower hydrophobicity (I17K) could promote peptide binding onto the bilayer surface,
whereas higher hydrophobicity (G1I) could promote the insertion of peptide into lipid
bilayer.
Nucleation of pores on cell membrane could be explained by classic nucleation theory 455.
Based on this theory, the formation of pores on cell membrane is an active process: growth
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of the pore and closure of the pore were controlled by the surface tension of cell membrane
and line tension associated with the rim of the pore

456

. Nucleation of pores occurs by

penetration of peptides into the lipid bilayer. The peptides aggregate to form pores of
different sizes. These pores grow by addition of peptide that is already adsorbed onto the
top surface of the cell membrane by surface diffusion. Once the peptide reaches the
periphery of an existing pore, it will penetrate the pore to increase the pore size. Pores can
also dissociate by removal of a peptide from the pore. Transmembrane pores are
continually formed and destroyed because of penetration and removal of AMP to and from
lipid bilayer. The formation and dissociation of pores of certain size are random. It is to be
noted that pores of size smaller than the critical size grow by fluctuation whereas the pores
of size greater than the critical size grow spontaneously. The lag time refers to the time
required for pore size to grow to critical pore size by fluctuations. Consequently, the initial
slope of fluorescence vs time after the lag time is a measure of rate of nucleation of pores.
This sequence of events is shown in Figure 8.5.
The size distribution of liposomes is also a good indicator for the size change of lipid. The
size distribution of liposomes treated by melittin and curcumin at different concentrations
were shown in Figure 6. Liposome without treatment showed a distribution with a peak at
450 nm and a small second peak at 5500 nm, which was believed to be due to vesicle
aggregation. When the liposomes were treated by melittin at low concentration, the size
distribution became wider and shifted to the right with a peak at 500 nm. When liposomes
were treated by melittin at high concentration, the size distribution became bimodal, with
the first peak at 110 nm and the second peak at 1080 nm. This result indicated that,
liposome treated by low concentration of melittin could cause the size of liposome to
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increase, whereas liposome treated by high concentration of melittin could cause the size
of liposome to both decrease and increase. The increase in size of liposome at lower
concentration of melittin is believed to be due to stretching of bilayer due to pore formation.
At higher concentration of melittin, however, pore formation and the resulting stretching
of bilayer is also accompanied by solubilization of some of the lipids into smaller vesicles.
Lee et al
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and Karal et al

457

observed an increase of surface area on giant unilamellar

vesicles (GUV) treated by melittin and magainin, they also concluded that membrane could
be stretched by the peptide, which was consistent with our results.
Unlike melittin treatment, curcumin treatment resulted only in a decrease in liposome size
(Figure 8.6). This decrease in liposome size was more pronounced at higher curcumin
concentration. This result further validated the hypothesized mechanism: curcumin could
solubilize the liposome into small micelles instead of forming stable pores on the lipid
bilayer.

8.4

Conclusions

This study characterized the fluorescence dye leaked from liposome by native melittin and
its two mutant variants (G1I and I17K). The results indicated that all these peptides could
induce peptide concentration dependent dye leakage. The fluorescence leakage properties,
including rate of pore formation, lag time, and rate of dye leakage, were consistent with
the antimicrobial activity of these peptides. It is also proposed that dye leakage experiment
not only captured the nucleation of pores, but also included the growth of pores. As a good
membrane deactivate indicator, the fluorescence dye leakage experiment can be used for
characterizing other molecules that target cell membrane with disruption mechanism.
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Tables and Figures
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Figure 8.1 Calcein leakage of Melittin and its mutants as a function of time with different
peptide/lipid (P/L) ratio. The fitted curves were calculated using equation: 𝑓 = 𝑓m\n (1 −
𝑒 (le/z{|) ), where 𝑓m\n was the maximum fluorescence intensity, 𝑡 was the time, 𝑇𝐴𝑂 was
the time constant for fluorescence intensity to reach equilibrium state.
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Figure 8.4 Rate of dye leakage from liposome for melittin and its mutant.
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Figure 8.5 Schematic of pore formation on liposome membranes induced by melittin
corresponding to the change of fluorescence intensity change with time.
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Figure 8.6 Size distribution of liposome by melittin and curcumin treatment at different
concentrations. MEL-H: melittin high concentration 5mg/mL, MEL-L: melittin low
concentration 0.0195 mg/mL, CUR-H: curcumin high concentration 300 mg/mL, CUR-L:
curcumin low concentration: 1.172 mg/mL, DMF: Dimethylformamide, Lipo: liposome
control.
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Table 8.1 Peptide sequence information and antimicrobial activity
Code

Sequence

Charge

Hydrophobicity
(kcal/mol)

Melittin
G1I
I17K

GIGAVLKVLTTGLPALISWIKRKRQQ
IIGAVLKVLTTGLPALISWIKRKRQQ*
GIGAVLKVLTTGLPALKSWIKRKRQQ

5
5
6

1.363E05
1.492E05
1.233E05

MIC against L.
monocytogenes
(ug/mL)264
0.315 ±0.008
0.494 ±0.037
0.814 ±0.006
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Table 8.2 Fitted equation of 1/𝑇𝐴𝑂 as a function of P/L ratio
AMPs
Melittin
G1I
I17K

Fitted equation
y = 0.0537x - 0.0032
y = 0.0281x - 0.0032
y = 0.0226x + 0.0056

R2
0.9355
0.9701
0.9951

222

9. SUMMARY AND RECOMMENDATIONS

Summary
The interaction between melittin and lipid bilayer was characterized through both unbiased
and biased MD simulation. Consistent with experimental results reported before, melittin
requires a critical P/L ratio for both peptide binding onto the bilayer surface and formation
of a pore inside the bilayer. Melittin adopted a parallel orientation that aligns with the
bilayer at surface state, and changed to perpendicular orientation when inserted into the
bilayer center. N-terminal of the peptide was able to insert into the bilayer, whereas the Cterminal of the peptide stayed on the bilayer surface due to electrostatic attraction. Melittin
was also found to maintain the helical structure both in surface state and transmembrane
state.
Umbrella sampling MD simulation was employed to calculate the free energy of insertion
of a melittin peptide into a lipid bilayer, either in the absence of a pore or in the presence
of a pore consisting of different number of peptides. Melittin needed to overcome an energy
barrier of 7.209±0.864 kcal/mol to insert into the bilayer without a pore. This energy barrier
was found to decrease when the peptide is inserted into an existing pore consisting of
peptides. Significant water channel formation could be observed only for larger membrane
pores. The structure of the pore was found to be toroidal and paraboloid. Both PMF profiles
and mathematic model calculations showed consistent free energy change.
A methodology for identification of antimicrobial peptide from soy protein was proposed
based on the physicochemical properties of peptides: (i) length: 20-40, (ii) net charge:
+2~+5, (iii) hydrophobicity: -0.4~-0.2, and (iv) hydrophobic moment: +0.1~+0.3. The
screened candidate peptides 7a16 and 7a187 were then used to perform MD simulation to
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further evaluate the interaction between peptide and lipid bilayer. Both surface binding and
transmembrane pore formation abilities indicated higher potential of antimicrobial activity
of the peptide 7a16, which was further validated by antimicrobial experiment. The
proposed methodology has higher accuracy than current online prediction tools.
Interactions between CUR and six different model lipid bilayers (POPE, POPC, POPG,
DOPC, DPPE, POPE/POPG) and two realistic membrane systems (E. coli and yeast) were
characterized through all-atom explicit solvent MD simulation. CUR was found to insert
into lipid bilayer within hundred nanoseconds scale and remain in the lipid tails region with
a predominantly parallel orientation. The behavior of CUR was significantly different in
lipid bilayer consisting of PE lipid, which was due to hydration property and non-bond
interactions. CUR insertion was able to alter some properties of lipid bilayer, such as order
parameter, membrane thickness, area per lipid, and lateral diffusion. Interactions of CUR
and E. coli and yeast membrane systems were similar to the mixed POPE/POPG mixed
lipid bilayer.
Antimicrobial activities of CUR against L. monocytogenes and E. coli were validated using
bioassay, viability assay, TEM, and fluorescence dye leakage experiments. CUR exhibited
antimicrobial activity when dissolved in DMF. The MIC of CUR against L. monocytogenes
was 78 ug/mL, and the MIC of CUR against E. coli was 156 ug/mL, these values fall in
range of reported MIC of CUR. TEM images indicated CUR may target these two bacteria
with different mechanisms: CUR attacked the gram-positive bacteria by disrupting both
cell wall and cell membrane, and deactivated the gram-negative bacteria by solubilizing
the cell membrane. PMF profiles illustrated an energy barrier for CUR permeated through
the bilayer center, which is consistent with CUR density distribution. Existence of multiple
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CUR molecules inside lipid bilayer could promote permeation of CUR through bilayer
center.
Fluorescence dye leakage of liposome by native melittin and its mutants were investigated.
Leakage of calcein entrapped within DMPC/cholesterol mixed liposomes by these peptides
indicated: (i) leakage of fluorescence is dependent on the peptide concentration whereas a
critical peptide concentration is needed for pore formation, (ii) there is a lag time for pore
formation above this critical peptide concentration, and (iii) fluorescence intensity
properties are consistent with the antimicrobial activities of these peptides. This technique
not only captures the nucleation of pore formation, but also describes the event of growth
of pore size. In addition, the balance between net charge and hydrophobicity is essential
for design of appropriate pore forming peptides.

9.2

Recommendations

1. Investigation of the effect of amino acid distribution, net charge, and hydrophobicity on
the antimicrobial activity and cytotoxicity on synthesized AMPs.
Design of AMPs with a balance of net charge and hydrophobicity requires the
consideration of amino acid distribution. Therefore, more melittin mutants (such as G3I
and G3K) or non-natural AMPs (such as peptides consisting of I, K, A only) could be
studied by experiments and MD simulations to better elucidate the general criteria for the
net charge and hydrophobicity.
2. Optimization of selection criteria for AMPs from natural protein
It is necessary to further validate more AMPs candidate based on current selection criteria
from soy protein, and optimize the selection criteria: such as length of peptide, distribution
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of amino acids, number of charged amino acids etc. It is also worthwhile to validate this
methodology using other natural protein.
3. Molecular dynamics simulation of multiple CUR with lipid bilayer
It is found that CUR could easily insert into lipid bilayer within hundred nanoseconds and
remain inside the lipid bilayer near top leaflet. Existence of multiple CUR in lipid bilayer
could promote permeation of CUR through bilayer center. PMF calculation is needed to
validate this phenomenon. Systematic unbiased MD simulations of interaction between
multiple CUR with model lipid bilayer and realistic membrane system are also needed to
explain the interaction between CUR and lipid bilayer.
4. Molecular dynamics simulation of CUR with cell wall and outer membrane
Experimental results showed different deactivating effect of CUR on L. monocytogenes
and E. coli thereby suggesting different disruption mechanisms. It is supposed that CUR
may also target cell wall of gram-positive bacteria and outer membrane of gram-negative
bacteria. MD simulation of CUR and cell wall or outer membrane can be performed to
validate phenomenon and provide insights on the atomic interaction information.
5. Exploration of relationship between fluorescence dye leakage and membrane pore
formation
It is proposed the fluorescence dye leakage experiment not only capture the nucleation of
pores but also include the growth of pore size. The change of fluorescence intensity may
also reflect the mechanism of pore formation. Therefore, it is needed to test more peptides
with different pore forming mechanisms using this technique, in order to find out the
relationship between fluorescence dye leakage and membrane pore forming mechanism.
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ABSTRACT: Melittin is a naturally occurring antimicrobial peptide that has the ability to kill bacterial cells through cell
membrane penetration, leading to pore formation. In this investigation, an all-atom molecular dynamics (MD) simulation has
been carried out to describe the interaction of two, four, or six peptides placed on the surface of a 3:1 1,2-dioleoyl-sn-glycero-3phosphocholine (DOPC)/1,2-di(9Z-octadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol) (DOPG) lipid bilayer (a mimic of the
bacterial cell membrane) corresponding to protein/lipid (P/L) ratios of 2:96, 4:162, or 6:166, respectively. MD simulation was
also carried out for (i) one to eight transmembrane peptides (corresponding P/L ratios of 1:128 to 8:128) in a 3:1 DOPC/
DOPG mixed membrane for symmetric as well as asymmetric placement of peptides and (ii) four to eight transmembrane
peptides (corresponding to P/L ratios of 4:128 to 8:128) for a pure DOPC lipid bilayer (a mimic of the mammalian cell
membrane) for the asymmetric placement of peptides. The broadening of phospholipid head regions in the bottom leaﬂet as well
as thinning of the membrane were found to occur for melittin placed on the top leaﬂet only for a mixed membrane. A critical P/L
ratio of 6:166 was observed for the penetration of melittin from the surface, with this critical value being 6:128 for water channel
formation in the case of transmembrane peptides. The phospholipid density proﬁle across the bilayer indicated a toroidal pore
structure. Asymmetric transmembrane pores were larger for the top leaﬂet and grew in size with time, whereas symmetric pores
were stable. The behavior for mixed and pure membranes was found to be similar for transmembrane peptides, thus implying
high toxicity of melittin.

1. INTRODUCTION
Antimicrobial peptides (AMPs) have the ability to penetrate
the cell membrane and kill the cell by cell membrane rupture.
They are a unique and diverse group of molecules, which are
divided into subgroups on the basis of their amino acid
composition and structure.1−4 They are mostly amphiphilic
with a net positive charge.5 Pore formation by AMP in
phospholipid bilayers begins by electrostatic attraction,
followed by the attachment and penetration of the cell
membrane, and has been the subject of several investigations.6−10 Experimental techniques such as ﬂuorescence,11
oriented circular dichroism,8 NMR12 spectroscopy, and X-ray
crystallography8 have been employed to monitor the pore
formation, secondary conformation of AMP, orientation of the
AMP as well as lipid, and thinning of the membrane. Several
studies of pore formation by AMP on model membranes have
elucidated diﬀerent mechanisms of pore formation such as the
hydrophobic (barrel-stave) pore, hydrophilic (toroidal) pore, or
micelle (carpet mechanism) formation and helped to identify
key factors that control pore formation. Peptides have been
shown to bind in two physically distinct states. At low peptide/
lipid ratios, they adsorb and embed into the lipid headgroup
region in a functionally inactive state (referred to as the surface
or S state) that stretches the membrane.13 The extent of
membrane thinning is speciﬁc to the peptide and directly
proportional to the peptide concentration. At high peptide/
lipid ratios, peptide molecules are oriented perpendicularly and
insert into the bilayer, forming transmembrane pores (referred
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to as the I state). The I state peptide/lipid ratio varies with both
the peptide and target lipid composition.8
Melittin is a much investigated AMP from the venom of
European honeybee (Apismellifera). It contains 26 amino acid
residues (GIGAVLKVLTTGLPALISWIKRKRQQ), which are
predominantly hydrophobic in the amino-terminal region,
whereas the carboxy-terminal region is hydrophilic, bearing
four out of the total number of six positively charged
residues.14−16 In an aqueous environment, melittin exhibits a
random-coil conformation and is monomeric at low concentrations. At suﬃciently high concentrations, it tends to
agglomerate, forming tetramers at high pH and ionic
strengths.16,17 In a phospholipid environment, melittin has
been shown to adopt an α-helical conformation.18−20
Molecular dynamics (MD) simulation, a technique in which
the evolution of the positions of all atoms belonging to AMPs
when interacting with a phospholipid bilayer accounting for
interatomic interactions such as van der Waals, electrostatic,
etc., has been employed to evaluate the potential energy of
interaction,21 peptide conformation,22 peptide orientation,23
and deformation of lipids.24 AMBER force ﬁeld has been
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Table 1. Details of the All-Atom MD Simulations That Were Performed

a

run

peptide/lipid ratio

lipid type

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

0:128
0:128
2:96
2:96
4:162
6:166
1:128
2:128
4:128
4:128
5:128
5:128
6:128
6:128
6:128
7:128
7:128
8:128
8:128

DOPC/DOPG
DOPC
DOPC/DOPG
DOPC/DOPG
DOPC/DOPG
DOPC/DOPG
DOPC/DOPG
DOPC/DOPG
DOPC/DOPG
DOPC
DOPC/DOPG
DOPC
DOPC/DOPG
DOPC/DOPG
DOPC
DOPC/DOPG
DOPC
DOPC/DOPG
DOPC

position

surface
surface
surface
surface
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane
transmembrane

a

arrangements

time (ns)

remarks

NC
NN
NN
NN
N inserted
NN inserted
asymmetric
asymmetric
asymmetric
asymmetric
asymmetric
symmetric
asymmetric
asymmetric
asymmetric
asymmetric
asymmetric

50
50
100
100
100
100
50
50
50
50
50
50
60
60
50
50
50
50
50

no pore
no pore
1 peptide insertion
surface
surface
3 peptide insertion
no pore
no pore
no pore
no pore
water diﬀusion
water diﬀusion
pore formation
pore formation
pore formation
pore formation
pore formation
pore formation
pore formation

N: N terminal. C: C terminal. Asymmetric: all N terminals inserted into the lipid bilayer. Symmetric: equal number of N and C terminals inserted.
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Figure 1. Initial arrangement of diﬀerent numbers of melittin peptides when placed on the surface of a lipid membrane: (a, c, e, and g) top views of
peptides; (b, d, f, and h) side views of the peptides. Color code: blue, charged residues; green, polar residues; white, nonpolar residues. Backbones
are shown only with secondary structure style. The ruler scale is 10 Å.

the phospholipids, consistent with the toroidal pore structure.29
For a pure 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) membrane, the arrangement of four transmembrane
melittin formed a stable toroidal pore with a water channel.20,30
An increase in the net charge of the N terminal in mutant
melittin resulted in a more disordered pore.31 However,
removal of the charge of basic residues seems to prevent
pore formation.27
In this manuscript, we investigate the interaction of melittin
with a mixed membrane (a mimic of the bacterial cell
membrane) consisting of 1,2-dioleoyl-sn-glycero-3-phospho-

employed to describe the interatomic interactions in systems
containing lipids.25,26 Even though the quantitative results of
MD simulation may vary from one force ﬁeld to the other, the
qualitative features of these results will be the same. Melittin is
shown to adsorb onto the phospholipid membrane surface20
although its subsequent penetration into the bilayer is found to
occur when the N terminal is protonated.19 Penetration of
melittin into the bilayer from the surface occurs only above a
critical P/L ratio27 and involves an energy barrier that is found
to be lower for larger P/L ratio.28 A transmembrane tetramer of
melittin inserted into the bilayer is found to result in bending of
10276
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Figure 2. Simulation snapshots at 50 ns and a normalized density proﬁle of a 3:1 DOPC/DOPG mixed membrane in the absence of melittin. (a)
Whole system of lipid membrane. (b) Same as part a, in which lipid tails are not shown for clarity. Phospholipid heads are only shown with the
phosphate atom for clarity. Color code: yellow, DOPC lipid heads; pink, DOPG lipid heads; gray, lipid tails; blue, water. (c) Normalized density
proﬁle of water and a lipid headgroup for a mixed membrane.

charged) bilayer. A pure DOPC bilayer mimicked the
mammalian cell membrane, whereas DOPC/DOPG mixed
bilayers are negatively charged membranes, mimicking the
bacterial cell membrane. Counterions were added to neutralize
the system and the ﬁnal ionic (KCl) concentration of the
system was 0.15 M to reproduce physiological conditions. The
periodic box was ﬁlled with water molecules based on the
TIP3P potential.
Careful minimization to remove bad contacts and steric
hindrances was performed before slow heating of the system to
303 K: ﬁrst, the conﬁgurational energy of the system was
minimized by performing 2000 steps of a steepest-descent
algorithm followed by 3000 steps of a conjugate-gradient
algorithm.38 The protein/membrane system then was relaxed
prior to running heating MD using constant pressure (NPT) to
reach the target temperature (303 K). During heating, the
positions of the lipid atoms were kept ﬁxed with harmonic
constraints. A 5 ns MD simulation at 303 K with a NPT
ensemble was performed to equilibrate the system followed by
50/100 ns production runs of constant surface tension “γ”
(NPγT) simulation. Langevin dynamics was employed with a
collision frequency 1 ps−1. Semiisotropic pressure scaling was
used to maintain the pressure at 1 atm with a constant surface
tension value set to 15 dyn/cm because this value was found to
well-describe diﬀerent membrane properties such as the
porosity, surface area, and electron density for a pure DOPC
membrane.34,39 Nonbonded interactions were calculated with a
cutoﬀ at 10 Å; full electrostatics was employed using the
particle-mesh Ewald method. Covalent bonds involving hydrogen atoms were held rigid with the SHAKE algorithm, allowing
a 2 fs time step.

choline (DOPC) and 1,2-di(9Z-octadecenoyl)-sn-glycero-3phospho-(1′-rac-glycerol) (DOPG) by MD simulation. Specifically, we investigate the eﬀect of the number of melittin
molecules (placed on either the membrane surface or
transmembrane) and orientation on the formation and growth
of the pores. Results indicate the formation of stable pores for
symmetric as well as asymmetric orientation of transmembrane
melittin only above a critical P/L ratio.

2. METHODS
We performed multiple all-atom simulations with AMP melittin
for both surface and transmembrane states. Details of all of the
simulation systems are given in Table 1.
For the surface arrangement, simulations were performed for
the cases of two, four, and six peptides placed on the membrane
surface as shown in Figure 1. For two peptides, they were
placed parallel to each other with two cases. In the ﬁrst case, the
two N terminals belonging to the two peptides were near each
other. In the second case, the C and N terminals belonging to
the two peptides were near each other. For four and six
peptides, the N terminals of all of the peptides faced each other.
The initial distances between peptides in all cases can be seen
in Figure 1. It is to be noted that the number of lipids increased
as more peptides were placed in the system (see Table 1).
We also simulated a system containing single or multiple
transmembrane peptides (one, two, four, ﬁve, six, seven, and
eight) and 128 mixed lipids (3:1 DOPC/DOPG) as well as
pure DOPC lipids. Initially, these peptides were asymmetrically
placed in the mixed or pure membrane center with hydrophilic
residues facing together. In addition, we compared structural
diﬀerences between asymmetric and symmetric arrangement
with six peptides in 128 3:1 DOPC/DOPG mixed lipids.
All of the simulations were performed following the same
procedure below. All MD simulations were carried out using
AMBER32 software. The AMBER ﬀ99SBildn33 force ﬁeld was
employed for the peptides, whereas the Lipid1134 force ﬁeld
was employed for all lipid force ﬁelds. The TIP3P model35 was
used for water molecules. The snapshots were visualized using
VMD36 software.
The initial peptide structure was obtained from a protein
data bank (PDB ID 2MLT, chain A). The initial lipid bilayer
with peptide structure for the simulation was built using the
CHARMM-GUI37 Web site (http://www.charmm-gui.org).
The bilayer in the simulation was represented by either pure
DOPC or a 3:1 mixed DOPC (neutral)/DOPG (negatively

3. RESULTS
3.1. Peptide Reorientation on the Surface of the Lipid
Bilayer. A snapshot of a 3:1 DOPC/DOPG mixed membrane
in the absence of melittin and the density proﬁles of water and
a lipid head are shown in Figure 2. The left panel (a) shows the
lipid tails, which are not shown in the right panel (b).
Two melittin (P/L = 2/96) were placed on the top leaﬂet of
a 3:1 DOPC/DOPG mixed membrane parallel to each other,
with the distance between the two backbones of ∼7.68 Å and
with two orientations. In the ﬁrst, the two N terminals were
placed adjacent to each other. The initial structure of melittin
was obtained from PDB. Because the hydrophobic residues of
melittin were allowed to fully interact with the lipid tails, the
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molecules were slightly bent, with the N terminals pointing
inward (see Figure 3a). In the second case, the C and N
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of electrostatic attraction. Normalized density proﬁles averaged
over the last 30 ns are shown as a function of the z coordinate
(vertical position within the bilayer) for the two cases in Figure
4. The density proﬁle of melittin for the asymmetric (CN)
orientation clearly shows (Figure 4b) penetration into the
bilayer. For the NN case, lipid heads are both located around z
= ±15 Å, which reﬂects the fact that the polar lipid heads are
oriented nearly parallel to the membrane−water interface. For
the NC case, however, the lipid density proﬁle does indicate
protrusion into the bilayer from the bottom leaﬂet, consistent
with Figure 3d. Even though no pore formation occurs in both
cases, an insigniﬁcant diﬀusion of water into the bilayer can be
seen for the asymmetric case (Figure 4b). For the NC
orientation, the density proﬁle of peptides also indicates the
penetration of peptide from the top leaf to the interior of the
bilayer, consistent with Figure 3d. The area per lipid remained
more or less constant in both cases (Figure S2 in the SI).
The snapshots of the initial and 100 ns conformations of four
and six peptide molecules placed on the top leaﬂet of a 3:1
DOPC/DOPG mixed bilayer, with their N terminals facing
each other, are shown in parts a−d of Figure 5, respectively. As
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Figure 3. Side views of the initial and ﬁnal two melittin on the surface
of the lipid bilayer. (a and b) Initial and 100 ns, respectively, for the
NN case. (c and d) Initial and 100 ns, respectively, for the NC case.
Color codes are the same as those described in Figures 1 and 2.
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terminals of two melittin were placed adjacent to each other.
Melittin consists of two α-helical regions separated by a
characteristic kink at Pro14. Moreover, the ﬁve charged
residues are not uniformly distributed along the peptide, but
four of them (KRKR) are concentrated in the C terminus. This
resulted in the C terminus being more hydrophilic than the N
terminus. Because of charge repulsion, the two α-helical
backbones are not parallel when viewed from the side (Figure
3c). The snapshots of the initial and 100 ns structures for the
two cases are shown in Figure 3. In the ﬁrst case (NN), the two
peptides did not penetrate the membrane, but the N terminal
bent to the top leaﬂet (Figure 3b). In the second case (CN),
however, because of the combined eﬀects of electrostatic
repulsion between the C and N terminals and electrostatic
attraction between the positively charged C and N terminals
and negatively charged leaﬂets, the protruding C and N
terminals shifted toward the top and bottom leaﬂets,
respectively (Figure 3d). The other C and N terminals
remained anchored to the top leaﬂet because of the
predominant eﬀect of electrostatic attraction with the negatively
charged leaﬂet. Movement of the N terminal toward the
bottom leaﬂet led to bending of phospholipid heads as a result

"
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Figure 5. Side views of the initial and ﬁnal four and six melittin on the
surface of the lipid bilayer. (a and b) Initial and 100 ns, respectively,
for the four peptides case. (c and d) Initial and 100 ns, respectively, for
the six peptides case. Color codes are the same as those described in
Figures 1 and 2.

pointed out above, the initial orientation of the peptides results
in the protrusion of part of the helical structure with the N
terminal into the bilayer because of a bend in proline residue
and hydrophobic interactions with the hydrocarbon tails. After
100 ns, four peptides bend back into the top leaﬂet, with all
four peptides residing on the surface of the membrane.
Thinning of the membrane can be observed, although no
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Figure 4. Normalized density proﬁles of two melittin on the surface of a 3:1 DOPC/DOPG mixed membrane averaged over the last 30 ns: (a) NN
case; (b) NC case.
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Figure 6. Normalized density proﬁles of (a) four and (b) six melittin on the surface of a 3:1 DOPC/DOPG mixed membrane averaged over the last
30 ns.

penetration of water molecules occurred. In the case of six
melittin molecules, however, after 100 ns, three of the six
peptides penetrate into the lower leaﬂet, whereas the other
three continue to remain at the upper leaﬂet. More bending of
the membrane is found to occur compared to the case of four
peptides. One can also see more phospholipid heads bending
toward the peptide in both the top and bottom leaﬂets. The
density proﬁles for four and six peptides are shown in parts a
and b of Figure 6, respectively. These proﬁles clearly indicate
penetration of the peptides as well as more bending of the
membranes for the case of six melittin molecules. In addition, a
slight penetration of water molecules near the top and bottom
leaﬂets can also be seen for six peptides.
The thickness of the lipid bilayer was inferred from the
distance between the peaks in the lipid density proﬁle.
Similarly, the thicknesses of the region within which the
phospholipid heads were conﬁned in the top and bottom
leaﬂets were also inferred from the widths (>1% of normalized
density) of the lipid density distribution for the top and bottom
leaﬂets, respectively. These values are given in Table 2 for

in which three reached the bottom leaﬂet. A similar broadening
eﬀect was reported for the MD simulation for interaction of an
amphiphilic corticotropin-releasing factor with the DOPC
bilayer.41 These results also indicate a critical P/L ratio for
penetration of melittin into the mixed bilayer, consistent with
ﬂuorescent leakage experiments for pore formation in liposomes.42 The critical P/L ratio for penetration of melittin into
the DOPC bilayer in the active state was observed by X-ray
diﬀraction.40 The critical P/L ratio was also reported from the
MD simulation of interaction of melittin with the DPPC
bilayer.27
In the following sections, the results of the structure of pores
consisting of vertical transmembrane peptides of diﬀerent sizes
are presented. It is to be noted that a transition of a horizontal
peptide on the lipid surface to a vertical transmembrane
orientation involves an energy barrier.28 The evaluation of this
energy barrier is relevant to the description of diﬀerent sets of
events involved in pore formation. We are currently performing
free-energy calculations to evaluate this energy barrier.
3.2. Diﬀerent P/L Ratios of Peptides at the Transmembrane State of a Mixed Lipid Bilayer. Figure 2 shows
the snapshot of a 3:1 DOPC/DOPG mixed membrane without
any peptide. The snapshots of the 50 ns conformation of
diﬀerent numbers of transmembrane peptides with N terminals
inserted into the lower leaﬂet are shown in Figure 7a−h. Lipid
tails are not shown for clarity. In addition, the right panels of
these ﬁgures do not show the peptide in order to better
visualize formation of the water channel, if any. Normalized
water density and lipid density proﬁles for these cases are
shown as a plot of density versus z coordinate in the
Supporting Information (SI; Figure S4). As expected, in the
case of no peptide, no water penetration occurred. However,
for one, two, and four transmembrane peptides, some
penetration of water molecules occurred although no water
channel was formed. The extent of water penetration was more
signiﬁcant (up to ±5 Å) only for four transmembrane peptides.
On the other hand, density proﬁles clearly show formation of
the water channel for six and eight transmembrane peptides
(Figure S4 in the SI), which can also be seen from the
snapshots (Figure 7). Unlike the simulation results for melittin
placed on the top leafet, the lipid proﬁles for transmembrane
peptides were found to be symmetric. No signiﬁcant broadening of the top and bottom phospholipid regions was
observed for one, two, and four peptides (see Table S1 in
the SI). However, for six transmembrane peptides, the density
proﬁle indicated penetration of the lipid head into the bilayer,
consistent with toroidal pore structure (refer to Figure 7e,f). In
addition, no signiﬁcant thinning of the membrane was also

Table 2. Thicknesses of the Lipid Head Regions and Lipid
Bilayera
lipid head regions >1%
run

P/L
ratio

thickness at the
lower leaﬂet (Å)

1
3
4
5
6

0:128
2:96
2:96
4:162
6:166

18.05
21.30
18.80
19.15
23.85

±
±
±
±
±

1.0062
0.2739
0.2092
0.5184
0.6982

thickness at the
upper leaﬂet (Å)
17.95
18.15
15.95
18.00
21.85

±
±
±
±
±

0.9585
0.2850
0.3260
0.5000
0.3791

lipid bilayer
thickness (Å)
33.85
32.60
31.35
31.05
31.45

±
±
±
±
±

0.2850
0.2850
0.1369
0.3260
0.3708

a

The simulation results for 50−80, 55−85, 60−90, 65−95, and 70−
100 ns were analyzed to obtain the error bars.

diﬀerent P/L ratios. The distance between the two peaks
decreased from 33.85 Å in the absence of peptides (baseline) to
31.05−32.60 Å, thus clearly indicating thinning of the
membrane due to interaction with the peptides. Chen et al.40
reported thinning of the DOPC membrane due to interaction
with melittin using X-ray diﬀraction. Broadening of the
phospholipid region in the bottom leaﬂet was observed
(Table 2), with the thickness of the region increasing with
the P/L ratio. Interestingly, such a broadening was not
observed for the top leaﬂet. This is believed to be due to
electrostatic attraction of the bottom phospholipid heads with
the N terminal of penetrating melittin. This is further evidenced
by the fact that broadening is most pronounced for six peptides,
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Figure 7. Snapshots of two, four, six, and eight transmembrane peptides in the lipid bilayer at 50 ns: (a and b) two peptides/membrane systems; (c
and d) four peptides/membrane systems; (e and f) six peptides/membrane systems; (g and h) eight peptides/membrane systems. Lipid tails are not
shown in parts a, c, e, and g, whereas lipid tails and peptides are not shown in parts b, d, f, and h for clarity. Color codes are the same as those
described in Figures 1 and 2.

observed, as can be seen from the inferred membrane thickness
for diﬀerent P/L ratios that is given (see Table S1 in the SI).
Top views of the 3:1 DOPC/DOPG mixed membrane with
six transmembrane melittin with their N terminals attached to
the bottom leaﬂet at 0 and 50 ns are shown in Figure 8. Water

size increased with time. Similar results were obtained for ﬁve,
seven, and eight transmembrane peptides. 0 and 50 ns
snapshots and dimensions of the pore for all of the cases are
given in the SI (Figure S5 and Table S3, respectively). Similar
results were obtained for the MD simulation of four
transmembrane melittin in the POPC bilayer.20 It is interesting
to note that phospholipid heads were found to line the pores in
addition to the hydrophilic part of the peptide at 50 ns, thus
demonstrating a toroidal pore structure. Earlier MD simulation
results29,30 for the structure of transmembrane melittin induced
pores in a pure DMPC as well as a pure POPC bilayer to be
toroidal in that the pores were lined with both peptides and
lipid heads. These results also indicate a critical P/L ratio for
pore formation consistent with earlier reported results27,40,43 as
discussed above.
3.3. Diﬀerent Numbers of Transmembrane Melittin in
a Pure DOPC Lipid Bilayer. Similar calculations were
performed for a pure DOPC membrane with four to eight
transmembrane melittin molecules, with their N terminals
attached to the lower leaﬂet. A pure DOPC membrane was
chosen to mimic the mammalian cell membrane. The results
were very similar to those described above for a mixed
membrane (mimic of the bacterial cell membrane). Consequently, these results indicate that melittin is toxic in that it
exhibits the same tendency for pore formation in mixed and

Figure 8. Snapshots of top views of six transmembrane peptides: (a)
initial; (b) 50 ns. Water molecules are not shown for clarity. Color
codes are the same as those described in Figures 1 and 2, and purple is
K+ and cyan is Cl−. All of the molecules are shown with all-atom style.

molecules are not shown for clarity. It is to be noted that at 0 ns
no water molecules were present inside the cavity formed by
hydrophilic parts of the transmembrane peptides. At 50 ns,
however, as pointed out above, water molecules do penetrate to
form a water channel. As can be seen from Figure 8, the pore

- - lipidh~

Figure 9. Snapshots of six transmembrane peptides at 50 ns and normalized density proﬁles for water and lipid heads. Lipid tails are not shown in
parts a and b. Peptides are also not shown in part b for clarity. Color codes are the same as those described in Figures 1 and 2.
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Figure 10. Snapshots of (a) asymmetric and (b) symmetric transmembrane arrangements for six melittin at various times during the MD simulation.
Water molecules and lipid tails are not shown for clarity. Color codes are the same as those described in Figures 1 and 2.
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pure membranes (an indication of its possible antimicrobial
activity and toxicity, respectively). The toxicity of melittin has
been conﬁrmed experimentally.44 Similar results of pore
formation for a pure DOPC membrane have been reported
from the MD simulation.27,29,45 Snapshots at 50 ns for six
transmembrane melittin molecules along with the density
proﬁles are shown in Figure 9. Similar plots for four, ﬁve, seven,
and eight are given in the SI (Figure S6). Water channel
formation was observed only for six, seven, and eight
transmembrane peptides similar to the results for a mixed
membrane. This is also clear from water density proﬁles (see
Figures 9c and S7 in the SI). The thickness of the bilayer as
well as the thicknesses of phospholipid head regions in the
upper and lower leaﬂets are given in the SI (Table S2). Top
views of the pores at 0 and 50 ns for these cases are given in the
SI (Figure S8). Similar to the behavior for mixed membranes, in
the case of a pure DOPC membrane, the pore size was found to
increase only for six, seven, and eight transmembrane peptides.
3.4. Symmetric versus Asymmetric Arrangements of
Six Transmembrane Melittin in a Mixed Lipid Bilayer.
Snapshots at diﬀerent times for six transmembrane peptides in
a 3:1 DOPC/DOPG mixed membrane are shown in Figure 10
for asymmetric (all N terminals attached to the lower leaﬂet)
and symmetric (equal numbers of peptides with C and N
terminals attached to the upper and lower leaﬂets, respectively)
arrangements. Normalized density proﬁles averaged over the
last 30 ns are also shown for the two cases in Figure 11. A water
channel is observed in both cases. The pore is found to be more
asymmetric, with the size being larger at the top leaﬂet for the
asymmetric case as a result of the stronger electrostatic
repulsion among charged C terminals (Figure 11a). In addition,
the peptide density distribution was also asymmetric with a
larger peptide density near the top leaﬂet because of the

stronger electrostatic attraction of C terminals with phospholipid heads. The increase in the pore size with time was more
pronounced for the asymmetric case, whereas for the
symmetric case, the pore size was more stable. Irudayam and
Berkowitz30 report stable toroidal pores for the symmetric
arrangement of transmembrane melittin in POPC bilayers. Lin
and Baumgartner20 also observed the expansion of asymmetric
transmembrane melittin pores in POPC membranes from the
MD simulation. Finally, the density of phospholipids in the
central region of the bilayer was higher for the asymmetric case
as a result of more bending of the phospholipid heads (see
Figure 11, insets).

4. CONCLUSIONS
An all-atom MD simulation was performed to investigate the
interaction of melittin with a 3:1 DOPC/DOPG mixed
membrane as well as a pure DOPC membrane. These
simulations were carried out for diﬀerent numbers of melittin
(one to eight) placed either on the top leaﬂet of the membrane
or fully inserted into the membrane. Broadening of the
phospholipid head regions in the bottom leaﬂet and thinning of
the membrane were found to occur for melittin placed on the
top leaﬂet only for a mixed membrane. A critical P/L ratio was
observed for the penetration of melittin from the surface as well
as for water channel formation for transmembrane peptides.
The pore structure was demonstrated to be toroidal.
Asymmetric transmembrane pores were larger for the top
leaﬂet and grew in size with time, whereas symmetric pores
were stable. The behaviors for mixed and pure membranes were
found to be similar for transmembrane peptides, thus implying
high toxicity of melittin, consistent with earlier observations.
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Potential of mean force for insertion of antimicrobial peptide
melittin into a pore in mixed DOPC/DOPG lipid bilayer
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Antimicrobial peptides (AMPs) inactivate microorganisms by forming transmembrane pores in a cell
membrane through adsorption and aggregation. Energetics of addition of an AMP to a transmembrane
pore is important for evaluation of its formation and growth. Such information is essential for the
characterization of pore forming ability of peptides in cell membranes. This study quantifies the
potential of mean force through molecular dynamics (MD) simulation for the addition of melittin,
a naturally occurring AMP, into a DOPC/DOPG mixed bilayer, a mimic of bacterial membrane, for
different extents of insertion into either a bilayer or a pore consisting of three to six transmembrane
peptides. The energy barrier for insertion of a melittin molecule into the bilayer was highest in the
absence of transmembrane peptides and decreased for the number of transmembrane peptides from
three to six, eventually approaching zero. The decrease in free energy for complete insertion of peptide
was found to be higher for larger pore size. Water channel formation occurred only for insertion into
pores consisting of three or more transmembrane peptides with the radius of water channel being
larger for a larger number of transmembrane peptides. The structure of the pore was found to be
paraboloid. The estimated free energy barrier for insertion of melittin into an ideal paraboloid pore
accounting for different intermolecular interactions was consistent with MD simulation results. The
results reported in this manuscript will be useful for the development of a model for nucleation of
pores and a rational methodology for selection of synthetic antimicrobial peptides. Published by AIP
Publishing. [http://dx.doi.org/10.1063/1.4979613]
I. INTRODUCTION

Cell death resulting from pore formation in cell membranes by peptides has important consequences in biology. An
important function of pore forming peptides is in the defense
of plants and animals against invading microbes. These antimicrobial peptides (AMPs) could be very useful for combating
microbes. Antibiotic action against bacterial cells includes
inhibition of cell wall synthesis, inhibition of protein synthesis, inhibition of nucleic acid synthesis, and antimetabolite
activity.1 However, AMP inhibits the growth of bacteria by
disrupting their cell membrane. As a result, it may be difficult
for drug resistant bacteria to develop resistance against AMP.
Previous studies2–4 have demonstrated this. Therefore, AMP
can be an attractive alternative to conventional antibiotics.
Pore formation is also believed to be one of the mechanisms
leading to neurological disorders such as Alzheimer’s disease,
Parkinson’s disease, spongiform encephalopathy, amyotrophic
lateral sclerosis, and Huntington’s disease. In these cases, fibrils formed by aggregation of amyloid beta peptides form pores
in neuronal cell membranes causing death. The exact mechanism of pore formation and cell death is not well understood.
a)
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Elucidation of this mechanism as a result of the work proposed here will help greatly in the development of guidelines
for the design of antimicrobial peptides to replace antibiotics. AMPs inactivate microorganisms by forming pores in
the cell membrane through adsorption and aggregation.5 They
are usually cationic and are about 20 to 40 amino acids in
length. They can target multiple microorganisms. When the
peptide concentration is low, peptides stay on the surface
of the membrane and are bound parallel to the lipid bilayer
(referred to as S state).6 With the increase of peptide concentration, peptides turn to be perpendicular to the bilayer,
insert into the membrane, and form transmembrane pores.7
The nucleation and growth of these pores occur through surface
diffusion of adsorbed peptides followed by their penetration
into the cell membrane. The pore structure is characterized
by the hydrophobic part of the peptide aligning itself with the
lipids and the hydrophilic part of the molecule forming the
interior of the pore.6,8,9 For AMP with sufficiently high positive charge, the inserted transmembrane aggregate induces
the lipid molecules to bend so as to partially neutralize the
positive charge of hydrophilic interior of the pore. The lipid
molecules tilt from the lamellar normal and connect the two
leaflets of the membrane, forming a continuous bend from
the top to the bottom in the form of a toroidal hole. This
type of pore is referred to as toroidal pore and is formed by
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magainins, protegrins, and melittin.6,10,11 Some amyloidrelated proteins/peptides form aggregates which may interact with phospholipid membranes (cell membranes) where
they form pores disrupting cellular homeostasis.12–15 A summary of different types of amyloidosis and peptides that
are involved in aggregation and pore formation in a variety
of neurological disorders such as Alzheimer’sdisease (AD),
Parkinson’s disease (PD), spongiform encephalopathies, amyotrophic lateral sclerosis, and Huntington’s disease is given.16
This mechanism of toxicity is similar to that displayed by
antimicrobial peptides. Several investigations have examined pore formation by melittin, a naturally occurring
AMP isolated from the venom of European honeybee
(Apis mellifera).6,7,17–21 It contains 26 amino acid residues
(GIGAVLKVLTTGLPALISWIKRKRQQ), which are predominantly hydrophobic in the amino-terminal region whereas
the carboxy-terminal region is hydrophilic bearing 4 out of the
total number of 6 positively charged residues.22–24
Molecular dynamics (MD) simulation which accounts
for interatomic interactions such as van der Waals and electrostatic has shown that melittin binds to the phospholipid
bilayer surface9 although its subsequent insertion into the
bilayer is found to occur when the N terminal is protonated.25 MD simulation has also been employed to quantify
the potential energy of interaction of peptides with a lipid
bilayer,26 secondary peptide conformation,27 peptide orientation,28 and deformation of lipids.29 It has been shown that
the melittin monomer adopts a random coil conformation
whereas it is ↵ helical in the tetrameric form when exposed
to aqueous environment.30–32 In lipid bilayer environment,
melittin has been shown to maintain a stable helical structure.33 The effect of different environments on conformation
of melittin has been investigated.34–36 Our previous investigation on pore formation by melittin in a 1,2-dioleoyl-snglycero-3-phosphocholine (DOPC)/1,2-di(9Z-octadecenoyl)sn-glycero-3-phospho-(10-rac-glycerol) (DOPG) mixed bilayer using all atom explicit solvent MD simulation indicated
that a critical P/L ratio was needed for insertion of the peptide
from the surface into the bilayer as well as for the formation
of water channel by transmembrane peptide aggregates.37 The
pore structure in a lipid bilayer formed by melittin aggregates
has been shown to be toroidal by MD simulation.37–43 Potential of mean force for insertion of a peptide into the bilayer
showed a decrease in the free energy for complete insertion of
the peptide with an energy barrier implying thereby that peptide insertion is favorable. Ladokhin and White44 estimated
that the free energy gain in a process when melittin transforms
from an unfolded structure in water to a folded conformation on a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) membrane surface is 7.6 kcal/mol. The energy barrier for insertion of a single melittin into a POPC lipid bilayer
was ⇠22 kT (⇠13 kcal/mol)45 which was found to decrease for
insertion of a peptide into a POPC bilayer consisting of three
transmembrane peptides.45 The energy barrier for the addition
of a peptide to an existing pore consisting of aggregate of different numbers of peptides, necessary to describe the rate of
pore formation by nucleation, is lacking. In a previous investigation, we have demonstrated a critical peptide/lipid ratio for
water channel formation for melittin, a model antimicrobial
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peptide, in bacterial and mammalian cell membranes. In this
manuscript, we employed the umbrella sampling method to
quantify the effect of number (0, 3, 4, 5, and 6) of transmembrane peptide aggregates on the energy barrier for the addition
of melittin into a bacterial cell membrane mimic. The results
reported in this manuscript will be useful for the development
of a quantitative model for nucleation of pores by antimicrobial
peptides and hence in a rational methodology for the design
of synthetic antimicrobial peptides.
II. SIMULATION METHODS
A. Simulation system setup

The initial structure of the solvated peptide-membrane
system was set up using CHARMM-GUI as described in our
previous work.37 Briefly, the structure of melittin was taken
from the protein data bank (PDB ID: 2MLT, chain A) and
the lipid bilayer was using 3:1 mixed DOPC/DOPG lipid
molecules mimicking the bacteria cell membrane. The periodic box was filled with water molecules based on the TIP3P46
potential. The system was neutralized by adding counter ions;
the final ionic (KCl) concentration of the system was 0.15M
in order to reproduce the physiological conditions.
Five cases (zero to one, three to four, four to five, five to
six, and six to seven peptides with 128 lipid molecules) were
investigated for the free energy calculation. In each case, one
peptide was placed at different positions within the bilayer,
from the surface state (no insertion into bilayer) to transmembrane state (complete insertion into bilayer). The reaction
coordinate corresponds to the z component (across the lipid
bilayer) of the distance between the center of mass of the first
three residues near N terminal of the peptide and center of
mass of the lipid bilayer. The reaction coordinate was varied by varying the extent of insertion of melittin within the
bilayer. The increment in the extent of insertion was 1 Å. In
the first window, the peptide was placed in the bulk solution
parallel to the upper leaflet of the lipid bilayer. In the next
window, the peptide was moved by 1 Å into the membrane
and restrained at that position. The force constant used for
restraining the peptide is 3.5 kcal mol 1 Å 1 . Since the thickness of membrane is around 40 Å, the total number of window
is 46 in order to cover all the positions. Other peptides were
arranged as a preformed aggregate in the lipid bilayer to form a
pore.
The setup of the simulation was also described in our
previous work.37 Briefly, all MD simulations were carried
out using the AMBER47 software. The AMBER ff99SBildn48
force field was employed for the peptides, whereas Lipid11
force field49 was employed for all the lipid force field. For
each restrained location of the N terminal of the peptide, the
system was first minimized for 25 000 steps in order to remove
bad contacts and steric hindrances. An equilibration of 2 ns
with a constant surface tension “ ” (NP T) ensemble was
performed. The temperature of the system was also heated
from 0 K to 303 K during equilibration. Production simulation was performed for 150 ns followed by the calculation and
analysis of potential of mean force (PMF) for the last 50 ns.
The simulation time step was 2 fs. The total simulation time
was approximately 34.5 µs. The PMFs were constructed using
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the weighted histogram analysis method (WHAM)50 in the
AMBER software package. The last 50 ns of calculation was
divided into 10 blocks each of 10 ns duration so that there is
overlap of time periods. The PMF values at each location of the
N terminal were evaluated from histograms that were obtained
from each interval using WHAM. The mean values and error
bars were evaluated from these. Snapshots were taken from
the VMD software.51 The density and position of the peptides were calculated using the cpptraj tool52 in AMBER. The
secondary structure analysis was performed using the DSSP
module.53
To elucidate the structure of the pore, the size of aggregate
at different values of reaction coordinate was calculated as well
as the radius of the water channel.
B. Aggregate size calculation

The size of aggregate was calculated based on the position of each peptide. The coordinates of each residue from
backbone were exported from the simulation result; the areas
surrounded by the peptides at different z coordinates were calculated and employed to evaluate the equivalent radius of a
circle of the same area.
C. Water channel radius calculation

Water channel radius was determined by counting the
number of water molecules in the center of the lipid bilayer
corresponding to z coordinates from 5 to 5 Å in order to characterize the pore. The space occupied by the water molecules
was approximated as a cylinder, and the density of water
molecules in the cylinder was considered to be the same as
that of bulk water. The radius was then calculated using the
following equation:
r
Mw N
,
(1)
r=
Na ⇡H

(a)

where r is the radius of the water channel, M w is the molecular
weight of water, and N a is Avogadro’s number, N is the number
of water molecules in the cylinder, and H is the height of the
cylinder.39,40
III. RESULTS AND DISCUSSIONS
A. Free energy of peptide insertion for different cases

Schematic of the potential of mean force profile for insertion of a peptide into a bilayer is presented in Fig. 1. Fig. 1(a)
depicts the positions of lipid heads, tails, and inserted peptide
at different locations of the free energy profile for insertion
of a single peptide. Fig. 1(b) depicts the insertion of a peptide into preexisting pores of different sizes. The existence of
an energy barrier when the N terminal of a peptide is close
to the center of the lipid bilayer can be clearly seen from the
schematic. Figs. 2(a)–2(e) show the plot of calculated potential of mean force versus different positions of the restrained
N terminal of the peptide inside the lipid bilayer. Comparison
of PMF profiles for a simulation time of 120 ns for all the
cases (Fig. S1 of the supplementary material) with the current
results (simulation time of 150 ns) shows a negligible difference between the two thereby indicating that the system is
close to equilibrium. The free energy of the peptide increases
when it is transferred from the top leaflet reaching a maximum
near the center of the bilayer and decreasing subsequently as
the peptide is inserted further into the bilayer. Consequently,
there is a free energy barrier of about 7.209 ± 0.864 kcal/mol
(see Fig. 2(a)) for insertion of a single peptide into the bilayer.
Irudayam et al.45 obtained a value of 13.20 ± 0.80 kcal/mol for
insertion of melittin into the POPC bilayer. The energy barrier
is lower for our case of mixed bilayer (DOPC/DOPG) because
of net charge of the bilayer. Negatively charged DOPG phospholipid heads will neutralize part of the peptide charge and
thus reduce the free energy. The asymmetric PMF profile is

Barrier state

} - Upper leaflet
} - Lower leaflet

Distance (A)
Transrnembrane state

S urface state

(b)
3 to 4

4 to S

S to 6

FIG. 1. Schematic of potential of mean
force profile for insertion of a peptide
into a lipid bilayer, (a) identifies different locations of the peptide inside the
bilayer in PMF calculations for insertion, energy barrier, and transmembrane
state in the free energy diagram and (b)
depicts the insertion of a peptide into a
preexisting pore of different sizes.
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region of lipid heads from 20 Å to 10 Å. Region II starts from
the interface of top leaflet lipid heads and lipid tails (⇠10 Å)
to the next interface of lower leaflet lipid heads and lipid tails
(⇠–10 Å). Region III is lipid heads of the lower leaflet, starting
from 10 Å to 20 Å. Transfer of a melittin molecule through
region I in general shows a free energy decrease indicating that
the insertion of peptide through region I is favorable (Fig. 2(a)).
Density profiles show that part of the hydrophobic residues of
the peptide has inserted into region II (Figs. 3(a) and 4(a) and
Fig. S3 of the supplementary material), which is hydrophobic
environment. Similar results were reported for the pure POPC
lipid bilayer.45 When melittin is inserted through region II, it
experiences an energy barrier of about 7.209 ± 0.864 kcal/mol
at a location which corresponds to a distance of around 4.52 Å
from the center (see Fig. 2(a)). As the peptide is inserted
through region II, lysine near the N-terminal (7 LYS) attracts
oppositely charged lipid heads leading to their bending as can
be seen from the peak in the density profile of charged residues
at around 4.52 Å in Fig. 3(c) and snapshot in Fig. 5(c). This
results in an increase in free energy of bending. Interestingly,
this lipid bending is predominantly from the bottom leaflet
and is more pronounced when the peptide is at 4.52 Å corresponding to the energy barrier. The second energy minimum
refers to the location (⇠–18.12 Å) when melittin becomes
perpendicular to the lipid bilayer, or in the transmembrane
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believed to be due to changes in the structure of the bilayer
as a result of the asymmetric environment created by peptides within the preexisting pore (as can be seen from the
peptide density profiles at different extents of insertion as
shown in Fig. 4 and Fig. S4 of the supplementary material).
It is important to note that the free energy of the peptide
decreases from the surface state to transmembrane state by
0.084 ± 0.120 kcal/mol. However, the rate of insertion would
be proportional to exp
fmax kT , f max being the energy
barrier. Similar plots of potential energy of mean force for
other cases (four, five, six, and seven peptide aggregates) are
shown in Figs. 2(b)–2(e). As shown in Fig. 2(f), the energy
barrier is found to decrease for insertion of peptide into a transmembrane peptide aggregate of larger size. Interestingly, the
energy barrier approaches zero (0.588 ± 0.185 kcal/mol) for
an aggregate of six to seven peptides. Fig. 2(f) also shows that
the free energy change f for complete insertion from the surface state to transmembrane state is more negative for larger
pore size thereby indicating that larger pores will be more
stable.
In order to better describe the energy profile, we adopt a
three-region model of the lipid bilayer based on the density
profile (see Fig. S2 of the supplementary material), similar to
that of the work of Marrink 54 and MacCallum.55 Starting from
the top leaflet of the lipid bilayer (⇠20 Å), region I refers to the
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FIG. 3. Density profile of single melittin at different locations of lipid bilayer, (a): region I, (b)-(c): region II, and (d): region III. Color code: blue: water, red:
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(b)-(d): region II, (e): region III, and (f): corresponding location at the free energy profile by arrows. Color code: yellow: hydrophobic residues of preexisting
peptides (t pho) and light green: charged residues of preexisting peptides (t c); other color codes are the same as Fig. 3.

state. At this location, the decrease in free energy occurs due to
(i) less lipid bending since the charged residue (7 LYS) near
the N terminal is in region III (corresponding to the peak in
the density distribution of charged residues around 15 Å as
shown in Fig. 3(d)), which is a hydrophilic region and (ii) most
part of the hydrophobic residues stays in region II.
It is important to notice that there exist multiple barriers and minimums when a single melittin penetrates into a
pore formed by an aggregate of peptides. For the case of 3
to 4 peptides, the first barrier occurs at 4.49 Å, which can be
attributed to part of hydrophobic residue insertion and bending of the upper lipid head as evident from the density profile
(Fig. 4(b)) and snapshot (Fig. 6(b)). The secondary barrier
is experienced by the peptide at a location of 1.04 Å from

the center. This barrier is higher than the first as a result of
further insertion of charged residue (7 LYS) and more bending
of lipid heads. This difference can be attributed to the difference in the environment experienced by inserting the peptide
into the preexisting pore compared to the pure bilayer. In addition, multiple free energy local maxima and minima in the case
of peptide insertion into preexisting pore formed by peptide
aggregates (see Figs. 2(b)–2(e)) are believed to be due to discrete distribution of amino acid side chains along the backbone.
The interactions between side chains of the inserting peptide
and the side chains belonging to the peptides in the preexisting
pores are not evenly distributed along the reaction coordinate.
A similar behavior was observed for the other cases which are
not presented here. It is important to note that the thinning of

FIG. 5. Snapshots of a single peptide inserting into the lipid bilayer–different extents of insertion of the peptide, (a): 11.79 Å, (b): 0.52 Å, (c): 4.52 Å, (d):
18.12 Å. Color code: yellow: DOPC lipid heads, pink: DOPG lipid heads, gray: lipid tails, cyan: water, blue: charged residues, green: polar residues, and white:
nonpolar residues.
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FIG. 6. Snapshots of a single peptide penetrating into a pore formed by the aggregate of three peptides, (a): 11.99 Å, (b): 4.49 Å, (c): 6.21 Å, (d): 15.34 Å.
Color code: orange: preformed transmembrane peptide aggregate; other color codes are the same as Fig. 5.

FIG. 7. Snapshots of a single peptide penetrating into a pore formed by the aggregate of four peptides, (a): 10.09 Å, (b): 0.97 Å, (c): 5.87 Å, (d): 15.05 Å.
Color code: orange: preformed transmembrane peptide aggregate; other color codes are the same as Fig. 5.

membrane as a result of bending of lipid is more pronounced
for the bottom leaflet especially for the case of preexisting
pores of multiple peptides. As a result, 20 Å refers to the
aqueous medium on the other side of the bilayer. In these cases,
a steep increase in the free energy profile is observed near
20 Å. This result is consistent with a separate study on the
free energy cost for one melittin peptide diffusing out of a
small membrane pore.39
B. Insertion of single peptide in lipid bilayer without
peptide aggregate

Figs. 5(a)–5(d) show snapshots of the conformations of
peptide along with the lipid bilayer at four different extents of
insertion when the peptide is introduced from the top layer with
its N terminal restrained as described in Section II. When the

peptide is at the top leaflet parallel to the surface (⇠11.79 Å),
it retained most of the helical structure. As the peptide penetrated the bilayer, its orientation changed. The peptide is
found to retain most of its helical conformation at different orientations until it reached the bottom leaflet as can be
seen from Fig. 5. When the peptide insertion is 0.52 Å (see
Fig. 5(b)), electrostatic attraction between the N terminal and
oppositely charged phospholipid heads at the upper leaflet led
to bending of the upper leaflet in the vicinity of the N terminal. The hydrophobic parts of the peptides (white part in
Fig. 5(b)) interact with the lipid tails whereas the hydrophilic
parts (green and blue part in Fig. 5(b)) interact with water
and lipid heads. This can be also seen from the density profiles of water, lipid heads, and lipid tail molecules, 6 LEU,
7 LYS, 8 VAL, and 9 LEU (Fig. S3 of the supplementary
material).

FIG. 8. Snapshots of a single peptide penetrating into a pore formed by the aggregate of five peptides, (a): 11.31 Å, (b): 1.49 Å, (c): 3.64 Å, (d): 13.36 Å.
Color code: orange: preformed transmembrane peptide aggregate; other color codes are the same as Fig. 5.
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FIG. 9. Snapshots of a single peptide penetrating into a pore formed by the aggregate of six peptides, (a): 11.38 Å, (b): 0.07 Å, (c): 5.11 Å, (d): 15.72 Å.
Color code: orange: preformed transmembrane peptide aggregate; other color codes are the same as Fig. 5.

Because of favorable interactions with water and lipid
heads, 7 LYS is found to lie in region I whereas the other
three lie in region II due to stronger hydrophobic interactions. When the peptide insertion is 4.52 Å (Fig. 5(c)),
the N terminal reached the lower leaflet thereby causing
bending of lower leaflet lipid heads in its vicinity as is
evident from lipid density profiles (see Figs. S3 and S4
of the supplementary material). However, the lipid heads
in the upper leaflet did not bend. In addition, considerable
number of water molecules can be found in the vicinity
of bent lipid heads though no water channel was formed
which can also be clearly seen from the snapshots (see
Fig. 5). When the peptide insertion is 18.12 Å, the peptide
becomes perpendicular to the lipid bilayer as can be seen from
Fig. 5(d).
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Figs. 6–9 show snapshots of the conformations of the peptide along with the lipid bilayer at four different extents of
insertion when the peptide is introduced from the top layer
with its N terminal restrained into an existing aggregate consisting of three, four, five, and six transmembrane peptides,
respectively. Although there are preexisting peptides in the
lipid bilayer, the distribution of the inserting peptide residues
is similar to the first case. For example, when the insertion
peptide is parallel to the bilayer, or at the surface state, the
hydrophobic residues are closer to region II while the charged
residues all stay in region I (see Fig. S4 of the supplementary
material). When the transferred peptide is at the center of the
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bilayer, the density profile of 6 LEU, 8 VAL, and 9 LEU is
still located in region II whereas 7 LYS lies in region I (see Fig.
S5 of the supplementary material). Significant water concentration was observed for a larger number of peptides inside the
aggregate (Fig. 10(f)). In addition, for the complete penetration of inserted peptide, the water channel can be observed for
the cases of four, five, six, and seven peptide aggregates. This
can also be seen from the 2D water density profiles as shown
in Figs. 10(b)–10(e). The variation of the equivalent radius of
aggregate opening (defined as the radius of circle whose cross
sectional area is equal to the area of the opening) with depths
of bilayer for different numbers of peptides in the aggregate is
shown in Fig. 11. The equivalent radius of aggregate is found to
be minimum at the center of the bilayer. Therefore, in the cases
in which the peptide is inserted into three to six peptide aggregates, the pore structure is found to be closer to paraboloid with
the cross sectional area being minimum at the center. This can
be also seen from the snapshots (Figs. 6–9). The equivalent
radius of the water channel was calculated based on the total
number of water molecules in the central region of the opening
as described in Section II. Fig. 10(f) shows the plot of water
channel radius versus number of peptides in the peptide aggregate. The water channel radius is found to increase with the
aggregate size with this increase being more pronounced from
six to seven peptides in the aggregate consistent with 2D water
density profiles (Figs. 10(b)–10(e)). In addition, all the peptides, including the inserting peptide and preexisting peptide,
maintain over 30% of the helical structure as can be from Fig.
S6 of the supplementary material.
D. Free energy calculation based on mathematic model

We present a model for the prediction of energy barrier
for peptide insertion into a pore. While MD simulation is
capable of providing rich information about pore formation,
such a mathematical model based on intermolecular interactions will be useful for the efficient analysis of nucleation
of pores. Nucleation of pores involves several steps, such as
adsorption of peptide onto lipid bilayer followed by surface diffusion and penetration into preexisting pores of different sizes
thereby leading to the formation of a pore of critical size. The
information on energy barrier for addition of a single peptide
into a preexisting pore will be necessary for the evaluation
30 ~ - - - - - - - - - - - ~
- - Poly. (4)
- - Poly. (5)
25
- - Poly. (6)
~ 20
- - Poly. (7)

of the rate of penetration of a single peptide and hence the
growth rate of pores. Since the radius of an aggregate at the
center is almost equal to the radius of the water channel, and
the water density profile indicates the presence of water in the
regions in the vicinity of top and bottom leaflets, the region
inside the aggregate opening can be assumed to be aqueous.
We can estimate the free energy change for insertion of a
peptide based on energetic considerations. We employ a simplified approach to estimate the hydrophobic, electrostatic,
and bending free energy when transferred from the surface
to the pore. This approach would provide a general correlation between the energy barrier for peptide insertion and the
size of the peptide aggregate in the preexisting pore. An ideal
toroidal pore will consist of an aggregate of peptides with their
hydrophilic side chains pointing inwards into the aqueous pore
and the hydrophobic side chains pointing outwards into the
lipid tails. Also, these peptides will not be close packed thereby
allowing some negatively charged phospholipid heads to bend
into the inner lining of the pore in regions between peptides
in order to partly neutralize the positive charge of the peptides. The electrostatic attraction of phospholipid heads with
charged groups of peptides will lead to bending of peptides
to form a paraboloid pore as was shown by the pore structure
obtained from the MD simulation (see Figs. 6–9). This analysis
makes the following simplifying assumptions, namely, (i) the
hydrophobicity of peptide is uniformly distributed along the
peptide backbone, (ii) the charge density of cationic peptide
is also uniform along its length, (iii) electrostatic repulsion
among point charges distributed along the hydrophilic side
groups inside the pore is approximated as electrostatic interaction inside a cylindrical cavity with uniform distribution of
surface charges—such an assumption is reasonable for pore
sizes much larger than the Debye length since the charges are
in the hydrophilic side chains facing inside that are subjected
to Brownian motion. The free energy change upon insertion
of a peptide into a pore consists of several contributions,
namely, (i) free energy of bending of phospholipid heads, (ii)
electrostatic free energy resulting from the confinement of
charges within the aqueous pore, and (iii) hydrophobic free
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FIG. 11. Pore radius vs reaction coordinate for different number of peptides
in the aggregate.

FIG. 12. Schematic of a paraboloid pore. A melittin molecule is inserted to
a penetration distance of x within the paraboloid pore. r is the radius of the
pore at the position corresponding to the tip of a melittin molecule. r0 is the
minimum radius of the pore at the center of the pore, t/2 is the radius of
curvature of the paraboloid pore.
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energy as a result of exposure of hydrophobic side groups into
the lipid environment. Detailed discussion of these contributions can be found elsewhere.56,57
In an ideal pore, the radius of curvature of this paraboloid
pore is taken to be t pore /2, tpore being the thickness of the
bilayer. From geometric consideration, ⇡t pore /2 = l 0 , where l 0
is the length of the peptide backbone (consisting of 26 amino
acid side chains with the spacing between them being 1.5
⇥ 10 10 m). The schematic of an ideal paraboloid pore is shown
in Fig. 12. The pore is symmetric about the central plane of
the lipid bilayer with the pore diameter being the smallest at
the center, increasing with the distance from the center and
becoming the largest at the top and bottom leaflets. Because
of the repulsion between phospholipid heads, the center to
2
dpore (na , nb ) tpore 66
61
+
2
2 66
4
2
dpore (na , nb ) tpore 66
61
=
+
2
2 66
4

r (x, na , nb ) =

In our simulations, the potential of mean force was evaluated for insertion of a peptide into a pore that can accommodate na peptides but consist only of na
1 peptides
with a vacant space for the insertion of additional peptide. Consequently, the paraboloid structure of the pore is
that for an aggregate of na peptide thereby ensuring that
the insertion of additional peptide did not change the pore
structure.
We are now interested in evaluating the change in free
energy when a melittin molecule is inserted to different extents
of penetration into a pore consisting of an aggregate of melittin. Understandably, the free energy change will depend on
how far the melittin molecule is inserted into an existing pore.
It is assumed that the melittin that is inserted is in ↵ helical
conformation within the pore. It is also assumed that the peptides belonging to the aggregate that form the pore are also in ↵
helical conformation. The change in hydrophobic free energy
f hy (x) as a result of insertion of a peptide up to a depth x is
given by
fhy (x, na ) = ghb

l (x)
.
L

(3)

In the above equation, ghb is the hydrophobicity of melittin,
L is the total length of the peptide backbone, and l(x) is the
length of the peptide inserted into the pore for a penetration of
x which is given by
l (x) =

! 2 3 1/ 2
⌅x 2
66
dr 7
661 + dx 777 dx.
5
0 4

(4)

Similarly, the bending free energy can be calculated as follows.
At any depth of insertion x, the two principal radii of curvature
for the bending of phospholipid head are r(x), the radius of the
pore, and tpore/2, the radius of the arc along which they are bent
(see Fig. 12). Consequently, the free energy f bend change due

center distance between two phospholipid heads is greater
than d h . Let this distance be ↵d h , ↵ > 1. Since the phospholipids are bent along the circumference (l + d h ), l and
d h being the length of the lipid tail and the diameter of the
phospholipid head, respectively, the number of layers nlayers
of phospholipids in a pore is given by nlayers = ⇡ (l + dh ) ↵dh .
The diameter of a pore d pore at the center consisting of
56
na peptides and⇣ nb phospholipids
⇣
. per⌘peptide
⌘ . is given by
dpore (na , nb ) = na dpep + na nb nlayers dh ⇡. If q is the net
(positive) charge of the peptide and qlipid is the net (negative)
charge of phospholipid head, the total charge inside the pore
qnet is equal to na q na nb qlipid . From geometric considerations, the radius of the pore r(x) at any depth x into the lipid
bilayer is given by
8
>
<1
>
:
8
>
<1
>
:

! 2 9 1/ 2 37
>
= 77
tpore > 77
; 5
! 2 9 1/ 2 73
> 7
2x
1 =
> 77
tpore
; 75

1

2x

if x 

tpore
2

otherwise.

(2)

to bending of phospholipid heads is given by
fbend (x, na , nb ) =

!2
⌅x
1 *.
2
1
Kc .
+
0
2
tpore r (x , na , nb )
,0

dl (x) 0+/
dx / .
(5)
dx
Confinement of positive peptide charges within the pore will
result in an electrostatic repulsion. These charges are in the
hydrophilic side chains of the peptide and therefore are distributed along the peptide backbone. These charges exhibit
Brownian motion. Consequently, it can be assumed that the
charges are uniformly distributed in the inner pore surface.
Based on the electrostatic interaction inside a charged cylindrical curved surface, the electrostatic free energy of the
paraboloid surface is given by56,58
⌅x ⌅1
qnet (na , nb )2 e2
fel (x, na , nb ) =
⇡y" r " 0 L 2
⇥ na nb

0 r(x0 )

26⌅y
6 I12 (y 0) 0
⇥ 66
dy +
y0
66
40

37
1 77 dl 0
dy dx . (6)
2 77 dx
75
Therefore, the net free energy change f (x, na ) for the
extent of insertion x into a pore consisting of na peptides is
given by
f (x, na ) = fhy (x, na ) + fbend (x, na , nb ) + fel (x, na , nb ) ,
(7)
where fhy (x, na ) is the hydrophobic interaction free energy,
fbend (x, na , nb ) is the bending free energy, and fel (x, na , nb )
is the electrostatic free energy. In the above, x refers to the
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hydrophobicity as well as the shape of the paraboloid pore
employed in the model for the evaluation of these potentials.
The energy barrier for insertion of a peptide into peptide aggregates of different sizes is important in the characterization of
rates of formation and dissociation of pores of different sizes
and therefore in the evaluation of the rate of growth of pores
due to nucleation.
IV. CONCLUSIONS
x(nm)
FIG. 13. Predicted dimensionless free energy of insertion of a melittin
molecule f (x)/kT vs insertion distance x. Plots labelled 3, 4, and 5 refer to
the cases for insertion of a melittin into a pore consisting of 3, 4, or 5 peptides.
The hydrophobicity of melittin is 140 448 J/mole. The other parameters are
nb = 20; K bend = 1.1 ⇥ 10 19 J/mole; I = 0.15; d pep = 1.12 ⇥ 10 9 m; q = 5;
= 3.9 ⇥ 10 11 J/m; s = 6.5 ⇥ 10 3 N/m; t pore = 5 ⇥ 10 9 m; qh = 0.0595;
" r = 78.8; d h = 3.86 ⇥ 10 10 m; ⇠ = 21.08.

extent of insertion of the peptide, and na and nb refer to the
number of peptides in the pore and number of bent phospholipid heads per peptide, respectively. The potential energy vs
extent of insertion as evaluated by Equation (7) for three different numbers of peptides in the pore as shown in Fig. 13
exhibits an energy barrier of 16.76kT for insertion of peptide into a pore consisting of 3 peptides which decreases to a
value of 3kT for insertion into a pore consisting of 4 peptides.
For a pore consisting of 5 peptides, however, insertion of a
peptide does not experience any energy barrier. These results
are consistent with the MD simulation results reported earlier.
Comparison of energy barriers obtained from MD simulation
with the model prediction for insertion of melittin into a pore
consisting of different numbers of peptides is shown in Fig. 14.
The predicted energy barriers decrease with the number of peptides in the pore and eventually become zero for five peptides.
Even though the predicted energy barrier agrees reasonably
well with the value obtained from MD simulation for pore sizes
of six and seven peptides, the predicted value is found to be
higher than the MD simulation value for pore sizes of four and
five peptides. The discrepancy between MD simulation and
model predictions can be attributed to the simplifying assumptions with regard to the uniform distribution of charges and
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SUPPLEMENTARY MATERIAL

See supplementary material for information on (a) PMF
results for all cases for 120 ns, (b) regions within the lipid
bilayer, (c) density profiles of water, lipid tails, lipid heads,
as well as LYS, LEU, and VAL residues when melittin is at
different locations within the bilayer, and (d) helicity of each
peptides in pores of different sizes.
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MD simulation of insertion of a melittin molecule into a
transmembrane pore consisting of different numbers of peptides inside a DOPC/DOPG lipid bilayer to different extents
of insertion indicated that the water channel formation occurs
only for insertion into pores consisting of four or more transmembrane peptides. The radius of the water channel was found
to be larger for a larger number of transmembrane peptides.
The structure of the pore is found to be paraboloid with the minimum radius being at the center of the lipid bilayer. Insertion
of peptide into a pore is found to be energetically favourable.
However, a melittin molecule had to overcome an energy barrier for its complete insertion into the pore. This energy barrier
is found to be highest for insertion into the lipid bilayer in the
absence of transmembrane peptides and is found to decrease
with the number of transmembrane peptides from three to six
eventually approaching zero at sufficiently large number. The
estimation of free energy of a melittin molecule at different
extents of insertion into an ideal paraboloid pore accounting for
different intermolecular interactions indicated the existence of
an energy barrier consistent with MD simulation results. Quantification of energy barrier for peptide insertion is important
for the evaluation of the rate of formation of pores of different sizes which is necessary for the evaluation of the rate of
nucleation of pores.
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Number of melittin in pore
FIG. 14. Comparison of energy barriers for insertion of a melittin molecule
vs pore size (number of peptides) for MD simulation and analysis. The energy
barrier for insertion as obtained by analysis is inferred from the plots given in
Fig. 13.
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a b s t r a c t
Antimicrobial peptides (AMPs) inactivate microbial cells through pore formation in cell membrane.
Because of their different mode of action compared to antibiotics, AMPs can be effectively used to combat
drug resistant bacteria in human health. AMPs can also be used to replace antibiotics in animal feed and
immobilized on food packaging films. In this research, we developed a methodology based on mechanistic
evaluation of peptide-lipid bilayer interaction to identify AMPs from soy protein. Production of AMPs from
soy protein is an attractive, cost-saving alternative for commercial consideration, because soy protein is
an abundant and common protein resource. This methodology is also applicable for identification of AMPs
from any protein. Initial screening of peptide segments from soy glycinin (11S) and soy !-conglycinin
(7S) subunits was based on their hydrophobicity, hydrophobic moment and net charge. Delicate balance
between hydrophilic and hydrophobic interactions is necessary for pore formation. High hydrophobicity decreases the peptide solubility in aqueous phase whereas high hydrophilicity limits binding of the
peptide to the bilayer. Out of several candidates chosen from the initial screening, two peptides satisfied
the criteria for antimicrobial activity, viz. (i) lipid-peptide binding in surface state and (ii) pore formation in transmembrane state of the aggregate. This method of identification of antimicrobial activity via
molecular dynamics simulation was shown to be robust in that it is insensitive to the number of peptides
employed in the simulation, initial peptide structure and force field. Their antimicrobial activity against
Listeria monocytogenes and Escherichia coli was further confirmed by spot-on-lawn test.
© 2016 Elsevier Inc. All rights reserved.

1. Introduction
The application of conventional antibiotics against pathogenic
bacteria has decreased in recent decades, because of the rising concern of generation of multi-resistant bacteria. As compared to the
traditional antibiotics, antimicrobial peptides (AMPs) kill bacteria
rapidly and can target multiple pathogens. Antimicrobial peptides
belong to a large and varied class of relatively short peptides family, typically containing 10–50 residues [1,2]. They are part of the
host-defense system in many living organisms, capable of killing
inter alia, Gram negative and Gram positive bacteria. This renders
them of great interest as potential alternatives to small-molecule
antibiotics and highly relevant from a pharmaceutical perspective
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[3]. Many of them adopt an " helical secondary conformation in
the hydrophobic environment of lipid bilayer [4] and are cationic.
They disrupt or permeabilize the cell membrane by pore formation,
leading to cell lysis and death [5,6].
Current research of AMPs is mainly focused on naturally occurring peptides, such as melittin from bee venom [7], cecropin from
insects or pig intestine [8,9], maculatin from skin of Australian tree
frogs [10], and several AMPs from plants [11,12]. There have also
been attempts to design synthetic peptides that exhibit antimicrobial activity [13,14]. However, these AMP resources are expensive,
infrequent and are not easy to produce in large scale. Therefore, commercial-scale production platforms to produce AMPs are
urgently needed. In this context, production of AMPs from soy protein may be an attractive, cost-saving alternative for commercial
consideration, because soy protein is an abundant and common
protein resource. In addition, AMPs from soy protein are considered
to be “natural”; these AMP segments show promise in replacement
of antibiotics in human health and animal feed. They can also find
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use in food safety as (i) antimicrobial coating in packaging film and
(ii) natural food additives. In this research, a method for identification of peptide segments with antimicrobial activity from soy
protein subunits is proposed. The applicability of this method is
demonstrated for the case of two main globulins from soy protein:
!-conglycinin (7S) and glycinin (11S). To the best of our knowledge, this is the first study that developed a methodology to identify
peptide segments with antimicrobial activity from a large protein
molecule. The proposed method avoids expensive experimental trials and would therefore decrease the cost of producing AMPs from
any natural protein.
7S is one of the most abundant storage proteins in soy, which
constitute 30–46% of the total water-extractable proteins in soy
[15]. 7S has a large molecular mass of 180–210 kDa [16] and a compact globular structure at physiological pH [17]. It consists of three
major subunits: ", "′ and ! [18]. 11S is also the major storage
protein of soybean. 11S has a molecular weight of 320 kDa [19].
The quaternary structure of this protein consists of five subunits,
namely G1, G2, G3, G4 and G5 [20]. 11S derived-peptides are generally more hydrophobic and prone to random aggregation [21].
Most of the known natural AMPs deactivate microorganisms
by pore formation. Pore formation by AMP in phospholipid bilayers begins by electrostatic attraction followed by attachment
and penetration of the cell membrane and has been subject of
several investigations [22–26]. Experimental techniques such as
fluorescent [27], oriented circular dichroism [24] and NMR [28]
spectroscopy, x-ray crystallography [24] have been employed to
monitor pore formation, secondary conformation of AMP, orientation of AMP and lipid as well as thinning of the membrane. Studies
using model membranes have elucidated different mechanisms of
pore formation by AMPs such as hydrophobic (Barrel-Stave) pore,
hydrophilic (toroidal) pore or micelle formation (carpet mechanism)
and have helped identify key factors that control pore formation
[23]. Molecular dynamics (MD) simulation, a technique in which
the evolution of positions of all atoms belonging to AMP when
interacting with phospholipid bilayer accounting for interatomic
interactions such as van der Waals, electrostatic etc. has been
employed to evaluate the potential energy of interaction [29], peptide conformation [30], peptide orientation [31] and deformation
of lipids [32].
In order to predict antimicrobial activity of a peptide, a combination of physicochemical properties and conformational features
such as size, charge, hydrophobicity, amino acid sequence, and secondary structure should be taken into account. Physicochemical
properties of some naturally occurring AMPs can be found in literature [33–36]. Higher hydrophobicity would result in lower free
energy of penetration of the peptide into the lipid environment. On
the other hand, hydrophobicity should not be so high as to make
the peptide insoluble leading to its aggregation in aqueous environment. Therefore, the hydrophobicity of the AMPs should be within a
desirable range as can be seen from the values for different naturally
occurring AMPs [33–36]. Most AMPs are positively charged which
facilities their attachment to the anionic bacterial cell membrane.
However, sufficiently high positive charge would result in higher
hydrophilicity thereby making it difficult for the peptide to penetrate into the lipid layer. In addition, high charge will also result
in high energy barrier for pore formation because of electrostatic
repulsion within the pore due to confinement of charge [37,38].
Several AMP prediction tools have been developed [39–45]. Current physicochemical prediction methods indicate that higher AMP
hydrophobicity increases its affinity to lipids [46] and higher positive net charge of AMP can result in increased interaction with
anionic membrane component [46]. Most physiochemical methods
use the "-helical peptide as the basis for their study. Consequently,
another important parameter is hydrophobic moment which is
an index of "-helix formation: peptides with higher hydrophobic

moment may have a favorable "-helical structure [46]. Many of
the current methods [39,42–45,47] for prediction of antimicrobial
activity are not mechanistic since they are based on comparison of
amino acid composition, charge, helicity and hydrophobicity with
corresponding properties of AMPs in the database. Consequently,
these methods cannot identify antimicrobial peptides with complex structure [48,49].
Naturally occurring AMPs are of limited availability. Designing
optimally active synthetic antimicrobial peptides (SP) by empirical screening of large numbers of potential candidates is cost
prohibitive. SP also suffers from the drawback of toxicity which
can be overcome by economical production of AMP from abundant common sources of protein. To address this, we developed
a methodology for identification of AMP segments from protein based on (i) their physicochemical properties and (ii) their
interaction with cell membrane mimic. The effect of different
physicochemical properties on the interaction of these peptides
with cell membrane mimic is ascertained using MD simulation.
Since the proposed methodology is mechanistic, it is capable of
accounting for interaction of AMP with the cell membrane of a specific microorganism. Consequently, the proposed methodology can
be employed to identify an AMP targeted for different microorganisms. We identified two AMP segments each from the 7S and 11S
subunits of soy protein and experimentally verified their antimicrobial activity against Listeria monocytogenes (L. monocytogenes)
F4244 and Escherichia coli (E. coli) O157:H7 EDL933. The method
described in this research can also be applied to identify AMP segments from other inexpensive proteins to produce value-added
products from these proteins and eventually, help broaden the
application of AMPs.
2. Materials and methods
2.1. Materials
Identified peptide segments were synthetized, purity >95%
(GenScript, USA). L. monocytogenes F4244 and E. coli O157:H7
EDL933, Trifluoroacetic acid (TFA) and Dimethyl sulfoxide (DMSO)
were from Sigma-Aldrich.
2.2. Selection of possible AMPs from soy protein subunits 11S and
7S
Possible AMPs segments were selected from five subunits from
11S: G1 (Uniprot: P04776), G2 (Uniprot: P04405), G3 (Uniprot:
P11828), G4 (Uniprot: P02858) and G5 (Uniprot: P04347) and
three subunits from 7S:" (Uniprot: P13916), "’ (PDB:1UIK) and
! (PDB:1UIJ), based on the criteria of (i) the number of amino
acids (20–30), (ii) net charge (>+2), (iii) Eisenberg scale hydrophobicity [50] (>−0.30 kcal/mol) and (iv) hydrophobic moment [51]
(>0.20 kcal/mol).
2.3. Molecular dynamics (MD) simulation in lipid bilayer system
The initial lipid bilayer structure for the simulation was
built using the CHARMM-GUI web tool [52]. The bilayer in the
simulation was represented by mixed 1-palmitoyl-2-oleoyl-snglycero-3-phosphocholine (POPC, neutral)/2-oleoyl-1-pamlitoylsn-glyecro-3-glycerol (POPG, negatively charged) in a 3:1 ratio
bilayer. POPC/POPG mixed bilayers are negatively charged membrane, mimicking bacterial membrane. The peptide/lipid ratio was
4/128 with four peptides inside the lipid system. Chosen peptides
were placed (i) inside the membrane in order to observe deformation of lipid membrane and formation of water channel, (ii) on
the surface of lipid membrane to observe the interaction of peptide and lipid membrane. 0.150 M KCl was added to neutralize the
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system. All-atom MD simulation was employed with Amber14 software package [53]. The snapshots were visualized using VMD [54]
software. Chosen peptides were placed (i) on the surface of lipid
membrane to observe the interaction of peptide and lipid membrane, (ii) inside the membrane in order to observe deformation of
lipid membrane and formation of water channel. Simulations were
also performed for peptide/lipid ratio of 6/128 with six peptides
in either transmembrane or surface states. These simulations were
performed for 3:1 mixed DOPC/DOPG lipid bilayer.

29

equilibrate the system followed by 50/100 ns production runs of
constant surface tension “!” (NP!T) simulation. Langevin dynamics
was employed with a collision frequency ! = 1 ps−1 . Semiisotropic
pressure scaling was used to maintain the pressure at 1 atm with a
constant surface tension value set to 15 dyn/cm. Nonbonded interactions were calculated with a cutoff at 10 Å; full electrostatics
was employed using the particle-mesh Ewald method. Covalent
bonds involving hydrogen atoms were held rigid with the SHAKE
algorithm, allowing a 2 fs time step.

2.4. Different initial structures
2.7. Bioassay and viability studies
Surface and transmembrane MD simulation were performed
for different initial structures for all peptides that are investigated
(G5466, G2250, 7a16 and 7a187). Initial structures from four different resources were involved in the MD simulation. The first and
second initial structures were obtained from online peptide structure constructor PEP-FOLD [55]. The two structures were chosen
as those with the largest structural difference (as quantified by
RMSD), and were coded as Model1 and Model2. The third structure was constructed based on an ideal helical structure and coded
as Helix, and the fourth initial structures, coded as Implicit, was
obtained from implicit MD simulation after 50 ns using AMBER14
software and AMBER ff99SBildn force field, as dielectric constant
set up to 20, which mimic the lipid environment. Table 1 lists the
initial structures in MD simulations that were performed for all the
peptides investigated.
2.5. MD simulation using CHARMM36 force field
Minimization of the structure to remove bad contacts and steric
hindrances is necessary before starting molecular dynamics calculations. Careful minimization before slowly heating the system to
303 K was performed: first, the configurational energy of the system was minimized by performing 100 steps of a steepest descent
algorithm with maximum 5000 minimization cycles. The proteinmembrane system, then, was relaxed prior to running production
MD to reach the target temperature (303 K). Molecular dynamics
simulation in the constant volume (NVT) ensemble was carried out
until the target temperature of 303 K was reached where the pressure is allowed to change so as to keep the volume of the box fixed.
Constant pressure (NPT) ensemble was used in the system simulation. Subsequent simulation ran at 303 K up to 500 ns with a
time step of 2 fs. Langevin dynamics was employed with a collision
frequency ! = 1 ps−1 . Pressure was maintained at 1 bar using semiisotropic pressure with the Berendsen barostat. Periodic boundary
simulations based on the particle mesh Ewald (PME) method was
carried out using NPT method, in which the temperature and pressure were kept constant and the volume is allowed to change, with
a cutoff at 8 Å.
2.6. MD simulation used Amber force field
AMBER ff99SBildn [2] force field (employed for the peptides)
and Lipid11 force field [3] (employed for lipid force field) were used
and the combination of these two force fields would be referred
to hereafter as Amber force field. Careful minimization to remove
bad contacts and steric hindrances was performed before slowly
heating the system to 303 K: first, the configurational energy of
the system was minimized by performing 2000 steps of a steepest
descent algorithm followed by 3000 steps of a conjugate gradient
algorithm [4]. The protein-membrane system, then, was relaxed
prior to running heating MD using constant pressure (NPT) to reach
the target temperature (303 K). During the heating, the position
of lipid atoms was kept fixed with harmonic constraints. A 5 ns
MD simulation at 303 K with a NPT ensemble was performed to

The potential candidates of peptide fragments from soy protein
for antimicrobial activity that were identified using MD simulation were commercially synthesized (GenScript, USA). 7a16 was
dissolved in 20% DMSO solution and 0.1% trifluoroacetic acid (TFA).
G2250, G5466 and 7a187 were dissolved in DI water with 0.1% TFA.
Antimicrobial activity of synthesized peptide (SP) fragments was
tested against L. monocytogenes F4244 (Gram positive) and E. coli
O157:H7 EDL933 (Gram negative) bacteria by using spot-on-lawn
test. The bacteria were stored as 10% frozen glycerol stocks in deepfreezer at −80 ◦ C. Prior to experiments, frozen stocks of bacteria
strains were added into a tube that contain 3.7% (w/v) brain heart
infusion (BHI) and incubated at 37 ◦ C for 24 h. Then 50 "L cultured
bacteria were transferred to 3 mL buffer that contain 3.7% (w/v) BHI
and 0.8% (w/v) agar. Next, the above solution was poured to a petri
plate followed by exposing to selected SP of different concentrations (10 "L each spots). The petri plates were incubated in 37 ◦ C
incubator overnight to observe the formation of inhibition ring.
Viability assay for the antimicrobial activity of 7a16 and G5466
was performed in 96 well micro-titer plate over a period of 7 h
by measuring absorbance (A595) every 30 min using a microplate
reader (Benchmark, BIO-RAD). 200 "L reaction volume was setup
in duplicate with sterile BHI broth inoculated with 5 × 107 cells of
L. monocytogenes and E. coli. For E. coli, 7a16 and G5466 were added
into the reaction volume at the concentration of 5, 2.5, 1.25, 0.63,
0.32 and 0.16 mg/mL. For L. monocytogenes, 7a16 was added into the
reaction volume at the concentration of 2.3, 1.15, 0.58, 0.29, 0.15
and 0.08 mg/mL, and G5466 was added into the reaction volume at
the concentration of 2.4, 1.2, 0.6, 0.3, 0.15 and 0.08 mg/mL.

3. Results
3.1. Identification of AMPs from soy protein
Initial screening of peptide segments belonging to soy protein subunits was undertaken based on physicochemical properties
such as total number of amino acids, hydrophobicity, hydrophobic
moment and charge. The criteria for screening was derived from
the physicochemical properties of many naturally occurring AMPs.
Proposed mechanism of pore formation by AMP in a cell membrane
(lipid bilayer) [23] suggest that they should first bind to the cell
membrane and subsequently aggregate within the bilayer to form
a transmembrane pore. In order to exhibit antimicrobial activity,
therefore, a peptide fragment should satisfy both criteria, namely,
(i) bind to membrane surface and (ii) its aggregate should form a
pore. Therefore, a surface MD simulation of peptide fragment was
first performed. In this simulation, peptide fragments were placed
on the surface and the evolution of their center of mass was tracked
to ascertain their ability to bind to the lipid bilayer. Those peptide
fragments were then subjected to transmembrane MD simulation
in which four molecules of the peptide were placed across the lipid
bilayer with their hydrophilic side chains facing inwards. These
simulation results indicated the ability of peptides to form a water
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Table 1
Number of initial structures performed in MD simulation.
Surface-membrane MD simulation

G5466
G2250
7a16
7a187

Trans-membrane MD simulation

Four peptides

Six peptides

Four peptides

Six peptides

Model1, Helix, Implicit
Model1, Helix, Implicit
Model1, Helix
Model1, Helix

Model1, Implicit
Model1, Implicit
Model1, Model2, Implicit
Model1, Model2, Implicit

Model1, Model2, Implicit
Model1, Model2, Implicit
Model1, Helix
Model1, Helix

Model1, Implicit
Model1, Implicit
Model1, Model2, Implicit
Model1, Model2, Implicit

channel across the membrane and hence a pore. The peptides that
satisfy both criteria are likely to exhibit antimicrobial activity.
3.2. Selection of possible AMP segments from soy protein
Fig. 1 shows an example of selecting possible AMP regions based
on physicochemical properties from soy glycinin G2 subunit. G2
subunit contains 485 amino acids; therefore, it would have 467
peptide segments with 20 amino acids per peptide. Hydrophobicity, hydrophobic moment and net charge were calculated for each
peptide, and the results are shown in Fig. 1. Peptide segments in
the red rectangular regions have hydrophobicity >−0.30 kcal/mol,
hydrophobic moment >0.20 kcal/mol and positive net charge ≥2,
criteria for selection of AMP that is based on properties of most naturally occurring AMPs, and therefore, are possible AMP candidates.
One peptide from five in the rectangular regions was chosen for further investigation since their sequences are similar. Possible AMP
candidates from other soy subunits with different peptide lengths
(20–30 amino acids) were calculated with the same selection criteria and the results are not shown. Four possible AMP candidates
(coded as G2250, G5466, 7a16 and 7a187) were selected from 11S
and 7S for further investigation, based on their physiochemical
properties, namely, their sequence, hydrophobicity, hydrophobic
moment and net charge (Table 2).
3.3. Surface-membrane MD simulation
Surface-membrane MD simulation was performed to evaluate
the potential antimicrobial activity of peptides G2250, G5466, 7a16
and 7a187 by investigation of their interaction with lipid bilayer.
These simulations were performed for multiple initial conformations. Four molecules of a peptide were placed on the top leaflet
of a 3:1 POPC/POPG mixed lipid membrane (a mimic of bacterial
cell membrane). The top view of their initial orientation and position are shown in Fig. S1. Here we present the results for one initial
conformation for illustrative purposes. The effect of different initial conformations on surface binding is discussed in Section 3.5.1.
Snapshots for G2250, G5466, 7a16 and 7a187 placed on the surface of mixed lipid membrane are shown in Fig. 2 and the distance
between center of mass of peptide and lipid membrane over time
is given in Fig. 3. After 500 ns MD simulation time, G5466 and 7a16
did not leave the lipid membrane and their center of mass remained
inside the bilayer indicating thereby that these peptides penetrate
the membrane. On the other hand, MD simulation results show
that only one out of four molecules of 7a187 remained inside the
lipid bilayer. This indicates that 7a187 would prefer water environment, and is not able to penetrate into the lipid membrane.
Therefore, 7a187 does not bind to the top leaflet of the lipid bilayer
and hence is unlikely to exhibit antimicrobial activity. 500 ns MD
simulation of G2250 revealed that some residues moved to the
aqueous environment outside the lipid membrane. Since more than
half of G2250 residues remained in the lipid bilayer, it is not clear
whether it prefers an aqueous or lipid environment. Therefore,
trans-membrane MD simulation was performed to further investigate peptide-lipid interaction.

3.4. Trans-membrane MD simulation
Transmembrane MD simulation was performed to investigate
the formation of a water channel (channel of water molecules
across the bilayer as indicated by non-zero water density) and
bending of lipid heads. The purpose behind transmembrane simulation is to ascertain the ability of transmembrane aggregates under
ideal conditions to form water channel. On the other hand, those
peptides that do form water channel will have high probability
of antimicrobial action. Therefore, the proposed transmembrane
simulation will screen peptides that cannot form a pore. These simulations were performed for multiple initial conformations. Here
we present the results for one initial conformation for illustrative
purposes. The effect of different initial conformations on water
channel formation is discussed in Section 3.5.2. A snapshot (at
500 ns) of a 3:1 POPC/POPG mixed lipid membrane in the absence of
peptide and the density profiles of water and lipid head are shown
in Fig. S2. Four molecules of a peptide were placed in the center
of the lipid membrane, with hydrophilic residues facing inwards.
Their initial positions are given in Fig. S3. Formation of a water channel indicates a pore and therefore potential antimicrobial activity.
Fig. 4 shows snapshots of MD simulation for the four peptides at
500 ns. Water channels as well as bending of phospholipid heads
can be observed for G5466, 7a16 and 7a187. Specifically for G5466
and 7a16, the bent phospholipids heads protrude into the peptides,
consistent with toroidal structure [23]. 7a187 tends to move to the
lower membrane leaflet. For G2250, no water channel formation
is observed and the bending of lipid heads is not significant. As a
result, it does not form a pore.
Normalized density profiles of water, lipid head and peptide
(Fig. 5) clearly indicate the formation of water channel and bending
of lipid heads for G5466 and 7a16, and no water channel formed for
G2250, which is consistent with the snapshot results (Fig. 4). Side
view of 2D density plots (Fig. 9), clearly show water channel for
G5466 and 7a16. Top views of water and peptide density profiles
also indicate pore formation. However for 7a187, the peptides lost
their original compact position as indicated by their contours in
lowest middle panel (Fig. 6), and therefore the water molecules do
not form a contiguous water channel. 2D density plot also clearly
indicates that no water channel formation occurs for G2250. Since
7a187 and G2250 do not satisfy both criteria, viz. peptide-lipid
binding and pore formation, they are not likely to exhibit antimicrobial activity. In order to investigate the effect of number of peptides
on the proposed methodology, we also performed both surface as
well as transmembrane calculations for G5466, 7a16 and 7a187
with six peptides and these results are given in SI (Figs. S4–S9).
MD simulation results with six peptides also indicated both binding as well as water channel formation for G5466 and 7a16. In
addition, MD simulation with six peptides for 7a187 also indicated
that it did not bind to the top leaflet though transmembrane peptides formed an unstable water channel. The results obtained with
six peptides were consistent with the results reported above for
four peptides. These results suggest that the proposed method for
antimicrobial activity is insensitive to the number of peptides (four
or six) employed in the MD simulation.
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Table 2
Possible AMP candidates from 11S and 7S.
subunits
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Fig. 2. MD simulation snapshots of four peptides placed on the top leaflet of 3:1 POPC/POPG bilayer for initial and 500 ns. Color code: yellow, POPC lipid heads; pink, POPG
lipid heads; deep blue, charged residues; green, polar residues; white, nonpolar residues. Lipid tails and water molecules are not shown for clarity. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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mixed lipid bilayer. The four peptides are denoted by different colors. (a) G2250; (b) G5466; (c) 7a16; (d) 7a187.

In order to ascertain the robustness of the above method for
identification of peptides for antimicrobial activity, the sensitivity
of this method to initial structure of chosen peptides as well as
number of peptides and force field was investigated. We present
these results in the following sections.

3.5. Effect of initial structures
3.5.1. Surface simulation
Table 1 lists the surface MD simulations that were performed
for all the peptides investigated. For illustration, here we present
only the results for one peptide (G5466) that binds to the bilayer
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Fig. 4. Snapshots of transmembrane MD simulation at 500 ns for four peptides placed across 3:1 POPC/POPG mixed lipid bilayer. Color code: grey, lipid tails; blue, water;
the other color codes are the same as that given in Fig. 2. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)

surface and for the second peptide (7a187) which does not bind.
Other results are not shown.
The binding affinity of G5466 for three different initial structures
were studied by performing MD simulation of four peptides that are
placed at the upper leaflet of the lipid bilayer. Model1 has a helicity
of 55%, Helix has a helicity of 100%. The third structure, Implicit
has a helicity of 0%. The helicity is calculated by DSSP method [56].
Fig. 7 shows the three initial peptide structures and snapshots of
peptides at 500 ns. From Fig. 7, one can observe that the peptide
remained inside the lipid bilayer after 500 ns simulation for all the
three cases.
The evolution of the distance between the center of mass of peptides and lipid membrane as shown in Fig. 8 further demonstrated
that all three initial structures are able to bind with the lipid bilayer
with all four peptides remaining inside the bilayer.
Fig. 9 shows the initial position of the hydrophobic and
hydrophilic residues of the peptides placed on the upper leaflet of
the bilayer. In all the cases, the distances of hydrophobic residues
from the center of mass of bilayer are smaller than those for
hydrophilic residues thus indicating that the former is facing inside
the bilayer. However, the distribution of distances for residues are

different for the three cases thus indicating that the orientation of
the residues are different. From Fig. 9, the initial structure coded as
Model 1 shows the most separation of hydrophobic and hydrophilic
residues, and the structure coded as implicit shows the most overlap of hydrophobic and hydrophilic residues on the upper leaflet of
the bilayer. Fig. 10 shows the evolution of distance of center of mass
of hydrophobic and hydrophilic residues from the lipid bilayer over
500 ns for three different initial conformations. As can be seen from
Fig. 10, the hydrophobic and hydrophilic residues tend to be separated within a short time of simulation (50 ns as shown in the inset
of Fig. 10); after 500 ns simulation, in all three cases, the hydrophobic residues are located at around 14 Å from the lipid center of mass
whereas the hydrophilic residues are located at around 17 Å. For the
initial peptide conformation coded as Implicit, which has the most
initial overlap of hydrophobic and hydrophilic residues, a clear separation of hydrophobic and hydrophilic residues can be seen during
the simulation. Similar qualitative behavior could be observed for
individual peptides in all the three models as can be seen from
Fig. S7 even though there are differences among individual peptides. This result indicated that irrespective of initial conformation
of peptides, the hydrophobic residues of the peptides tend to bind
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Fig. 5. Normalized density profiles of four transmembrane peptides in 3:1 POPC/POPG mixed membrane averaged from 300 ns to 500 ns: (a) G2250; (b) G5466; (c) 7a16; (d)
7a187. Solid line: water; dashed line: lipid; dotted line: peptide. The inset in these figures give the normalized density near the center of the bilayer in expanded scale.

into the lipid environment whereas the hydrophilic residues prefer to locate near the lipid head groups. These results demonstrate
that the binding affinity of peptides onto the top leaflet of lipid
bilayer is insensitive to their initial conformation. Similar calculations were performed for six 7a187 peptides for the three models.
The results of these calculations, namely, (i) snapshots of peptides at 500 ns (Fig. S8) (ii) the evolution of center of mass of all
six peptides (Fig. S9), (iii) the initial positions of hydrophobic and
hydrophilic residues (Fig. S10) and (iv) the evolution of center of
mass of hydrophobic and hydrophilic residues (Fig. S11) show that
the hydrophobic as well as hydrophilic residues move out of the
lipid bilayer for all initial conformations thereby further validating
the insensitivity of binding affinity to initial conformations.
3.5.2. Transmembrane simulation
The same peptide, coded as G5466 was used to study the effects
of initial structure on formation of water channel and bending of
lipid head. Model1 has a helicity of 55%, Model2 has a helicity of
60%. The third structure, Implicit has a helicity of 0%.
Fig. 11 shows the initial peptide structures and snapshots
for the three different structures inside POPC/POPG lipid bilayer
after 500 ns simulation. From the snapshots one can observe that
although their initial structure and helicity vary a lot, they all form
water channel, and the lipid head bending are all significant for all
three cases. For Model1, which is a helix and straight structure, the
four peptides kept vertical inside lipid membrane, and for Model2,
one peptide moved to the upper leaflet and the other three moved
to the lower leaflet. For the Implicit structure, all the four peptides
shifted to the lower leaflet.
The normalized density profiles along z direction for water
molecules, lipid head groups and peptides for the three structures

are given in Fig. 12. All three structures formed water channel as
indicated by their water density profiles. In addition, density distributions of bent lipid head groups are similar for all three structures.
The only difference is that for Model1, peptides stayed in the middle of lipid bilayer, whereas for Model2 and Implicit, most peptides
shifted to the lower leaflet, which is consistent with the snapshots
in Fig. 11. G5466 has four charged residues, one closes to its Nterminal, one in the middle and other two close to C-terminals.
With a straight structure (Model1), the charged residues are almost
evenly distributed inside bilayer; however, with bent structures
(Model2 and Implicit), the charged residue closest to N-terminal
bent inside lipid bilayer, thus resulting in accumulation of more
charged residues near the bottom leaflet. This is believed to be the
reason that Model2 and Implicit all moved toward the lower leaflet.
Besides water channel formation inside lipid bilayer and bending of lipid heads, one other indication of formation of a stable pore
is that the water channel is surrounded by peptides. From 2D density plots (Fig. 13), all three structures formed a clear water channel
(xz plane). For Model1, the coordinate of center of water channel
at xy plane is (5, −10), and the center of four peptide coordinate is
also (5, −10) at xy plane, which indicates the water channel formed
inside the peptides. Water channel was also observed inside the
peptides for Model2 even though the actual orientation of peptides
around the channel may be slightly different. Whereas for Implicit
structure, although the center of water channel is also same as the
center of peptides (−10, −10), the four peptides are not oriented
around the water channel. This could be an indication of an unstable pore, however, it is also possible that an oblique water channel
was formed instead of a vertical one.
Different initial structures of a peptide can result in different
evolution of its secondary conformations during MD simulation. In
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Fig. 6. 2D density plot of four transmembrane peptides placed across 3:1 POPC/POPG membrane. Density was averaged from 300 ns to 500 ns, showing water density (from
top), peptide density (from top) and water density (from side), respectively. The unit for coordinate is Å. Color bar represents the number of atoms.

addition, the peptide position inside lipid membrane can also be
affected, for the reason that with different structures, there is a different charge density over the length of the peptide. For example,
with a helical and straight structure, G5466 is able to keep vertical inside lipid membrane since its charged residues are almost
evenly distributed over the peptide. On the other hand, with a bent
structure, the charged residues could be accumulated on one side,
thereby resulting in excess electrostatic interaction which in turn
would attract the peptide to either lower or upper leaflet of the lipid
bilayer. However, different initial structures yielded the same qualitative features for the formation of water channel and deformation
of lipid membrane. In addition, the helicity is not a prerequisite for
water channel and lipid head bending. The result agrees with MD
simulation investigation on pore formation by melittin [57], which
indicated that melittin lost its helicity during the pore formation
but still water channel formation and lipid heads bending were
observed. Similar results were observed for the other three peptides, namely, G2250, 7a16 and 7a187, which are given in SI (Figs.
S12–S20).
3.6. Effect of force fields
Two force fields, Charmm36 and Amber were compared in this
study. Typical comparison of the two force fields is given in Fig. 10
depicting the snapshots at 200 ns of secondary conformational
change, number of lipid heads and number of water molecules in
the central region of lipid bilayer (z coordinates from −10 to 10 Å)

for peptide G5466. The initial simulation boxes that contain peptides, POPC/POPG 3:1 mixed lipids, water and ions were identical
for the two force fields.
Three major differences can be observed in between Charmm36
and Amber force fields from the snapshots at 200 ns for G5466
as shown in Fig. 14a. The helical peptide structure was maintained with Charmm36, whereas with Amber, there was partial
loss of helicity (Fig. 14b). Second, the membrane bending is
more significant for Charmm36. Third, although water channels formation occurred in both cases, the numbers of water
molecules in lipid bilayer is higher with Charmm36 than with
Amber (Fig. 14a). The evolution of number of lipid heads in
the bilayer central region as shown in Fig. 14c indicates that
bending of lipid heads occurred much earlier for Charmm36,
increasing to a value of 10, whereas with Amber, the number of lipid heads increased much slower attaining a value of
only 3. The number of water molecules inside bilayer is also
higher for Charmm36 than Amber. The comparison between
Charmm36 and Amber was also applied to other two structures for G5466, the results for snapshots and normalized water
and lipid heads density plots are given in SI (Fig. S21 to
S22).
Table 3 summarizes the comparison of Charmm36 and Amber
force fields on number of water molecules inside lipid membrane
and number of bent lipid heads. From the comparison, one can
note that the two force fields do not have a significant effect on
the number of water molecules inside lipid bilayer. Number of
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Fig. 7. MD simulation snapshots of G5466 with three different initial structures. Four peptides were placed on the top leaflet of 3:1 POPC/POPG bilayer for initial and 500 ns.
Color code: yellow, POPC lipid heads; pink, POPG lipid heads; deep blue, charged residues; green, polar residues; white, nonpolar residues. Lipid tails and water molecules
are not shown for clarity. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 11. Snapshots of MD simulation of three structures of G5466 at 500 ns for four peptides placed across 3:1 POPC/POPG mixed lipid bilayer. Color code: yellow, POPC lipid
heads; pink, POPG lipid heads; gray, lipid tails; blue, water; deep blue, charged residues; green, polar residues; white, nonpolar residues. (For interpretation of the references
to colour in this figure legend, the reader is referred to the web version of this article.)
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bended lipid heads in membrane is somewhat less with Amber
than Charmm36. This could be an indication that the lipid membrane with Charmm36 is more flexible. However, the results for
water channel formation was found to be the same for both force
fields. Therefore, the prediction of water channel formation for
transmembrane peptides is insensitive to the two force fields.

3.7. Bioassay and viability studies
As pointed out above, the peptides that satisfy (i) ability to bind
to top leaflet of lipid bilayer and (ii) ability for transmembrane
peptides to form water channel are likely to exhibit antimicrobial
activity. G5466 and 7a16 satisfied both criteria. In order to test
the validity of proposed methodology, we tested the antimicro-
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Fig. 13. 2D density plot of four peptides averaged from 300 ns to 500 ns, showing water density (from top), peptide density (from top) and water density (from side),
respectively. The unit for coordinate is Å. Color bar represents the number of atoms.
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G5466 with Charmm36 and Amber over time. (c) Number of lipid heads in lipid bilayer center z(−10, 10) for Charmm36 and Amber over time. (d) Number of water molecules
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bial activity of all four peptide segments against Gram positive L.
monocytogenes F4244 and against Gram negative E. coli O157:H7
EDL933 by spot-on-lawn assay, as shown in Fig. 15. Their susceptible MIC and inhibitory zone diameter are given in Table 4. No

inhibitory ring was observed for peptide G2250 and 7a187, whereas
G5466 is able to inhibit the growth of L. monocytogenes at concentration of 5.3 !M/mL and above, and E. coli at concentration of
10.1 !M/mL and above. 7a16 is able to inhibit the growth of both
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Fig. 15. Spot-on-lawn test of antimicrobial activity of G2250, G5466 7a16 and 7a187 against L. monocytogenes F4244 and E. coli O157:H7 EDL933. The inhibitory rings at
different concentrations are indicated by circles.
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Table 3
Comparison of Charmm36 and Amber with 3 structures.
Code

G5466 (Model1)
G5466 (Model2)
G5466 (Implicit)

Water inside bilayer

Lipid heads bending

Charmm36

Amber

Charmm36

Amber

+++
+++
+++

++
++
+++

++
+++
++

+
+
+

+++: significant; ++: medium; +: negligible.

L. monocytogenes at concentration of 5.0 !M/mL and above, and
E. coli at concentration of 19.8 !M/mL and above. Bacterial optical
density measurement (OD) for 7a16 and G5466 also indicates that
both peptides are more sensitive to L. monocytogenes with a minimum inhibitory concentration (MIC) of 0.91 !M/mL (7a16) and
1.02 !M/mL (G5466) (Fig. 16) respectively. Experiments could not
be performed at higher peptide concentration because of limited
solubility.
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Table 4
Susceptible MIC of G2250, G5466 7a16 and 7a187 against L. monocytogenes F4244 and E. coli O157:H7 EDL933 obtained by spot-on-lawn assay.
L. monocytogenes

G5466
G2250
7a16
7a187

E. coli

Susceptible MIC
(!M/mL)

Susceptible MIC
(!g/!L)

Zone Diameter
(mm)

Susceptible MIC
(!M/mL)

Susceptible MIC
(!g/!L)

Zone Diameter
(mm)

5.3
>49.4
5.0
>42.2

12.5
>100
12.5
>100

3.7
Not observed
7.5
Not observed

10.1
>49.4
19.8
>42.2

25.0
>100
50.0
>100

6.3
Not observed
10.8
Not observed

Table 5
Comparison of experimental antimicrobial activity with predictions by online AMP prediction tools.
Peptides

Experimental results

Our prediction

G2250
G5466
7a16
7a187

No
1.02 !M/mLa
0.91 !M/mLa
No

No
Yes
Yes
No

a

Online AMP prediction
APD

CAMP

DBAASP

iAMP-2L

AntiBP2

Yes
Yes
Yes
Yes

Yes
No
Yes
Yes

No
Yes
No
Yes

No
No
No
No

No
No
No
No

Corresponding to 2.4 mg/mL for G5466 and 2.3 mg/mL for 7a16 in OD measurement of MIC on the growth of Listeria monocytogenes.

3.8. Comparison with online prediction
In general, predictions of antimicrobial activity by different
online prediction tools did not agree with our results (Table 5).
Antimicrobial Peptide Database (APD) [39] and Collection of AntiMicrobial Peptides (CAMP) [42] predictions for 7a187 and G2250
as well as Database of Antimicrobial Activity and Structure of Peptides (DBAASP) [41] predictions for G2250 did not agree with our
experiments. iAMP-2L [47] and AntiBP2 [44] were unsuccessful in
predicting antimicrobial activity for G5466 and 7a16.

4. Discussion
The proposed methodology consists of three steps. The first
prescreening step is based on selection of peptides with physicochemical properties that are close to natural AMP. Based on MD
simulation that accounts for mechanistic peptide-lipid interaction,
subsequent two steps identify peptides (from prescreened candidates) that exhibit (i) binding affinity to surface of lipid bilayer
and (ii) ability of transmembrane peptide aggregates to form
water channel under ideal conditions. Consequently, the proposed
method is feasible with respect to its requirement of computational resources. The robustness of proposed methodology was
established by performing MD simulation for surface binding and
water channel formation for limited number of different initial
conformations. The proposed method identified the same peptides
for antimicrobial activity from the list of candidates (from initial
screening) when AMBER or CHARMM36 force fields were employed
in MD simulation. In spite of high hydrophobic moment, concentration of its charge near the C terminal favors G2250 to reside
near the top leaflet mainly due to electrostatic attraction (Fig. 4)
thereby preventing water channel formation. Although the physicochemical properties of 7a187 are similar to those of 7a16, high
total charge of 7 for the former results in it moving away from
the top leaflet into the water phase in surface simulation (Fig. 2).
High total charge also leads to its movement to the lower leaflet in
transmembrane simulation (Fig. 4), not conducive to water channel formation. Since adsorption of peptide is the first step in its
penetration into the cell membrane to form a pore, it is important
that the two criteria, namely, tendency to stay on the lipid surface
in surface simulation and water channel formation in transmembrane simulation be satisfied for antimicrobial activity. Unlike the
online prediction tools, this methodology accounts for the effect of
specific amino acid sequence of peptide on its interaction with cell

membrane. On the other hand, the current AMP prediction tools
are data based. Since APD [39] prediction is based on the assumption of helical structure, it does not give sufficient weightage to
the effect of charged residues and hydrophobicity on lipid-peptide
interaction. Since CAMP [42] and AntiBP2 [44] predictions are based
on existing antimicrobial peptide database, they are not mechanistic. The DBAASP [41] tool uses an algorithm of prediction based
on charge density, hydrophobicity, amphipathicity, location of the
peptide in relation to membrane, propensities to disordered structure and aggregation but does not account for the interaction of
lipid head and water molecular with peptides in its prediction.
iAMP-2L [47] takes physicochemical properties of each amino acids
(such as hydrophobicity, pK1 (C COOH),A pK2 (NH3 ), PI (25 ◦ C)
and molecular weight) into account in its fuzzy K-nearest neighbor
(FKNN) algorithm to predict antimicrobial activity and does not
consider structural features and amphiphilic characteristics. The
main drawback of all these online prediction tools is that they often
fail to predict antimicrobial activity of peptides that does not have
any similarity to existing peptides in their database.
The results show that both G5466 and 7a16 exhibit higher
antimicrobial activity to L. monocytogenes. This could be that L.
monocytogenes a Gram-positive bacterium, involves a single cytoplasmic membrane [58], whereas Gram-negative bacteria such as
E. coli have an outer membrane and an inner membrane [59],
which could increase the difficulty of penetration of AMPs into the
bacterial cell membrane thereby resulting in lower antimicrobial
activity.
We believe that our methodology is better than existing online
AMP prediction tools since it provides a detailed information on
the effects of charge distribution, amino acid sequence and secondary structure of peptide on its interaction with cell membrane,
and has the potential of predicting antimicrobial activity against a
specific microorganism and more importantly, it is feasible with
respect to its requirement of computational resources. We also
demonstrated the robustness of this methodology to number of
peptides employed in MD simulation, initial peptide structure and
force field. Our methodology is validated by the fact that the
antimicrobial activity of four peptides (G2250, G5466, 7a16 and
7a187) as predicted by the proposed methodology, based on the
ability of (i) surface peptides to bind to the cell membrane and
(ii) transmembrane peptides to form water channels in the cell
membrane, is consistent with the experimental measurements
against L. monocytogenes F4244 (Gram-positive) and E. coli O157:H7
EDL933 (Gram-negative). The proposed methodology, therefore,
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can be applied to identify new sources of AMP from several protein
sources.
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